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ABSTRACT 
 
Synchronized Multi-material Bioprinting of Hetero-cellular Models to Study  
Drug Efficacy in Co-culture 
 
 
Jessica Elizabeth Snyder 
Wei Sun, Ph.D. 
 
Bottom-up tissue engineering pursues automated process control over human tissue 
fabrication using the fundamental cellular, soluble, and architectural components as the working 
material. Key technology for methodological progress of bottom-up tissue engineering includes 
advanced biofabrication techniques to assemble viable biological material in 3-dimensional space 
and microfluidic devices to control timing and sequence of environmental stimulation. The 
presented research’s objective is the development of design, characterization and fabrication 
approaches which integrate physiologically relevant microfluidic techniques and hetero-cellular 
architecture for cell-laden models by leveraging combinations of the biofabrication techniques; 
including precision extrusion deposition, multi-nozzle cell printing, replica molding, and a novel 
synchronized multi-material bioprinting system. This research focuses on the development of a 
synchronized multi-material bioprinter for the fabrication of 3D hetero-cellular models. The 
specific research objectives are:  (1) combine multi-nozzle deposition system with a microlfuidic 
platform for controlled cell seeding in a microfluidic device for a hetero-cellular in vitro model for 
drug testing, (2) to define a 3D printing and replica molding processes to fabricate microfluidic and 
scaffold environments with control of the macro-scale (10-3-10-1 m) patterning of 
channels/structural elements and micro-scale (10-4-10-3 m) channel cross-section of internal 
features, (3) to develop and characterize an integrated synchronized multi-material bioprinter 
system to produce nano-liter droplets and 10-4-10-3 m diameter filaments with a heterogeneous 
packaging resolution of 10-5-10-3 m, and (4) to apply the synchronized multi-material bioprinter 
system to produce hetero-cellular models to study radioprotective drug efficacy in co-culture and 
xix 
 
metabolism rates in simulated weightlessness environments.  The presented biofabrication methods 
are applied to fabricate a hetero-cellular liver model to study drug efficacy of the pro-drug 
amifostine to shield liver from radiation genetic damage and pharmacokinetic up-take in model 
microgravity.  
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CHAPTER 1: INTRODUCTION 
1.1 Bio-inspired micro-devices for tissue engineering 
Tissue engineered in vitro models are reverse engineered from mature functional tissue’s 
fundamental elements, architecture and the physical stimulation acting in the environment. The 
fidelity of an in vitro model is evaluated by biochemical and physiological self-organization 
processes; which are strongly correlated in vivo to signaling and contact between cell types. 
Methods to improve in vitro model fidelity include co-culture conditions and greater biomimetic 
complexity. Model complexity is limited by biomanufacturing capability to assemble multiple cell 
types in macro/micro-scale architecture within a bioreactor system. 
Biomimetic benchmarks of an engineered in vitro tissue include defining the functional 
entities of mature functional tissue, heterogenous assembly of the defined entities, and a porous 
network for mass transfer of nutrients and removal of waste.  Physiological intelligence enables 
individual cells to behave collectively as agregates for tissue-level function both in vivo and in 
vitro. The stability of parenchymal cells, support role of non-parenchymal cell types and 
physical/chemical processes within a target tissue and between tissues are key facets of a tissue 
microenvirnment. Histological characterization of tissues, similar to a blueprint, defines the micro-
scale packaging of cell types, porous space and strutural matrix as well as and the macro-scale 
architecture of the tissue in relation to neighboing organism’s other tissues. High diffusivity of 
oxygen and other water soluble metabolites through an in vitro model correlate to viable cells and 
minimize cell death (Ling et al., 2007; Y. S. Song et al., 2009). A successful extra cellular matrix 
material mimics mass transfer characteristics, including porosity and polarity, to allow for adequate 
for nutrient/soluble factor exchange. Physical processes including cell’s anchoring substrate 
stiffness, mechano-stimulation by strain in an elastic matrix, shear stress due to fluid flow, electrical 
current in piezoelectic tissues (such as bone), and pressure from hydrostatic fluid column or 3-
dimensional culture.  
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Each application of an in vitro model has a target sensitivity and acceptable tolerance based 
on the nature of the study and manufacturing limitations. Prototyping a specific in vitro design 
within a defined tolerance is critical to evaluating performance in an iterative design cycle.  Key 
technology for methodological progress in microfluidic devices for drug discovery includes 
microfabrication techniques and 3-dimensional cell patterning. Miniaturization of perfusion system 
by microfabrication produces biomimetic interconnected network of channels (Becker, Carstens, 
Elbracht, & Gartner, 2010). Current techniques include photolithography, etching, and molding. 
Controlled cell assembly is required to produce specific cellular microenvironments and 
heterogeneous cell-to-cell contact (S. Khalil & Sun, 2009a). Design models use bottom-up tissue 
engineering to assemble modular cell environments to achieve biomimetic spatial and temporal 
interactions of soluble and biological cues. Current techniques include surface patterning by 
standard photolithography liftoff, photoreactive chemistry, micro-contact printing with lamination, 
molding, and photo-polymerization (Borenstein et al., 2007). Cell migration and separation after 
printing can be achieved by labeling cells with magnetic nanoparticles or gradient surface 
treatments to substrate.  Cell deposition techniques such as syringe-based cell deposition, rapid 
prototyping of hydrogel structures, and inkjet-based cell printing include cells as part of the 
working material to directly assemble biologics in 3-dimensional space (S. Khalil, Nam, & Sun, 
2005). A pumping mechanism is required to precisely transport volumes of liquid to induce specific 
transient delivery of soluble cues and hydrodynamic strain.  
Mature, functional tissue’s components, assembly and the physiological process between 
cells in niche microenvironments are characterized in literature. The biomimetic characterization 
is reverse engineered into bioreactor platforms to prescriptively stimulate cells with dynamic 
perfusion, cyclic strain and temporal gradients of soluble cues. In vitro cell-laden model use 
microfabrication techniques to engineer hetero-cellular architecture and mechanical stress cues in 
a bioreactor environment. Biomimetic fabrication leveraging advanced micro- and nano- 
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manufacturing improves in vitro cell model fidelity for (1) regenerative medicine to treat injury 
and disease with lab-grown implants, (2) therapeutic micro-devices, (3) mechanistic model of 
physiological process between cells in niche microenvironments and between tissue and (4) 
pharmaceutical trials on human cell models (Linda G. Griffith, Wells, & Stolz, 2014). Therapeutic 
tissue engineering successfully combined donor cells and scaffold material to culture bladder 
(Atala, Bauer, Soker, Yoo, & Retik, 2006) and trachea (Omori et al., 2005) tissue to be used as a 
surgical implant in human patients.  
Therapeutic micro-devices are reverse engineered to provide the function of tissue and organ 
system without building the device from the same components as native tissue. Therapeutic micro-
devices supplement existing bodily function without replacing existing tissue. Wyss Institute’s 
spleen-on-a-chip is an extracorpeal micro-device for sepsis therapy (Yung, Fiering, Mueller, & 
Ingber, 2009).  Sepsis blood is mixed with magnetic nano-beads by injection in the microfluidic 
device. An electromagnet removes the nano-beads with pathogens attached before the cleansed 
blood is collected. Magnetic nano-bead coated with MLB-fp1 binds to C. albicans fungus with an 
isolation efficiency above 99%.  
Human-on-a-chip network discrete cell-laden chamber to model the effect of drug on a 
specific cell model of a target tissue and model the sequence of pharmacokinetic and 
pharmacodynamic interaction downstream of the initial cell model (Marx et al., 2012).  Phylogenic 
distinctions between laboratory animals and human diminish the reliability of animal testing for 
acute systemic drug toxicity. An alternative testing system are micro-devices engineered to model 
the causality and sensitivity of mature functional human tissue. Microfluidic platforms are an 
enabling technology to network cell-laden compartments and control forced convection through 
the cell-laden models. Further, Further, bioreactor platforms include mechanical stimulation and 3-
dimensional heater-cellular arrangement for biomimetic cell-to-cell contact in niche 
microenvironments to capture physiology and pathophysiology (Ebrahimkhani, Neiman, Raredon, 
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Hughes, & Griffith). Liver-on-a-chip is of particular interest for applications to toxicity of small 
molecule drugs and observations of off-target reaction to proteins and regenerative therapies. A 
liver-on-a-chip model as a multi-chamber modular bioreactor uses low shear to model liver sinusoid 
hemodynamics (Mazzei, Guzzardi, Giusti, & Ahluwalia, 2010).   
Wyss Institute’s lung-on-a-chip mimics biochemical cell-to-cell contact using co-culture 
and cell mechanosensation during lung expansion/contraction using cyclic strain (Huh, Mammoto, 
Montoya-Zavala, & Ingber, 2010). The United Kingdom’s National Center for the Replacement, 
Refinement and Reduction of Animals in Research (NC3Rs) 2013 prize recognized Donald Ingber 
and the Wyss Institute’s lung on a chip as the most promising scientific advancement to reduce the 
use of animals in research ("UK: 3Rs Prize awarded to Donald Ingber for lung-on-a-chip device," 
2013).  Alternate sides of a permeable membrane are seeded with lung cells and capillary blood 
vessel cells. The membrane slides longitudinally into a channel, dividing the channel in half. The 
lung side of the channel is perfused with air and capillary side is perfused with human white blood 
cell-laden liquid to mimic the two phase’s arrangement in lung tissue. Cyclic strain of the cell-laden 
membrane due to suction of vacuum chambers on either side mimic in vivo expansion/contraction 
during breathing. Lung-on-a-chip studies include: (1) Infection and white blood cell response is 
studied by introducing bacteria to the air phase. Bacteria migrate from the air, through the cell-
laden membrane and become engulfed by white blood cells. (2)  Pulmonary edema (accumulation 
of fluid in the lung’s air sac) is observed in lung-on-a-chip model when the cancer drug known to 
cause pulmonary edema interleukin 2 (IL-2) is added to the liquid phase (Huh et al., 2012).  Fluid 
leakage is the same as physiological observations when cyclic strain is observed. Minimal fluid 
leakage is observed in the model without cyclic strain to mimic breathing. (3) Toxic effects of air-
born nanoparticles, confirmed in animal studies (Huh, Matthews, Mammoto, Montoya-Zavala, & 
Ingber, 2011).    
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In vitro phenotype stability and stem cell differentiation is also attributed to abiotic and 
biotic factors. Physical stress is a recurring stimulus to direct stem cell differentiation.  Nikukar et. 
al. of the University of Glasgow promoted osteoblastogenisis of human mesenchymal stem cells 
using mechanotransduction (Nikukar et al., 2013). Cyclic nano-scale displacement on the order of 
10-14 nm across the culture induced by a reverse piezoelectric caused a significant shift in total 
genomic expression towards osteogenic after 1 week of stimulation. Benishti and Cohen of Ben-
Gurion University of the Negev used physical conditioning to direct a culture of cardiomyocytes 
to reorganize into a stratified biomimetic structures (Shachar, Benishti, & Cohen, 2012). Daily 
treatments of 1 Hz 15% compression and fluid shear stress preserved cell-specific gap junctions 
and growth factors and cells self-assembled into a biomimetic stratified structure.    
Figure 1-1 presents images of the Griffith Lab’s liver-on-a-chip for high-throughput  drug 
toxicity and metabolism studies (left), Wyss Institute lung-on-a-chip co-culture model with 
breathing stimulation and air/liquid interface (center) and spleen-on-a-chip micro-device to clean 
pathogens from blood (right).  
 
Figure 1-1: State of the art bioinspiried micro-devices for tissue engineering. Bioinspiried micro-
devices mimic whole human organ function have the potential to replace animal testing and bring 
new therapies to patients faster and at a lower cost (Baker, 2011; Huh et al., 2011).  
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1.1.1   In vitro cell model for drug development 
Pre-clinical determinations of drug toxicity to liver would greatly improve screening 
technology (L. G. Griffith et al., 2005). The purpose of in vitro cell models is to represent in vivo 
performance. The challenge of in vitro models is to reverse engineer the spatial-temporal 
arrangements of the biology, chemistry and physics of the in vivo microenvironment within an 
acceptable tolerance. The acceptable tolerance compares the collective behavior of an in vitro 
culture to the behavior of tissue in the human body. In vitro models balance realism and simplicity 
to prevent false findings or misinterpretations (van der Meer & van den Berg, 2012).  Engineering 
in vitro models using prescriptive environmental stimulation and advanced manufacturing to 
assemble biological material in 3-dimensional space can enable self-organizing behavior in cells 
(Fischbach et al., 2007).  
In vitro models are relevant experimental, diagnostic and therapeutic tools (Sato & Clevers, 
2013). Experimental tool to study the cell behavior as a response to prescriptive biological, 
chemical or physical conditions. Diagnostic tool to investigate patient specific function and 
phenomenon. Therapeutic tool have applications to regenerative medicine.  Cell-laden microfluidic 
devices recreate in vivo cell-to-cell interactions, a current challenge in drug screening, through 
reproducible quantifiable patterning of spatial and temporal gradients (Dickson & Gagnon, 2004; 
Jensen, El-Ali, & Sorger, 2006; Shuler, Viravaidya, & Sin, 2004). Conventional cell culture of a 
monolayer on petri dish is a well-established methodology which has been optimized for various 
drug’s ADMES-Tox profiles in humans (van Midwoud, Verpoorte, & Groothuis, 2011). However, 
the fidelity of conventional models is limited due to local depletion of drug-metabolizing enzymes 
and transporters, lack of controlled cell seeding and static medium reservoir. Failure to predict drug 
toxicity by conventional culture methodology is considered the principle reason 90% of new drugs 
fail during Phase 1 preclinical tests (Brandon, Raap, Meijerman, Beijnen, & Schellens, 2003). 
Biomimetic extra-cellular cues, cell-to-cell contact and definable gradient of drug conditions are 
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engineered into microenvironments for high throughput measurement of toxicity and 
pharmacokinetics (S. Kim & Marimuthu, 2011; Wu, Huang, & Lee, 2010). Cell-laden microfluidic 
devices improve fidelity of in vitro platforms by physiologically relevant surface area to volume 
ratio, mass transfer by diffusion, biomimetic microenvironment engineering, dynamic perfusion, 
and dual organ model (Buyukhatipoglu, Chang, Sun, & Clyne, 2010a; Walker, Zeringue, & Beebe, 
2004).  
The advantage of drug discovery by cell-laden microfluidic devices is reproducible 
quantifiable control over the stimulation and patterning of biological material (Yeo, Chang, Chan, 
& Friend, 2011). Micron-scale quantities of cell-laden matrix and microfluidic channel produce a 
cell to interstitial fluid volume ratio of approximately one, as is physiologically relevant 
(Whitesides et al., 2010). The microfluidic length scale improves uniformity of temperature field 
and gas supply through cell laden matrix, induce laminar flow pattern and therefore mass transfer 
by diffusion. These factors reduce variability caused by proportions of experimental design. 
Hydrodynamic forces on the cells by extracellular fluid produce physical cues stimulate and direct 
cell function. Dynamic perfusion causes naturally occurring gradients of diffusing chemicals and 
produces controllable gradient of drug conditions. Cells are assembled in 3-dimensional 
biomimetic microenvironments to produce biomimetic morphology, cytoskeleton alignment, cell-
to-cell contact, focal adhesion of cell to matrix and signaling (Bornens et al., 2005). Lab-on-a-chip 
bioanalytic micro-systems introduce multi-component co-cultures to simulate an array of cells by 
external factors and signals secreted by the cells themselves to engineer a functional tissue. A 
controllable gradient of drug captures downstream effects of metabolized drug on target organ and 
conditions in parallel for physiologically-based pharmacokinetic (PBPK) models (Cheng et al., 
2009).  
Leading microfluidic devices use microfluidic systems and controlled cell seeding to 
produce cellular microenvironments to facilitate homotypic interaction by co-culture. Vasculature 
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and metatastic prostate cancer microfluidic models use co-culture to understand specific cytokines 
and growth behavior mechanisms (J. W. Song et al., 2009; Takayama et al., 2009). The effect of 
stem cells on cancer apopotosis is evaluated in vitro by unidirectional perfusion of a microfluidic 
device (Kong, Song, & Li, 2008). Microfluidic co-cultures of hepatocytes with non-parenchymal 
and stem cells are used to study 3-dimensional capillary morphogenesis and drug toxicity (Cheng, 
Novik, Maguire, Chao, & Yarmush, 2010; Kamm et al., 2009).   In these leading microfluidic 
devices, microfluidic channels are fabricated in an elastoployer by soft lithography with wet 
chemical etching or integrated on a polystyrene biochip and cell seeding is controlled by diffusion 
across matrix, semi-permeable membranes or time course introduction of cell types.  
1.1.2 NASA space life science interest 
NASA and its partners are committed to introducing appropriate new technology to enable 
learning and living safely beyond the Earth for extended periods of time in a sustainable and 
possibly indefinite manner. In the responsible acquisition of that goal, life sciences is tasked to tune 
and advance current medical technology to prepare for human health and wellness in preparation 
for long term manned missions. The space environment changes the condition and function of 
biological systems from organ system level function to the shape of individual organelles.  
The space environment causes psychological, physiological and pathological changes in 
biological behavior (Harris et al., 2010; Tamma et al., 2009; Vernikos & Schneider, 2010; 
Williams, Kuipers, Mukai, & Thirsk, 2009). Organ system level function to the shape and volume 
of individual cell organelles are effected by microgravity, stress, and radiation in space environment 
(Baqai et al., 2009b; Talbot, Caperna, Blomberg, Graninger, & Stodieck, 2010b). Biological 
systems in the space environment are subjected to a suite of environmental stimulation not present 
on Earth (F. A. Cucinotta, M. H. Kim, V. Willingham, & K. A. George, 2008a; Hellweg & 
Baumstark-Khan, 2007). NASA and its partners must characterize biological deviations between 
Earth conditions and space environment and possible vulnerabilities of current space flight 
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medicine. The effect of space stress and effectiveness of existing medical technology must be 
characterized to prepare appropriate health systems requirements. NASA and its partners are 
leveraging biomimetic design and microfluidics to fabricate in vitro ground models of biological 
systems. These closed systems with tunable dynamic perfusion allow provide researcher control 
over the environmental stimulation and transient interaction between various cell types.  
1.1.2.1 Radiation 
Space radiation is comprised of protons, helium nuclei, high-Z high energy ions and other 
high energy sub-atomic particles generated in secondary collisions with tissue and spacecraft (F. 
A. D. Cucinotta, M., 2009). Astronauts on the International Space Station are exposed to 50-2000 
mSv (milli-Sievert) of radiation over 6 months, compared 1.8 mSv for the average human on Earth 
over the same period (F. A. Cucinotta & Durante, 2006; F. A. Cucinotta, M. H. Y. Kim, V. 
Willingham, & K. A. George, 2008b).  Radiation effects biological tissue in the following two ways 
(1) impairment of tissue function due to significant cell death and (2) increased risk of 
carcinogenesis caused by genetic dysfunction due to DNA molecule damage. Additional health 
effects include increased incidence of early appearance of cataracts after low doses of space 
radiation, less than 8 mSv (F. A. Cucinotta et al., 2001). 
NASA’s Chief Health and Medical Office define permissible exposure limits for short term 
and career astronauts to limit the risk of exposure induced death from fatal cancer. A lack of proven 
radioprotective measures shortens an astronaut’s time in space and increases the risk of serious 
health complications. The risk of cancer morbidity due to radiation exposure in space significantly 
affects the longevity of astronaut’s careers and long term health.  NASA’s Human Research 
Program recognizes effective radioprotective measures as essential for interplanetary travel and 
long-term manned space exploration (F. A. Cucinotta et al., 2008b).  
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1.1.2.2 Microgravity 
Gravitational forces or the lack thereof effect dispersion of interstitial fluids in the body, 
cell secretion and therefore biochemistry of tissues, gene expression, and volume of individual 
organelles (Baqai et al., 2009b; Khaoustov, Risin, Pellis, & Yoffe, 2001; Talbot, Caperna, 
Blomberg, Graninger, & Stodieck, 2010a). NASA’s space life science enterprise studies cell 
function in microgravity to prepare clinical dosing requirements and pharmacological thresholds 
for long term manned space exploration. 
1.2 Biomimetic design considerations 
1.2.1 Forced convection and mechanosensation thresholds  
Forced convection of blood through the body’s tissues creates shear stress on cells anchored 
to lumen wall.  Also, shifting interstial fluid in the cell’s microenvironment physically deforms the 
cell’s lipid membrane and actin cytoskeleton, which activates pathways linked to the cell’s nucleus 
and gene expression (Hayward & Morgan, 2009; J. H. Kim et al., 2009). Mechanosensitive ion 
channels, such as the transient receptor potential (TRP) proteins, on the cell membrane respond to 
deformation in the lipid bilayer to sense the force of a vibration and osmotic membrane stretch 
(Kung, 2005). Cells are dynamic materials, which fluidize and reorganize under mechanical 
stretch.(Hayward & Morgan, 2009; Trepat & Fredberg, 2007) A cell actively responds to 
mechanosensation by realigning its cytoskeleton to counterbalance applied load.(Katsumi et al., 
2002; Matthews, Overby, Mannix, & Ingber, 2006) Elastic and inelastic distortion of the cell effects 
cell function.(Yang, Beqaj, Kemp, Ariel, & Schuger, 2000) The biological response to exogenous 
force is governed by both the initial input force and subsequent alteration in cell generated 
forces.(Guilak et al., 2009)  The mechanical stretch stimulates myosin motor activity which 
increases tension between the cell membrane and extracellular matrix.(Balaban et al., 2001; Pelham 
& Wang, 1999; Tan, Stronach, & Perrimon, 2003) The cell adapts to transient changes in the cell’s 
intracellular tension and any externally applied force by adjusting its membrane tensile force using 
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biochemical signaling as molecular feedback to the myosin motors.(Ridley et al., 2003; Sarasa-
Renedo, Tunc-Civelek, & Chiquet, 2006; Shiu et al., 2004; Torsoni, Marin, Velloso, & Franchini, 
2005; Zhao et al., 2007) Either of these stimuli may be sufficient to create a microenvironment for 
widespread reprogramming of function and possibly cell differentiation.  
In the liver, diffusion through a 3-dimensional network of microvasculature and bile 
canaliculi network carries nutrients, waste, and oxygen to parenchymal cells, hepatocytes, and non-
parenchymal cells, such as the Kupffer and stellate cells (Neville et al., 2008). The relative volume 
of interstitial fluid to cell matrix is approximately one to one in liver sinusoid. The hemodynamic 
system flow rate and architecture cause capillary and hydrodynamic forces acting on the cells. 
These forces physically strain cell membrane and actin cytoskeleton to induce biomimetic 
environmental stimulation and cell-to-cell contact necessary to maintain phenotype stability (L. G. 
Griffith et al., 2002).   
1.2.2 3D Heterotypic cell-to-cell contact for biomimetic in vitro function 
In vitro liver fidelity of acute drug toxicity, species specificity, and phenotype stability are 
improved by heterotypic interactions and 3-dimensional culture (Y. Kim, Larkin, Davis, & 
Rajagopalan, 2010; Y. Kim & Rajagopalan, 2010; Kostadinova et al., 2013).  Kim et. al. of Virginia 
Polytechnic Institute and State University mimics the hepatic sinusoid using stratified structure of 
hepatocytes, endothelial cells, and a polyelectrolyte surface to model the space of disse and 
biomimetic extra-cellular matrix modulus and hydration (Y. Kim et al., 2010; Y. Kim & 
Rajagopalan, 2010). In Kostadinova et. al. of Hoffmann-La Roche Ltd’s 3-dimensional liver co-
culture system, non-parenchymal cells synthesize an extra-cellular matrix through a screen between 
two interconnected nylon meshes (Kostadinova et al., 2013). Kostadinova‘s 3-dimensional co-
culture demonstrated increased sensitivity to acute drug toxicity, human vs. rat toxicology 
specificity, and up-regulated  3 out of 4 hepatic proteins to in vivo levels over 2-dimensional 
cultures. 
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The Hayflick phenomenon quantifies the number of times a normal cell is able to divide 
before cellular senescence (Hayflick, 1965). Wistar Institute researcher Leonard Hayflick 
empirically demonstrated normal human fetal cells divide 40-60 times before genetic 
transformation. Hayflick’s cultures were mono-layer cell sheets, fed with medium and stored in an 
incubator. More recent work stabilized epithelial cells for more than 1.5 years using a 3D in vitro 
culture environment and the extracellular matrix material Matrigel (Sato et al., 2009). In vivo the 
structure of intestinal crypts collapse as a result of local depletion of Lgr-4 and Lgr-5 Wnt signal 
enhancer.   
1.2.3 Tortuosity through the internal cell-laden features  
Macro (>10-3 m) external surface geometry and micro-scale (10-3–10-6 m) internal pore 
architecture and interconnectivity is controllable using bio-additive manufacturing techniques 
(Yoo, 2012). Yoo of Daejin University developed a library of internal pore architecture designs 
into a unit cell library to design and assemble entire scaffolds (Yoo, 2012). Yoo designed and 
fabricated a fully interconnected porous scaffold of pre-determined exterior and interior geometry 
using automated process using the intersection Boolean operation recursively (Yoo, 2012).  
Engineering scaffold permeability to decrease resistance of mass transport by shortening 
diffusion pathways improves scaffold performance (Pennella et al., 2013; Sachlos & Czernuszka, 
2003). Permeability of interconnected pore structures fabricated from mathematically defined 
scaffolds is greater than salt leached structures (F. P. Melchels et al., 2010b; F. P. W. Melchels et 
al., 2010). Controllable scaffold parameters are pore size and an interconnected pore structure 
which optimizes phenotype specific surface area preferences, cell migration, and mass transport 
profiles of nutrients and waste (F. P. W. Melchels et al., 2010; Oh, Park, Kim, & Lee, 2007; Owen 
& Shoichet, 2010; Sobral, Caridade, Sousa, Mano, & Reis, 2011). Sobral et. al. of the University 
of Minho manipulated the mechanical properties and cell seeding efficiency of a 3-dimensional 
scaffold by optimizing the internal pore structure and gradients using rapid prototyping techniques 
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(Sobral et al., 2011).  Pore size gradients of 750-100-750 and 100-750-100 µm increased cell 
seeding efficiencies from 30-40% for homogenous pore structures to 70% and 65% respectively. 
Oh et. al. of Hannam University published phenotype-specific scaffold pore size preferences based 
on in vitro cell proliferation over 8 weeks (Oh et al., 2007). Fibroblasts proliferation was fastest in 
186-200µm pores of the surveyed 88-405µm pore range, possibly due to increased surface area for 
greater cell attachment. Melchels et. al. of University of Twente mathematically defined the pore 
space in a scaffold to fabricate volume fraction and size gradients as well as variable pore structures 
(F. P. Melchels et al., 2010b; F. P. W. Melchels et al., 2010).  The Young’s modulus was greatest 
for cube structure and the scaffold’s deformation during loading was more homogenously 
distributed through gyroid structure than the cube (F. P. W. Melchels et al., 2010). Interconnected 
gyroid pore structure delays the formation of a cell colony covering the scaffold periphery and 
increases cell migration into the scaffold and mass transport, compared to salt-leeched scaffolds (F. 
P. Melchels et al., 2010b).  
1.3 Methodological progress toward a high fidelity in vitro model 
The key technological challenge for methodological progress of in vitro cell models is 
fabrication of the proportion and sequence of mass transfer through an in vitro micro-organ network 
(Derby, 2012).  The engineering solution is technology to control and stimulate cells, including 
abiotic environmental factors and biotic cell-to-cell signaling. Abiotic factors include forced 
convection through cell-laden architecture. Nutrient renewal/waste removal is controllable by the 
rate of forced convection using pumping mechanisms. The mechanical sensitivity of the cells in 
the flowing fluid is investigated or negated by the selection of the channel geometry and fluid speed. 
In vivo vascular networks modeled as microfluidic channels cell volume: fluid volume closer to 
the biomimetic 1:1 than conventional petri-dish culture of a mono-layer of cells in a pool of 
medium. Additionally, microfluidic platforms require less cells and soluble agents than petri-dish 
experimentation. Macro-scale patterning of cell-laden architecture by scaffold-guided tissue 
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engineering or 3D printing techniques produces explicit architecture. The macro-scale patterning 
is designed to fit patient specific implant sites for regenerative medicine applications and more 
generally ensure diffusion to the cell-laden core for in vitro models. Micro-scale patterning mimics 
in vivo cell-to-cell contact and hetero-cellular packaging. Table 1-1 presents the key technology 
for methodological progress in microfluidic technology for drug discovery.  Figure 1-2 presents 
resolution considerations (macro-, micro- and nano- ) to assemble biomimetic cell-laden 
architecture.  
Table 1-1. Key technology for methodological progress in microfluidic technology for drug 
discovery. 
 In Vivo Characteristic Advantage 
Enabling 
Technology 
Abiotic Forced convection through tissue 
Nutrient renewal/Waste removal 
Mechanosensation 
Pumping 
mechanism 
Abiotic Microfluidic vascular network 
Similar cell to fluid volume ratio 
Small sample size 
Microfluidic 
technology 
Biotic Macro-scale 
patterning 
Shaped to fit patient’s implant 
site 
Scaffold 
fabrication/3D 
printing 
Biotic Ensure diffusion of nutrients/waste removal Controlled cell 
seeding 
 Biotic Hetero-cellular packaging 
Cell-to-cell contact 
Embed structural components and 
nano-scale artifacts 
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Figure 1-2: Bio-additive techniques to control architecture and interconnectivity.  
1.3.1 Microfluidic technology 
Decisions regarding the biologically relevant sequence of events and criticality of separating 
up-stream and down-stream biological responses between cells along the device’s channel or 
between cell-laden compartments are considered. The pathway of the channels defines the sequence 
of events throughout the microfluidic system. The medium perfused through the channels is a 
source of nutrients and sink for waste, biologically synthesized proteins and other non-membrane 
bound paracrine/autocrine signals. Medium containing drug or other soluble cues is a source of the 
soluble cue and a sink for the metabolized drug or non-membrane bound biologically synthesized 
response to the drug. Dissolved cues lock-and-key bind to receptors on the cell’s plasma membrane 
or are engulfed by the cell. The cell responds to the binding or absorption action with changes in 
viability, self-organization, and signaling or gene expression over time.  Through a linear system 
with a single inlet and a single outlet the soluble cue first effects the biology closest to the inlet. 
Cells downstream of the inlet are effected by soluble cue itself and the response of the biology 
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upstream. The reaction time is controlled by the flow rate. The sequence of interactions between 
the drug and specific biological entities is controlled by distribution of such entities between the 
inlet and outlet. Channel patterns with a single flow path between the inlet and outlet strictly 
separate the reaction of the cells or distinct cell-laden compartments as a consequence of the up-
stream biology. Channel patterns with a network design where channels cross cannot as easily 
separate up-stream and down-stream facets of the biological response. However, the bifurcating 
flow patterns of a network design may better model the micro-circulation and hydrodynamics 
forces present in mature, functional human tissue.  
1.3.2 3-dimensional controlled cell seeding 
Interfacing biology and architecture in built biological systems with reproducibility and 
engineering process control requires advanced manufacturing (Hamid, Wang, Zhao, Snyder, & 
Sun, 2014; W. Sun, Starly, Darling, & Gomez, 2004). Bioprinting is a computer aided 
manufacturing method with process control over (1) macro-scale (10-3-10-1 m) architecture and (2) 
micro-scale (10-4-10-5 m) heterogeneous packaging of components and internal features. Cell 
printing assembles biologics during scaffold fabrication to avoid characteristically low cell seeding 
efficiencies and asymmetric distribution caused by seeding post-fabrication (Li, Ma, Kniss, Lasky, 
& Yang, 2001; F. P. Melchels et al., 2010b).  Colonization on periphery of the scaffold due to cell 
seeding process or limited mass transport through the scaffold prevent viable 3-dimensional 
colonization to the interior of the scaffold. Incorporating cells into the scaffold fabrication process 
provides controlled cell seeding for uniform cell density or pre-determined cell assembly.   
Macro-scale architecture is critical if the built biological system is designed to physically fit 
into a larger system.  Micro-scale heterogeneous packaging of organisms and support artifacts is 
critical to the function of the built biological system. Additional artifacts heterogeneously packed 
with the biology during printing spatial-temporally effect the built system’s mechanics, physics, 
and chemistry. Artifact candidates include - load bearing structural elements (Hamid et al., 2011; 
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Shor, Guceri, Wen, Gandhi, & Sun, 2007), open porous network for diffusion(S. Khalil & Sun, 
2009b), and magnetic nanoparticles(Buyukhatipoglu, Chang, Sun, & Clyne, 2010b).  
The advantage of multi-nozzle deposition are summarized as (1) controlled chemical cross-
linking, (2) 3-dimensional porous network for controlled gas and soluble cue exchange, and (3) 
heterogeneous 3-dimensional scaffold assembly.   
1.3.2.1 Controlled Chemical Cross-linking 
One fast effective method to form rigid polymer formations is chemical cross-linking. A 
cross-linking solution polymerizes a pre-polymer via contact during a reaction time. Controlled 
extrusion of both the pre-polymer and cross-linking solution is desirable to pattern the polymer 
structure and control volume fraction of both solutions in the reaction environment. Two techniques 
for the controlled extrusion include (1) single and (2) dual nozzle printing. Single nozzle printing 
requires mixing the matrix material and cross-linker before loading them into the dispensing 
chamber. Cross-linking begins when the two components are combined; prior to printing. Dual 
nozzle printing requires each component to be loaded into separate nozzles, and then extruded 
simultaneously. Mixing would take place during extrusion. Figure 1-3 presents a schematic and 
photograph of both techniques.   
Single nozzle printing has a greater risk of nozzle occlusion and introduces geometric 
variation into scaffold architecture. The process parameters and applied pressure to extrude the 
material are constant during the printing episode. As the scaffold is printed and time passes since 
the components were combined, the degree of cross-link and viscosity of the printed solution 
increases. The applied pressure to extrude the solution remains the same, while the viscosity is 
increasing. Therefore, the diameter of the extruded strut will be decrease as the printing episode 
continues. Additionally, layers must be cross-linked prior to addition of subsequent layers. If the 
first layer is cross-linked, then the remaining material in the nozzle must also be cross-linked, as 
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components were combined at the same time. This means the nozzle is occluded and printing is not 
possible. Dual nozzle printing solves the occlusion risk and geometric variance by combining the 
components on the scaffold.   
Dual nozzle printing allows the investigator to more fully leverage the multi-nozzle 
deposition system’s capability to reproducibly print polymer scaffolds. Dual nozzle printing 
requires each component to be loaded into separate nozzle, and then extruded simultaneously. 
Mixing would take place after extrusion. The risk of occlusion can be mitigated by the position of 
the nozzles. Additionally, the fluid properties of the solutions remain constant during printing. 
Multi-nozzle deposition process parameters are tuned to control the volume fraction of both the 
pre-polymer and cross-linking solution during printing.  Printing will be conducted using the dual 
nozzle printing set-up.  
 
Figure 1-3: Single (left) and dual (right) nozzle techniques for controlled extrusion of pre-
polymer and cross-linking solution. The flow rate of each nozzle in dual set-up is independently 
controlled.  
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1.3.2.2 3D Porous Network for Controlled Gas and Soluble Cue Exchange 
Fabrication of defined pore dimensions is a significant challenge of scaffold guided tissue 
engineering.  Oxygen diffusion is limited to 100µm (Sant, Hancock, Donnelly, Iyer, & 
Khademhosseini, 2010). In vitro control over the principle spatial features of vascularized solid 
tissues (the  lumen, endothelium, and extra-vascular space) regulates and balances mass transfer in 
3-dimensional cell-laden constructs (Miller et al., 2012).  Engineering control over the multi-scale 
architecture of pore channels and junctions, as well as lumen diameter and circularity are key 
advantages of bio-additive manufacturing. Miller et. al. of the University of Pennsylvania templated 
a porous network through a 3-dimensional cell-laden construct using a printed carbohydrate glass 
scaffold (Miller et al., 2012). Cell viability and function is improved over non-perfused models for 
near-physiologic cell densities. The porous network is templated using a carbohydrate glass 
scaffold fabricated using 3-dimensional printing and temperature controlled pneumatically driven 
extrusion.  
Printed scaffolds assume two complementary environments (1) open network for diffusion 
of gas and soluble cues and (2) printed polymer. Figure 1-4 presents photographs of two 10+ layer 
scaffolds fabricated by multi-nozzle deposition. The cell-laden environment and open pore network 
for diffusion are engineered to maintain cell viability from the scaffold surface to the core. The 
additive manufacturing process uniquely offers control over internal scaffold architecture.   
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Figure 1-4: Porous printed scaffold by multi-nozzle deposition system. Scaffold is a 10-layer 3-
dimensional scaffold of printed polymer square waves. Scaffold contains two complementary 
environments (1) open network for diffusion of gas and soluble cues and (2) printed polymer. Alg 
(left) and mineralized Alg -Alg-HA (right) scaffold pictured.  
1.3.2.3 Heterogeneous 3-Dimensional Scaffold Assembly 
Cell printing assembles biologics during scaffold fabrication to avoid characteristically low 
cell seeding efficiencies and asymmetric distribution caused by seeding post-fabrication (Li et al., 
2001; F. P. Melchels et al., 2010b).  Colonization on periphery of the scaffold due to cell seeding 
process or limited mass transport through the scaffold prevent viable 3-dimensional colonization 
to the interior of the scaffold. Incorporating cells into the scaffold fabrication process provides 
controlled cell seeding for uniform cell density or pre-determined cell assembly within a scaffold.  
Macro (>10-3 m) external surface geometry and micro-scale (10-3–10-6 m) internal pore 
architecture and interconnectivity is controllable using bio-additive manufacturing techniques 
(Yoo, 2012). Yoo of Daejin University developed a library of internal pore architecture designs 
into a unit cell library to design and assemble entire scaffolds (Yoo, 2012). Yoo designed and 
fabricated a fully interconnected porous scaffold of pre-determined exterior and interior geometry 
using automated process using the intersection Boolean operation recursively (Yoo, 2012).  
Multi-nozzle deposition for scaffold printing is expanded to multiple materials with 
additional print heads. Each print head is loaded with a unique material. Each print head is 
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independently controlled to fabricate specific macro- and micro- scale architecture. Architecture 
includes the pattern of the printed polymer, volume fraction of disperate materials, width of the 
printed strut, and layer-to-layer height.  Figure 1-5 presents photographs of multi-material scaffold 
printing by multi-nozzle deposition. Scaffold is assembled by additive manufacturing layer-by-
layer. The technique offers control over internal architecture of the scaffold.  
 
Figure 1-5: Heterogeneous 3D Scaffold Assembly by Multi-Material Deposition. Printed 3-
dimensional multi-material scaffold fabricated by multi-nozzle additive manufacturing. Yellow 
and green polymer solutions are individually extruded into square wave pattern from independent 
nozzles. Dispensing capillary tip is raised up away from printing substrate to print additional 
layers on previous layers to fabricate 3-dimensional scaffold.  Final scaffold is 3 layers. Each 
layer is a nested yellow and green polymer solution.  Images are in time sequence from 1-6.  
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1.3.3 Hetero-cellular packaging 
The objective of biomimetic design for tissue engineering applications is to reverse engineer 
the in vivo performance and responsiveness of a target tissue or set of tissues in a lab environment 
based on histology and physiology. The framework of concepts for biomimetic design includes 
define key structure-function relationships, support simplifying assumptions and design within 
manufacturing limitations (Hoganson et al., 2010; Nawroth & Parker, 2013).  A novel synchronized 
multi-material bioprinter (SMMB) deposition head packages discrete solutions in a controllable 1-
dimensional array to be printed as a heterogeneous filament or nano-liter droplets. The printhead is 
integrated with the bio-additive manufacturing technique multi-nozzle cell printing’s design model, 
motion, and material delivery sub-systems. 
Bio-additive manufacturing techniques for cell-laden 3-dimensional scaffolds and 
microfluidic devices are an enabling technology for high fidelity in vitro liver models. Yamada et. 
al. of Chiba University engineered a microfluidic device to package hepatocytes, endothelial cells, 
buffer, and gelation solution in a single outlet stream as a heterotypic hepatic fiber (Yamada et al., 
2012). Independent regulation of each solution’s flow rate controls the fiber diameter and the 
proportion of each phenotype to biomimic native liver. Heterotypic and homotypic interaction 
preserved in vitro liver-specific function during the 90 day study. A novel synchronized multi-
material bioprinter (SMMB) deposition head packages discrete solutions in a controllable 1-
dimensional array to be printed as a heterogeneous filament or nano-liter droplets. The printhead is 
integrated with the bio-additive manufacturing technique multi-nozzle cell printing’s design model, 
motion, and material delivery sub-systems. 
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Figure 1-6: Heterotypic hepatic fiber of hepatocytes and endothelial cells fabricated using a 
microfluidic device (Yamada et al., 2012) and schematic of 1-dimsensional array of hepatic 
tissue. 
Microfluidic techniques assemble multiple material inlets in a single outlet channel without 
mixing due to low inertial forces in micro-scale cross-sectional channels. SMMB deposition head 
leverage non-mixing microfluidic flow to combine multiple materials in a heterogeneous array 
prior to deposition. SMMB improves printing resolution over MND and offers the opportunity for 
mass transfer and chemical reactions, such as partial cross-linking, prior to deposition. The SMMB 
deposition head design process is as follows: (1) Component materials are selected based on 
composition of the target mature, functional tissue, support material, and requirement for cross-
linking solution. (2) The arrangement of the materials is defined based on cell-to-cell contact in 
vivo and construction requirements. The volume fraction of each constituent component can be 
dynamically varied during the build cycle and is not restricted by the channel network in the 
deposition head. (3) The layout of the channel network is defined to assemble the materials 
heterogeneous layered method or axisymmetric style, as presented in figure 1-7.  
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Figure 1-7: Microfluidic network layouts for homogenous, heterogeneous, axisymmetric, and 
asymmetrical combination of up to three materials. 
Unit cell design of a fiber cross-section printed using synchronized multi-material (SMMB) 
system. Solutions may include cell-laden, chemically reactive, sacrificial support material to 
produce void space. Volume fraction of each solution can be tuned using the flow rate controlled 
by programmable syringe pumps. Assembly of solutions is controlled by the design of the 
microfluidic system. Conventional 2-dimensional microfluidic system can produce 1-dimensional 
array of solutions. A more sophisticated 3-dimensional microfluidic system can produce a 2-
dimensional array of solutions.  
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Figure 1-8: Unit cell design of a fiber cross-section printed using Simultaneous Multi-Material 
Print head  and Bioprinter System. Solutions may include cell-laden, chemically reactive, 
sacrificial support material to produce void space. Volume fraction of each solution can be tuned 
using the flow rate controlled by programmable syringe pumps. Assembly of solutions is 
controlled by the design of the microfluidic system.  
Conventional 2-dimensional microfluidic system can produce 1-dimensional array of 
solutions. A more sophisticated 3-dimensional microfluidic system can produce a 2-dimensional 
array of solutions.   SMMB channel networks to combine multiple materials in a 1-dimensional 
array are presented in figure 1-9. 3-dimensional SMMB deposition head channel networks enable 
more sophisticated 2-dimensional heterogeneous array of multiple materials. Figure 1-10 presents 
3-dimensional SMMB channel networks to assemble multiple materials in a 2-dimensioanl array. 
3-dimensional features such as arches and channels joining from the top (not just left and right) are 
required to achieve the presented 2-dimensional array in the SMMB combined flow outlet channel.  
26 
 
 
Figure 1-9: Front/right/section view of homogenous (left), layered (center) and axisymmetric 
(right) 2-dimensional SMMB deposition head channel concepts to assemble multiple materials in 
1-dimensional array. 
 
Figure 1-10: Front/right/section view of homogenous (left), layered (center) and axisymmetric 
(right) 3-dimensional SMMB deposition head channel concepts to assemble multiple materials in 
2-dimensional array. 
1.4 Research objective and approach 
The objective of the presented research is the development of design, characterization and 
fabrication approaches which integrate physiologically relevant microfluidic techniques and 
hetero-cellular architecture for cell-laden models by leveraging combinations of the biofabrication 
techniques precision extrusion deposition, multi-nozzle cell printing, replica molding, and a novel 
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synchronized multi-material bioprinting system. This research focuses on the development of a 
synchronized multi-material bioprinter for the fabrication of 3D hetero-cellular constructs. The 
specific research objectives are:   
1. To combine multi-nozzle deposition system with a microlfuidic platform for controlled 
cell seeding in a microfluidic device for a hetero-cellular in vitro model for drug testing.  
2. To define a 3D printing and replica molding processes to fabricate microfluidic and 
scaffold environments with control of the macro-scale (10-3-10-1 m) patterning of 
channels/structural elements and micro-scale (10-4-10-3 m) channel cross-section of 
internal features.  
3. To develop and characterize an integrated synchronized multi-material bioprinter 
system to produce nano-liter droplets and 10-4-10-3 m diameter filaments with a 
heterogeneous packaging resolution of 10-5-10-3 m.  
4. To apply the synchronized multi-material bioprinter system to produce hetero-cellular 
models to study radioprotective drug efficacy in co-culture and metabolism rates in 
simulated weightlessness environments.   
The presented biofabrication methods are applied to fabricate a hetero-cellular liver model 
to study drug efficacy of the pro-drug amifostine to shield liver from radiation genetic damage and 
pharmacokinetic up-take in model microgravity. An outline of the biomiemtic condition, 
biomanufacturing processes and apllication are presented in figure 1-11.  
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Figure 1-11: Outline of the presented research approach to combine biomanufacturing processes 
to achieve physiologiclaly relevant hetero-cellular architecture and perfusion with microfluidic 
and cell printing enabling technology.  
1.5 Thesis outline 
This thesis outline is as follows:  
Chapter 2 develops 3D printing and replica molding processes to fabricate interconnected 
and hierarchical structural environments for cell culture. Two different 3D printing and replica 
molding processes are introduced: (1) a precision extrusion deposition and replica molding process 
to produces microfluidic networks and (2) a multi-nozzle deposition and freeze casting process to 
produce hierarchical tissue scaffolds.   Both 3D printing processes integrate a 3D motion system 
with a continuous extrusion material delivery system to print patterns of the extruded filament. 
Internal features and external surfaces are explicitly assembled due to the layer-by-layer 
construction of the printed pattern. The 3D printing process parameters control the macro-scale 
structure of the printed pattern/void space (10-3-10-1 m resolution) and extruded cross-section’s 
shape and size (10-4-10-3 m). Once fabricated, the printed pattern is embedded in a liquid-phase of 
a secondary material, which is subsequently cured. The composite printed pattern/ secondary 
material is either directly used or the printed pattern is removed, leaving a template of open 
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channels or pores. Cell-material attachment is presented. The presented processes introduces the 
capability to fabricate 3D hierarchical, composite or porous/open channel architecture for scaffold 
guided tissue engineering.  
Chapter 3 integrates the advanced biomanufacturing techniques developed in chapter 2 to 
fully construct a hetero-cellular microfluidic devices for drug efficacy applications.  3-dimensional 
open channel networks fully embedded in PDMS are fabricated by precision extrusion deposition 
(PED) and replica molding. Forced convection through the channels is controlled by additional 
hardware components and a programmable syringe pump. Cell suspension is pumped into the 
device, left static for 12-24 hrs for adhesion and then perfused for nutrient supply/waste removal.  
Alternatively, multi-nozzle deposition (MND) for hetero-cellular seeding throughout the network 
and in channel cross-section defines the position of cell types, support material and matrix. 
Applications of the system include space life science in vitro models to study radioprotective pro-
drug efficacy in co-culture. Hetero-cellular contact is controlled by forced convection through a 
multi-chamber co-culture microfluidic device. Cell-laden devices are stimulated with 
radioprotective drug and radiation exposure to study drug efficacy in co-culture compared to mono-
culture microfluidic devices.   
Chapter 4 develops the synchronized multi-material bioprinting (SMMB) system to package 
different cell types and structural matrix material in a heterogeneous array and extrude the 
heterogeneous array along a tool path to build 3D biology-laden structures. The fully integrated 
system includes a 3D motion system, multi-nozzle material delivery system with synchronized 
multi-material deposition head and temperature control system. The 3D motion system is a set of 
three linear slides, each independently controlled by automation software. The motion system is 
used in two ways (1) as a linear build cycle discretizes a design into a stack of 2D tool paths for 
layer-by-layer construction or (2) as a periodic build cycle to control the accumulation and 
dispensing of a predetermined material volume. The multi-nozzle material delivery system with a 
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synchronized multi-material deposition head packages tissue matrix material-laden with cells and 
complementary support material in a heterogeneous array. The heterogeneous array is extruded 
along a tool path to produce a pattern (linear build cycle) or controlled total volume with constituent 
volume fractions of the component materials is dispensed (periodic build cycle). The resolution of 
internal features of the heterogeneous array is 10-5-10-3 m, which improves the motion system’s 
extruded filament patterning capability of 10-3-10-1 m.  Additional nozzles containing other 
heterogeneous arrangements, support material or crosslinking agents are each is independently 
controlled by automation software. A temperature control system expands the feasible set of tissue 
matrix materials to include thermally cross-linked materials such as Matrigel and collagen. The 
effect of the process on cell viability is presented.  
Chapter 5 characterizes the synchronized multi-material bioprinting system’s controllability 
and capability to fabricate heterogeneous nano-liter droplets and   104-10-3 m diameter printed 
filaments. Applications of the system include space life science in vitro models to study metabolic 
rate and drug efficacy in co-culture. Printed hetero-cellular droplets are loaded into high aspect 
ratio vessels and conditioned to weightlessness using a rotary cell culture system to study drug 
metabolic rate in model microgravity.    
Conclusions of the conducted research and recommendations for future work are presented 
in Chapter 6.  
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CHAPTER 2: 3D PRINTING AND REPLICA MOLDING PROCESS FOR 
HETEROGENEOUS CELL CULTURE ENVIRONMENTS 
2.1 Rationale 
3D printing of porous scaffolds produces a built volume containing a minimum of two 
complementary microenvironments; one of the printed material and one of the porous void space 
surrounding the printed material. After the material/void space is defined during 3D printing build 
cycle, the void space can be filled with a secondary material. The secondary injected material is 
not constrained by rheological limitations or damaged by physical or thermal stress during printing. 
The second material can be more or less viscous than the manufacturing process requires or more 
sensitive to phyiscal or chemical degradation than printed materials. Injection and replica molding 
extend the advantages of additive manufacturing to include a greater library of materials and 
heterogenous multi-material designs. Advantages include controlled formation of internal features 
during the build cycle and heterogeneous placement of multiple materials throughout the 3-
dimensional volume.  In this work, PDMS elastomer and ceramic slurry are injected into 3D printed 
structures after fabrication. The resultant structure is heterogeneous and multi-material. Replica 
molding to remove the original printed scaffold from the second material creates a void space 
templated from the printed structure. In this work, two distinct processes are introduced which 
leverage 3D printing to fabricate two types of open channel networks: (1) a microfluidic network 
of open channels in a PDMS substrate and (2) hierarchical porous networks in a ceramic scaffold.  
2.2 Precision extrusion deposition and replica molding of microfluidic networks 
2.2.1 Purpose and description of method 
The purpose of the fabrication method is to produce an interconnected 3-dimensional 
network of open channels with process control of the channel’s cross-sectional width and height to 
10-3 -10-4 m throughout the network. Conventional subtractive manufacturing methods to produce 
an open network of channels leverage chemical reactions or physical bombardment to remove 
material. The current challenge of subtractive techniques is control of the network’s internal 
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features across multiple layers. Replica molding addresses this challenge using template structures, 
which are removed after molding to produce open porous space and channel networks. Therefore, 
the formability advantages of additive manufacturing are applicable to the design and fabrication 
of void space, including microfluidic networks.  
Fabrication of a microfluidic network for multi-material deposition head or device is an 
indirect 3-dimensional printing process.  Step 1 is the design of the microfluidic network. The 
design includes the macro-scale pattern of the network (10-1-10-3 meter) and micro-scale channel 
cross-section (10-3-10-4 meter). Step 2 is printing the design by precision extrusion deposition. The 
tool path is generated from the design’s macro-scale pattern. The design is discretized into a stack 
of 2-dimensional layers. Each layer is printed, one on top of another, to produce the complete 3-
dimensional design.  Manufacturing process parameters are selected to control the flow rate and 
consequently the dimension of the extruded filament’s cross-sectional width and height. Step 3 is 
replica molding of the printed pattern in polydimethylsiloxane (PDMS). Printed pattern is either 
attached to a surface and covered with uncured liquid PDMS or suspended in a pool of PDMS. 
PDMS fully cures over 48 hours at room temperature. Step 4 is removal of the printed pattern from 
the fully cured PDMS. The technique to remove the printed pattern depends on position of the 
printed pattern chosen in step 3. Printed patterns attached to a substrate and covered with PDMS 
can be manually removed, as they are exposed once the substrate is removed. Printed patterns 
entirely embedded in the PDMS are removed by liquefying and draining the printed pattern. Printed 
pattern is thermally liquefied or chemically dissolved with no effect to the PDMS. Figure 2-1 
presents the fabrication method to produce a microfluidic network in a PDMS substrate by 
precision extrusion deposition and replica molding.     
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Figure 2-1: Fabrication method to produce a microfluidic network in a PDMS substrate by 
precision extrusion deposition and replica molding. 
2.2.2 Step 1. Design microfluidic network 
Step 1 is the design of the microfluidic network. The design is defined as the pathway of the 
channel network and geometric size of the channels. Design considerations capture the key facets 
of mature, functional tissue within manufacturing limitations and include the size and pathway of 
in vivo microfluidic networks. The microfluidic network’s channels are sized to accommodate 
flowing fluid, viable cellular material with proliferative potential and extra-cellular matrix volume. 
The design includes the macro-scale pattern of the network (10-3-10-1 meter) and micro-scale 
channel cross-section (10-4-10-3 meter).  
2.2.3 Step 2. Print pattern by precision extrusion deposition 
Step 2 is printing a polycaprolactone (PCL) pattern by precision extrusion deposition. The 
tool path is programmed to draw the geometric pattern of the channel network.  The design’s macro-
scale pattern is discretized into a stack of 2-dimensional layers. Each layer is printed, one on top of 
another, to produce the complete 3-dimensional network. Manufacturing process parameters are 
selected to produce a predetermined cross-sectional dimension and shape of the extruded filament 
by controlling the location and rate of material deposition. The dimension and shape of the cross-
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section are defined in the set of design variables. Separate control of the printhead height and 
deposition rate on the substrate diminish the co-dependency of the cross-section’s height and width.  
The PED’s process information pipeline utilizes three sub-systems. Fabrication begins with (1) 
design model inputs to automation software, (2) motion system generates of a series of 2-
dimensional tool paths, stacked layer-by-layer to produce a 3-dimensional volumetric construct, 
and (3) material delivery system to liquefy and extrude controlled amounts of thermoplastic 
material. Figure 2-2 presents the process information pipeline, as-built photograph and blow-out 
schematic of the material delivery system’s extruder screw.  
 
Figure 2-2: System configuration for precision extrusion deposition process.  Process 
information pipeline and as-built system photograph presented. Inset is diagram of material 
delivery system extruder, reproduced from Wang et. al. 2004 (Wang et al., 2004).   
A single build cycle may include variable printed geometric patterns and cross-sectional 
widths/heights. The set of design parameters is controlled by the process parameters, which can be 
automated to fluctuate during fabrication to produce gradient structures or irregular topologies. As 
an additive manufacturing process, this process control can be extended to internal features of a 3-
dimensional printed construct.   Figure 2-3 presents a time-lapse of a single layer PED build cycle. 
The geometric pattern and cross-sectional variations between the square wave and sinusoidal waves 
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are automated. Each geometric pattern and extruder screw speed are programmed to effect the 
printed filament shape and cross-sectional width. The extruder screw speed of the square wave is 
less than sinusoidal wave. Consequently, the width of the square wave is less than the width of the 
sinusoidal wave.   
 
Figure 2-3: Macro-scale patterning of printed PCL square wave and sinusoid patterns by 
precision extrusion deposition.  
2.2.3.1 Definition of PED process parameters, material properties and design variables 
PED system performance is defined by a set of geometric design variables to arrange a 
thermally extruded polymer in 3-dimensional space with controlled deposition along a pathway 
and width/height of the extruded filament. The set of design variables, ߖ௉ா஽, are a function of the 
set of geometric parameters of the built system Χ௉ா஽, the set of process parameters, ߗ	୔୉ୈ, and the 
extruded material properties, Φ௉ா஽.  Process parameters are automated and can be adjusted 
dynamically during the build cycle period to fabricate gradient structures and multiple design 
variables in a single printed construct.  As such, the process parameters are a function of time. 
Equation 2-1 defines the set of design variables as a function of the geometric parameters, process 
parameters and material properties.  
ߖ௉ா஽ሺݐሻ ൌ ݂ሼߕ௉ா஽, ߗ௉ா஽ሺݐሻ, ߔ௉ா஽ሽ 2-1 
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Figure 2-4 is a schematic of the PED extruder barrel mounted to the motion system 
depositing a printed filament as extruder moves across a stationary printing substrate. Process 
parameters are identified, with the exception of extruder barrel temperature. The set of design 
variables are called out on cross-section of the printed filament.    
 
Figure 2-4: PED schematic of process parameters and printed filament design variables.  
The PED system’s fabrication objectives define the design variables. The fabrication 
objective is a 3-dimensional scaffold. The 3-dimensional scaffold’s architecture features specific 
macro-scale (10-3 – 10-1 m) placement and micro-scale (10-4 – 10-3 m) cross-sectional width/height 
of the extruded filament. The macro-scale pathway of material deposition is controlled by the 
motion system to be repeatable to less than 10µm. Micro-scale design variables to characterize the 
printed filament’s cross-section are controlled by system’s process parameters. The dependence of 
the width and height of the printed filament is diminsihed, as each parameter is independently 
controllable and automated to be varied over the build cycle to transform throughout the construct. 
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Equation 2-2 defines the set of design variables as the printed filament’s cross-sectional width, ܽ,  
and height, ܾ.   
ߖ௉ா஽ሺݐሻ ൌ ሾܽ ሺݐሻ ܾ ሺݐሻ ሿ 2-2 
The raw printing material is thermoplastic pellets and are loaded into the extruder barrel,  
heated above the melt temperature, and extruded as a filament from a die secured to the outlet. 
Process parameters are defined by the system’s hardware and software configuration. PED 
controllable process parameters are extruder die diameter, ݀, dispensing pressure, ܰ, temperature 
of material delivery system, ௜ܶ, printhead speed, ݒ, and height of the dispensing tip above the 
printing substrate, ݖ. The temperature of the extruder barrel is regulated by two independent heating 
elements; (1) the first near the material inlet to melt the polymer and (2) the second near the outlet 
to maintain a molten polymer phase through extrusion. The pressure printhead speed, and height 
are automated and their value can be programmed to dynamically change during a build cycle. Such 
variables are presented as a function of time in equation 2-3. The diameter of the dispensing tip is 
selected from a prefabricated set of tips and cannot be changed dynamically during a build cycle.  
Equation 2-3 defines the set of independently tunable system process parameters.    
ߗ௉ா஽ሺݐሻ ൌ ሾ݀ ܰሺݐሻ ௜ܶ ݒሺݐሻ ݖሺݐሻሿ 2-3 
The material property relevant to characterzing the flow through the extruder is visocsity. 
Polymer rheology is empirically defined from a parametric study of the temperature- and strain 
rate- dependence of viscosity. Equation 2-4 defines the set of material properties relevant to 
precision extrusion deposition of a thermoplastic as viscosity, ߤ. Viscosity is generalized as a 
function of strain rate ߛ, and temperature ܶ.  
ߔ௉ா஽ ൌ ሾ ߤ ൌ ݂ሺߛ, ܶሻ ሿ 2-4 
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Geometric parameters are measured using photographs of the as-built system and the image 
processing software ImageJ (NIH). Internal features of the extruder die could not be photographed 
and were defined using the manufacturer provided engineering drawing of the extruder die.  
Geometric parameters require changes to system’s parts or configuration and remain constant from 
build cycle to build cycle. The set of PED geometric parameters are all specific to the barrel, screw 
and die of the extruder and include barrel diameter ܦ, screw channel depth ܪ, pumping zone length 
ܮ, die length ݈, screw channel width ܹ, die characteristic ߝ, screw helix angle ߠ, equation 2-5. 
ߕ௉ா஽ ൌ ሾ ܦ ܪ ܮ ݈ ܹ ߝ ߠሿ 2-5 
Table 2-1 presents the geometric, process, material, design, and derived parameters. Derived 
parameters assist in analytical characterization of the system. Derived parameters are not directly 
controlled by the operator and are not the specific performance objective of the process.   
Table 2-1. Precision extrusion deposition system design variables, derived, geometric, material, 
and process parameters. 
Symbol Description Process Window Parameter 
Type 
࡭	 Cross-sectional area of printed 
filament  
-  Derived  
ࢇ Printed filament width   - Design  
࢈ Printed filament height   -  Design 
ࡰ PED extruder barrel diameter  20.0 ݉݉  Geometric 
ࢊ PED extruder die diameter  100, 150, 200, 	250, 	 
300, 350, 500		ߤ݉  
 Process 
ࡴ PED extruder screw channel depth  3.0 ݉݉  Geometric 
ࡷ PCL viscosity coefficient  2.0 ∙ 10଻Pa   Material 
ࡸ PED extruder pumping zone length  150.0 mm  Geometric 
࢒	 PED extruder die length 4.57 mm Geometric 
ࡺ PED screw RPM  0.1 ൑ ܰ ൑ 100.0	RPM  Process  
࢔ PCL viscosity index  െ2.46 Material  
ࡽ Net volumetric flow rate from PED 
extruder  
 -  Derived 
ࡽࡰ Drag volumetric flow rate  -   Derived 
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cont’d    
Symbol Description Process Window Parameter 
Type 
ࡽࡺ Die restriction volumetric flow rate -   Derived ࡽࡼ Pressure volumetric flow rate -  Derived ࢖ Pressure in PED extruder   -   Derived 
ࢀ૚ PED extruder barrel temperature, 
inlet 
65 ൑ ଵܶ ൑ 120°ܥ Process 
ࢀ૛ PED extruder barrel temperature, 
outlet 
65 ൑ ଶܶ ൑ 120°ܥ Process 
࢚ Time -  
࢜ PED deposition head speed 0.1 ൑ ݒ ൑ 10.0 ݉݉ ݏ⁄  Process 
࢜ࢠ Maximum down channel fluid 
velocity through PED extruder  
 Derived 
࢜ࢠതതത Average down channel fluid 
velocity through PED extruder  
 Derived 
ࢃ PED extruder screw channel width 17.0 mm Geometric 
ࢠ Height between nozzle and 
substrate 
0.1 ൑ ݖ ൑ 2.0	mm Process 
ࢻ Drag flow coefficient ߨܦܪܹ cos ߠ Derived 
ࢼ Pressure flow coefficient  ܹܪଷ 12ܮ⁄  Derived 
ࢿ PED extruder die characteristic - Geometric 
ࣂ Screw helix angle 18.5°  Geometric 
ࣆ	 Material viscosity ܭܶ௡ Material 	࣋	 Material density 1.145 ݃ ܿ݉ଷ⁄ 	 Material ࣓ Die restriction coefficient ߨ 128݈⁄  Derived 
ࢶࡼࡱࡰ PED material parameters - Material વࡼࡱࡰ PED geometric parameters  Geometric ࢸࡼࡱࡰ PED design variables - Design  ࢹࡼࡱࡰ PED process parameters - Process 
 
2.2.3.2 Empirical characterization of PCL material parameters  
In continuum mechanics the material property viscosity corelates the force in a fluid element 
with the velocity of the element, alternatively viscosity corelates the shear stress and shear rate. 
The form of the analytical expression requires the fluid to be classified as either (1) Newtonian or 
(2) non-Newtonian fluid. Linearly correlated viscous stress and fluid velocity are characteristically 
Newtonian fluids. Non-linear correlations are characteristically non-Newtonian fluids. The 
appropriate continuum mechanics classification of liquid phase PCL within PED operating 
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conditions is measured experimentally and then analyzed for classification. Equation 2-6 presents 
the viscosity,	ߤ, as a function of shear stress,߬, and shear rate,ߛ,  for both fluid categories. 
			ሺ1ሻ ܰ݁ݓݐ݋݊݅ܽ݊ ܨ݈ݑ݅݀ ߤ ൌ ߬ ߛ⁄ሺ2ሻ ݊݋݊ െ ܰ݁ݓݐ݋݊݅ܽ݊ ܨ݈ݑ݅݀ ߤ ൌ ݀߬ ݀ߛ⁄  2-6 
The viscosity of liquid phase PCL is experimentally evaluated for thermal and mechanical 
sensitivity. Equation 2-7 generalizes liquid phase PCL viscosity as a function of shear stress,ߛ, and 
temperature, ܶ.   
ߤ ൌ ݂ሼ ߛ, ܶ ሽ 2-7 
PCL viscosity is measured using shear rate and temperature sweep to identify the 
dependence of each variable. The effect of shear rate is used to classify the material as Newtonian 
or Non-Newtonian. A viscometric test method to applied temperature and shear rate sweeps and 
then measured shear stress in the molten thermoplastic sample. Polycaprolactone (PCL), 
(C6H10O2)n  pellets (Sigma-Aldrich) are loaded between the parallel plates of TA Instrument’s 
AR2000ex Advanced Rheometer System.  The AR2000ex Rheometer’s non-contact drag cup 
motor controls the angular rotation and rate of rotation of a Peltier plate. The rotating plate is a 
parallel to a static plate. The testing platform temperature was controlled by the instrument’s 
temperature control system to within ൅/െ	0.1Ԩ and logged with the recorded experimental data. 
PCL is loaded between the rotating and static plate and heated to liquefy the pellet to liquid phase. 
The controlled shear rate testing mode continuously deforms the fluid using a shear rate sweep to 
exponentially increase the rotation of the plate from 0.1-100 1/s over a 45 minute test period. The 
rheometer measures the Peltier plate’s rate of rotation (shear rate) and motor’s torque (shear stress) 
and temperature. The 65°C test condition is evaluated first. Temperature is increased by 5°C for 
each trial up to the maximum 90°C condition.  Figure 2-5 presents photographs of the AR2000ex 
advanced rheometer system with Peltier set-up and PCL pellet positioned on lower plate (center).  
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Figure 2-5: AR2000ex advanced rheometer system with Peltier plate set-up to test temperature 
and strain rate sensitivity of thermoplastic viscosity.  
Figure 2-6 presents the rheometer study results for the strain rate- and temperature- 
dependence of PCL viscosity for PED system operating conditions. Strain rates between 0.1 1/s to 
the maximum fluid shear rate effect the fluid viscosity significantly less than 5°C change in test 
temperature, as each isothermal line is distinct. PCL in the PED operating conditions is classified 
as a Newtonian fluid.  The temperature dependence of PCL viscosity is measured using a 
temperature sweep from 65-90°C for a constant 1.0 1/s strain rate. Liquid phase PCL viscosity is 
modeled as a Newtonian fluid with power law sensitivity to temperature. 
 
Figure 2-6: PCL viscosity as a function of shear rate (left) and experimental data with least 
square fitting (right).  
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Equation 2-8 uses the power law with a coefficient ܭ, and index ݊, to define the viscosity 
as a function of temperature ܶ.  
ߤ ൌ ߬ߛ ൌ ܭܶ
௡ 2-8 
Least square fitting regression using a power law model of the experimental data is a 
function of the form presented in equation 2-9.    
ݕ ൌ ܣݔ஻ 2-9 
The least square fitting coefficients represent the material properties for the viscosity 
coefficient and index are presented in equation 2-10 and 2-11, respectively.   
ܭ ൌ ܣ ൌ ݁௔ 2-10 
݊ ൌ ܤ ൌ ܾ 2-11 
Coefficients are evaluated using the experimental data of temperature (independent variable, 
x) and viscosity (dependent variable, y) using equation 2-12 and 2-13. 
ܾ ൌ ݊∑ ሺ݈݊ ݔ௜ ݈݊ ݕ௜ሻ െ ∑ ሺ݈݊ ݔ௜ሻ
௡௜ୀଵ௡௜ୀଵ ∑ ሺ݈݊ ݕ௜ሻ௡௜ୀଵ
݊ ∑ ሺ݈݊ ݔ௜ሻଶ௡௜ୀଵ െ ∑ ሺ݈݊ ݕ௜ሻଶ௡௜ୀଵ  2-12 
ܽ ൌ ∑ ሺ݈݊ ݕ௜ሻ െ ܾ ∑ ሺ݈݊ ݔ௜ሻ
௡௜ୀଵ௡௜ୀଵ
݊  2-13 
The power law model of PCL viscosity as a function of temperature (65Ԩ ൑ ܶ ൑ 90Ԩ) 
with empirical coefficients takes the form presented in equation 2-14.  
ߤ ൌ 1.4 ൈ 10଼ ܶିଶ.ସ଺ 2-14 
Empirical coefficients are compared to values from similar studies of thermoplastics in peer 
reviewed literature. Molecular weight and density varies greatly between PCL from this and peer 
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studies. Standard deviation between this study and peer reviewed viscosity index is +/- 0.06. The 
viscosity coefficient is 2 orders of magnitude greater for our study than peer reviewed work. 
Variation in source, molecular weight and density contribute to the disparity.   
Table 2-2. Power law model coefficients for thermoplastics polycaprolactone (PCL) and poly-L-
lactice (PLLA) from literature 
Polymer Molecular 
Weight 
Density
g/cm3 
K 
Pa.sn 
n 
 
Ref 
PCL 45,000 1.15 1.4 ൈ 10଼ െ2.46 Experimental  
PCL 62,450 1.09 1.4 ൈ 10଺ -2.54 (Liang, Zhou, Tang, & 
Tsui, 2013) 
PCL 80,000 - 8.4 ൈ 10଺ െ2.41 (Kalambur & Rizvi, 2006) 
PLLA 100,000 2.55 1.1 ൈ 10଺ -2.44 (Liang et al., 2013) 
 
2.2.3.3 Design variables as a function of the process and material parameters 
PCL flow from the PED extruder accumulates on the substrate. Conservation of mass 
requires the mass flow rate from the extruder is equal to the mass of PCL accumulating as a filament 
on the substrate.  Equation 2-15 presents the mass flow from the extruder equals the mass 
assumulating on the substrate in the printed structure.  
൬݀݉݀ݐ ൰௙௥௢௠	௘௫௧௥௨ௗ௘௥ ൌ ൬
݀݉
݀ݐ ൰௦௨௕௦௧௥௔௧௘ ௔௖௖௨௠௨௟௔௧௜௢௡ 2-15 
PCL is modeled as a constant density fluid. Mass and volume flow rate are proportional. 
The net volumetric flow rate from the extruder is equal to depsotion head speed ݒ, multiplied by 
the cross-sectional area of the deposited PCL filament ܣ, equation 2-16.  
ܳ ൌ ܣݒ 2-16 
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Cross-sectional area of the printed filament is modeled as half an ellipse.  The area of the 
printed cross-section is a function of the major axis (width) and minor axis (height), equation 2-17.   
ܣ ൌ ߨܾܽ4  2-17 
The height of the printed filament is controlled by the height of the PED extruder die outlet 
above the printing substrate, equation 2-18.  
ܾ ൌ ݖ 2-18 
PCL pellets loaded into the inlet of the PED extruder barrel are liquefied and blended by 
heating and the mechanical action of the screw. The rotating screw in the stationary barrels builds 
pressure and forces the liquefied PCL from the inlet towards the outlet at the bottom of the barrel. 
PCL flow through the extruder is modeled as an unrolled screw helix presented as a rectangular 
channel, figure 2-7, and as-built extruder with geometric parameters annotated, figure 2-8. 
  
Figure 2-7: PED extruder schematic and unrolled single turn of the extruder screw helix  with 
geometric parameters. 
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Figure 2-8: Photographs of fabricated extruder barrel and screw with geometric parameters 
annotated. 
Die restriction at the extruder outlet shapes the extruded filament. PED system only includes 
a pre-fabricated set of circular cross-section die of variable diameter. Die diameter is directly 
measured. The die length is an internal feature and is taken from engineering drawing drafted to 
manufacture the die, presented in figure 2-9.  
 
Figure 2-9: PED extruder die schematic of front and top (left) and fabricated result (right) with 
ruler. Geometric parameters length and diameter are read from schematic and measured from 
photograph respectively.  
The volumetric flow rate from the extruder head is a combined Drag-Poiseuille flow. The 
Drag flow induced by the turning screw in the extruder barrel is opposed by pressure build up due 
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to the restrictor dye at the outlet. Equation 2-19 presents the net volumetric flow ܳ , as a combination 
of the Drag flow ܳ஽,	 and Poiseuille flow ܳ௉.  
ܳ ൌ ܳ஽ െ ܳ௉ 2-19 
Drag, or Couette, flow is a function of geometric parameters and the screw speed.  Velocity 
profile through the PED extruder pumping zone is modeled as a laminar flow with a no-slip 
boundary condition on the rotating screw surface and stationary barrel wall. The down channel 
component of the velocity proportional to the screw speed, as presented in equation 2-20.  
ݒ௭ ൌ ݀ݖ݀ݐ ൌ ߨܦܰ ܿ݋ݏ ߠ 2-20 
Laminar flow of a Newtonian fluid with a no-slip boundary condition produces a linear 
velocity profile. The average PCL velocity through the pumping zone is half the maximum fluid 
velocity, equation 2-21.  
ݒ௭ഥ ൌ 12ݒ௭ 2-21 
Volumetric flow rate caused by the turning screw is the down channel of the flow rate 
integrated over the cross-sectional area of the flow channel. Volumetric flow rate is the average 
fluid velocity integrated over the cross-sectional area of the channel, equation 2-22.  
ܳ஽ ൌ න ݒ௭ഥ ݀ܣ
஺
଴
ൌ න න ݒ௭ഥ ݀ݔ ݀ݕ
௫ୀு
଴
௬ୀௐ
଴
 2-22 
Combining equation 2-20, 2-21 and 2-22 defines the drag flow rate as a function of 
geoemtric and process parameters, equation 2-23. Geometric parameters represented as a single 
drag flow coefficient ߙ.   
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ܳ஽ ൌ ߨ2 ܦܪܹܰ ܿ݋ݏ ߠ ൌ ߙܰ 2-23 
Linear momentum through the pumping zone of the PED extruder’s pumping zone is 
conserved. Poiseuille flow is produced by a pressure gradient caused by flow restriction due to an 
extruder die secured to the PED extruder barrel outlet, equation 2-24. Geometric parameters 
represented as a single Poiseuille flow coefficient ߚ.   
ܳ௉ ൌ ܸ݀݀ݐ ൌ
ܹܪଷ
12ߤଵ
݌
ܮ ൌ
ߚ
ߤଵ ݌ 2-24 
Equation 2-24 and the temperature-dependent power law model of PCL, equation 2-14, are 
combined to form equation 2-25.  
ܳ௉ ൌ ߚܭ ଵܶ௡ ݌ 2-25 
Net volumetric flow rate through the extruder die is a function of the geometry of the die 
itself, a presented in equation 2-26.  
ܳ ൌ ܳௗ 2-26 
Flow due to restriction die is a function of viscosity ߤ, pressure ݌, and die geometry 
coefficient ߝ, as presented in equation 2-27.   
ܳௗ ൌ ߝߤଶ ݌ 2-27 
Extruder die characteristic for a circular die is modeled from Hagen-Poiseuille Law as a 
function of geometric variables diameter ݀, and extrusion length ݈, as presented in equation 2-28. 
ߝ ൌ ߨ݀
ସ
128 ݈ 2-28 
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Equation 2-27 and 2-28 are combined to define the flow rate through the extruder die, 
equation 2-29. Geometric parameters are combined by the die flow coefficient ߱. 
ܳௗ ൌ ߨ݀
ସ
128 ݈
1
ߤଶ ݌ ൌ
߱݀ସ
ߤଶ ݌ 2-29 
Equation 2-29 and the temperature-dependent power law model of PCL, equation 2-14, are 
combined to form equation 2-30.  
ܳௗ ൌ ߨ݀
ସ
128 ݈
1
ߤଶ ݌ ൌ
߱݀ସ
ܭ ଶܶ௡ ݌ 2-30 
The net volumetric flow rate (equation 2-19), drag flow (equation 2-23), Poiseuille flow 
(eqaution 2-24), and die restriction flow (equation 2-30) are combined to solve for the pressure in 
the extruder barrel due to the restirctor die as a function of the process, geometric, and material 
parameters, equation 2-31.   
݌ ൌ ߙܭܰ ଵܶ
௡
݀ସ߱ ቀ ଵܶଶܶቁ
௡
൅ ߚ
 2-31 
The net volumetric flow rate (equation 2-19), drag flow (equation 2-23), Poiseuille flow 
(eqaution 2-24), and pressure in the extruder barrel (equation 2-31) are combined to solve for the 
net volumetric flow rate through the restirctor die as a function of the process, geometric, and 
material parameters, equation 2-32.   
ܳ ൌ ߙܰ൮1 െ 1
݀ସ ߱ߚ ቀ ଵܶଶܶቁ
௡
൅ 1
൲		 2-32 
PCL density, ߩ, is assummed constant, therefore the mass, ݉, and volume, ܳ, flow rates are 
propotional, equation 2-33.  
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݉ ൌ ܳߩ  2-33 
Equation 2-33 combines equation 2-31 and 2-32 to present mass flow rate from the extruder 
as a function of the process parameters, geometric coefficients and material properties. 
݉ ൌ ߙߩܰ൮1 െ 1
݀ସ ߱ߚ ቀ ଵܶଶܶቁ
௡
൅ 1
൲		 2-34 
Accumulation on the substrate is a function of the printhead speed and extruder flow rate 
(equation 2-15), model of printed filament’s cross-sectional area (equation 2-16), equivalence of 
printed filament height to extruder tip height (equation 2-18), and net volumetric flow rate from the 
extruder (equation 2-32) combine to define the design variable for printed filament height, 
presented in equation 2-35.  
ܽ ൌ 4ߙܰߨݒݖ ൮1 െ
1
ܦௗସ ߱ߚ ቀ ଵܶଶܶቁ
௡
൅ 1
൲ 2-35 
Equation 2-35 is plotted to present the theoretical effect of each process parameter on the 
printed filament width, presented in figure 2-10. Increasing the extruder outlet temperature 
increases the width of the printed filament, as does increasing the inlet temperature. Increasing 
screw speed also increases printed filament width, as does increasing extruder die diameter. 
Increasing printhead exponentially decreases speed width, as does increasing the distance between 
the substrate and extruder die outlet.  
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Figure 2-10: Theoretical effect of extruder temperature, screw speed, printhead velocity and 
height of extruder die and substrate on the print filament width 
2.2.3.4 Comparison of theoretical and experimental PED extruder flow rates  
PCL is loaded into 80°C PED extruder barrel with Ø350μ݉ extruder die secured to the 
outlet. The extruder screw is programmed for a specific displacement and RPM to force the PCL 
from the outlet. PCL is collected on a high precision mass balance. The time of extruded is reported 
by the software. Mass flow rate is experimentally quantified from the measured PCL weight and 
extrusion time.  Equation 2-34 is plotted to present the derived mass flow rate from the PED 
extruder for comparison.  
ܧݔ݌݁ݎ݅݉݁݊ݐ݈ܽ	ܯܽݏݏ ܨ݈݋ݓ ܴܽݐ݁ ൌ ܹ݄݁݅݃ݐ,݉݁ܽݏݑݎ݁݀ܧݔݐݎݑݏ݅݋݊	ݐ݅݉݁,݉݁ܽݏݑݎ݁݀	 
݉௘ ൌ ௠ܹݐ௠  
2-36 
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The theoretical and experimental mass flow rates demonstrate strong agreement between 
10-120 RPM. Both the theoertical model (equation 2-34) and experimental results calculated from 
measurements (equation 2-36) present a propotional increase in mass flow rate per increase in 
screw speed rotation.    
 
Figure 2-11: Comparison of derived and experimental mass flow rate through PED extruder with 
Ø350µm nozzle and uniform 80°C heating of extruder barrel.  
2.2.3.5 Independent control of printed width and height  
Height and width of printed cross-section independently controlled by printhead speed and 
height of the outlet tip above substrate. Elevation of the tip sets the height of the printed filament. 
Width of the printed filament is adjust by increasing or decreasing the total cross-sectional area. 
Printhead speed or screw speed can be adjusted without changing the elevation. PCL is printed with 
PED system to form filaments using three printhead speeds. Figure 2-12 presents three profiles of 
PCL extrusions fabricated using PED system examined using the Zygo NewView 6000 optical 
profiler. Samples are sputter coated 5 nm thick layer of platinum-palladium to provide a conductive 
path during imaging.   Blue profile printed with faster printhead speed than green profile. Green 
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profile printed with faster printhead speed than red profile. Increasing printhead speed decreases 
the PCL accumulation rate on the substrate, which decreases the total cross-sectional area of the 
printed filament. Height is determined by the elevation of the extruder outlet. The width is 
independently varied by increasing or decreasing the other process parameters.   
 
Figure 2-12: Three PED printed PCL filament cross-section. Blue profile printed with faster 
printhead speed than green profile. Green profile printed with faster printhead speed than red 
profile.  
2.2.4 Step 3. Replica molding of printed pattern in PDMS  
Step 3 is replica molding of the printed pattern in polydimethylsiloxane (PDMS). PDMS is 
selected for the microfluidic device as a biocompatible, non-toxic, optically transparent, & highly 
gas permeable material (Mata, Fleischman, & Roy, 2005). PDMS is Slygard 184 Silicone 
Elastomer (Dow Corning) base and curing agent mixed 10-15:1 respectively by weight for optimal 
bond strength between PDMS layers (Eddings, Johnson, & Gale, 2008).  The PCL pattern is either 
(1) placed in a glass or polystyrene dish and covered with freshly mixed PDMS or (2) placed on 
partially cured PDMS and covered with freshly mixed PDMS. In the first case, the PCL pattern 
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produces channels on the surface of the fully cured PDMS substrate. In this case an additional cover 
with inlet/outlet ports is required to seal the channels in a device. In the second case, the PCL 
pattern produces channels embedded in the PDMS substrate.  In this case no additional cover 
component is required to seal the channel network as a device. However, inlet and outlet ports are 
added as capillary tips punctured through the fully cured PDMS. Layers of PDMS are bonded by 
an adaptation of the stamp-and-stick room temperature bonding technique for micro-devices 
(Satyanarayana, Karnik, & Majumdar, 2005). A 1 mm thick layer of PDMS is poured into a 
polystyrene dish and stored in ambient conditions, 22°C and 1 atm, to partially cure over 12 hours. 
The PCL pattern is printed on top of the partially cured PDMS substrate. Additional PDMS is 
poured over the PCL pattern; up to an additional 1 mm. PDMS is stored for an additional 24 hours 
at room temperature to fully cure.  
 
Figure 2-13: Top and front view of PCL pattern printed by precision extrusion deposition fully 
embedded in PDMS substrate.   
2.2.5 Step 4. Remove printed pattern to produce the microfluidic network 
Step 4 is removal of the printed pattern from the fully cured PDMS. The technique to remove 
the printed pattern depends on position of the printed pattern chosen in step 3. Printed patterns 
attached to a substrate and covered with PDMS can be manually removed, as they are exposed once 
the substrate is removed. PCL cleared from PDMS channel after curing by one of two methods (1) 
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gently peeling PCL from channels using forceps or (2) dissolving PCL from channels by sonication 
in dichloromethane (Sigman et al.) for 50 min at room temperature (Vazquez, Luduena, & Alvarez, 
2007). After the printed pattern is removed, the templated network is an open set of channels.  
 
Figure 2-14: Process to remove PCL pattern from surface of fully cured PDMS substrate.  
A fully embedded printed pattern is removed from fully cured PDMS by alternating 
melt/drain cycles and dissolve the PCL pattern without damaging the PDMS substrate. After the 
PDMS is fully cured, a syringe or capillary tip is used to puncture the surface of the PDMS to the 
embedded PCL pattern. The risk of tearing is minimized by allowing the PDMS to equilibrate to 
room temperature and using a droplet of water on the puncture site. Slow even pressure is applied 
to the capillary or syringe tip during penetration. The tip is the inlet and is plumbed to a 
programmable syringe pump using silicone tubes for continuous perfusion. A hole created using a 
capillary tip drains molten PCL out of the PDMS, leaving an open network of channels. First the 
PDMS substrate is placed on a hot plate, submerged in water and heated to >60°C. PCL becomes 
molten and perfusion from the syringe pump begins 0.2mL/hr. The flow is increased to 1.0mL/min 
as PCL is removed from the channels. An alternating cycle to dissolve the PCL by solvent is used 
to fully clear channels of PCL. The PDMS substrate is cooled to room temperature, submerged in 
dichloromethane and sonicated for 30-60 minutes. Dichloromethane will evaporate at high 
temperature, therefore the thermal and chemical processes cannot be successfully combined. 
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Further, dichloromethane dissolves silicone tubes and syringes used in perfusion. Contact with 
dichloromethane longer than 60 minutes causes PDMS substrate to deform and delaminate. The 
heat/perfusion and solvent/sonication cycles are alternated until channels are clear of PCL.   Once 
channels are cleared, either from the surface or embedded in the PDMS, channels are flooded with 
dye for visualization.  
 
Figure 2-15: Process to remove PCL pattern embedded in fully cured PDMS substrate. Process 
using a heat/perfusion cycle to melt and drain PCL and a solvent/sonication cycle to dissolve PCL 
without damaging PDMS.  
 
Figure 2-16: Forced convection from a programmable syringe pump plumbed to the embedded 
printed pattern through a syringe tip ejects melted pattern from the cured PDMS. Arrow points to 
ejection of water and PCL from embedded channels.  
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Figure 2-17: Microfluidic network templated by PCL scaffold fabricated by additive 
manufacturing technique precision extrusion deposition. Printed PCL scaffold cured in PDMS – 
photograph and binary image of PCL/PDMS (black/white) presented in Fig. A and B 
respectively. Thermal and chemical treatment removes PCL without damaging PDMS. After PCL 
is removed, the void space is perfused with water with food coloring for visualization. PDMS 
after PCL is removed presented in photograph and binary image of water with food 
coloring/PDMS (black/white) presented in Fig C and D respectively.  Fig. B (blue) and D (red) 
superimposed in Fig. E. 
 
Figure 2-18: Open channel on the surface (left) and fully embedded 3-dimensional (right) 
microfluidic networks in PDMS substrate fabricated by precision extrusion deposition and replica 
molding.  
2.2.6 Fabricated microfluidic networks 
2.2.6.1 Channels embedded in surface of PDMS substrate 
Inspection of two geometric designs for fabricated PCL pattern and PDMS channels was 
performed to demonstrate the pattern could be created, molded, and cleared from PDMS channel. 
In a third example the goemetric design were comined in a single interconnected microfluidic chip. 
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Figure 2-19 presents design model input, printed PCL pattern produced by PED system, and PDMS 
cured against PCL pattern for single layer square wave pattern of dimensions 20mm x 20mm with 
struts spaced 1mm on center. Figure 2-20 presents design model input, printed PCL pattern 
produced by PED system, and PDMS cured against PCL pattern for single layer square and sinusoid 
wave pattern of dimensions 20mm x 22mm with struts spaced 3mm on center and radius of 1mm. 
Figure 2-21 presents design model input, printed PCL pattern produced by PED system, and PDMS 
cured against PCL pattern for single layer multi-compartment array of two square and one sinusoid 
wave arranged in series. 
 
Figure 2-19: Single layer square wave pattern of dimensions 20mm x 20mm with struts spaced 
1mm on center design model input (left) and printed PCL pattern produced by  PED system  
(center) and PDMS cured against PCL pattern with channels flooded with green dye (right). 
 
Figure 2-20: Single layer sinusoid wave pattern of dimensions 20mm x 22mm with struts spaced 
3mm on center and radius of 1mm design model input (left) and printed PCL pattern produced by  
PED system (center) and PDMS cured against PCL pattern with channels flooded with green dye 
(right).  
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Figure 2-21: Single layer multi-compartment array of square and sinusoid wave design models 
printed PCL pattern produced by  PED system (left) and PDMS cured against PCL pattern with 
channels flooded with green dye (right). 
Inspection using phase contrast microscope and image analysis software was performed on 
fabricated samples to characterize PCL pattern and PDMS channel depth and width. Single layer 
square wave PCL pattern and PDMS chip were viewed from the top and then sliced through the 
center to inspect cross-section. Figure 2-22 presents top view and section view of printed PCL 
pattern and PDMS channels for square wave channel. PDMS curing against the PCL pattern yields 
a network of channels.  
 
Figure 2-22: Top and section view of PDMS Channels printed using 350µm nozzle tip. Top view 
of PCL pattern inset. 
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Having established PDMS channels can be produced by PCL patterns and the micro-system 
structures can be controlled by PED manufacturing process parameter, we next investigated the 
effect of SFF to increase channel aspect ratio. Inspection using phase contrast microscope and 
image analysis software was performed on PDMS channel fabricated using 1, 2, 3, and 4 layers to 
characterize channel width, depth and aspect ratio.  A scalpel is used to cut PDMS chip along its 
centerline to view cross-section of channels. The aspect ratio (AR) is defined as the channel depth 
divided by the channel width. The depth of the channel is increased by printing additional layers 
on top of the first layer. The width of the channel is increased by printing additional layers on top 
of the first layer. One layer produced a 1.0 aspect ratio channel. Two layers increased the aspect 
ratio 30%, three layers increased the aspect ratio 60%, and 4 layers increased the aspect ratio 120%.   
 
Figure 2-23: Cross section view of PDMS channels molded from multi-layer PCL patterns. 
2.2.6.2 3D network of channels embedded in PDMS substrate 
Having established PDMS channels can be produced by multi-layer PCL patterns and the 
micro-system structures can be controlled by SFF manufacturing in 3-dimensions, we next 
investigated the effect of mutually orthographic layers to create interconnected network of 
channels. Inspection using phase contrast microscope and image analysis software was performed 
on PCL scaffold and PDMS channel fabricated using scaffold to characterize channel width, depth 
and orientation.   
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Figure 2-24: Printed 0-90 scaffold pattern using two layers as viewed from the top 
macroscopically and under 4 x magnifications using phase contrast microscope (B) from the top 
(A) and front (B). PDMS Channels after PCL is removed by sonication and the construct is 
viewed from the top under 4x magnification using phase contrast microscope (C).  
A porous 3-dimensional PCL scaffold is produced by PED manufacturing. Two mutually 
orthographic layers are printed by continuous extrusion in the same z-plane. A second set of 
mutually orthographic layers are printed on top of the first set to produce a scaffold. PCL is 
continuously extruded during entire printing episode to produce a continuous pattern. PDMS cures 
against PCL scaffold to pattern produce a polymer replica with channel network. PCL scaffold is 
cleared from PDMS chip without disturbing PDMS due to the difference in material melting 
temperature and solubility. After replica molding PCL is cleared by 50 minutes of sonication in an 
80ºC dichloromethane bath.  A scalpel is used to cut PDMS chip along its centerline to view cross-
section of channel network. The top view of PDMS chip and two orthographic cross-section views. 
Two layers of channels are produced in PDMS chip. Two rows of pores are visible in both Figure 
2-25 section view A and B. PED manufacturing is used to layer 2-dimensional PCL patterns to 
create 3-dimensional architecture. This architecture is replica molded and cleared from PDMS chip 
to produce a 3-dimensional microfluidic system. The depth of the channels from the top of the chip 
to the bottom of the lower row is 325-385µm. 
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Figure 2-25: Continuous extrusion during PCL patterning creates an interconnected 3-D network 
for replica molding. 
2.2.6.3 Minimum feature size achieved 
The minimum set of design variables fabricated by PED printing and replica molding 
process is determined by experimentation. The minimim diameter extruder die is selected from a 
pre-fabricated set and secured to the outlet. Next the process parameters are iteratively decreased 
to identify the minimum temperature and screw speed for extrusion. The extruder tip height above 
the printing substrate is then set. Then the depsotion head speed is increased until continuous line 
formation is not reproducible. The set of process parameters to fabricate the set of minimum feature 
size is presented in equation 2-37. 
ߗ௉ா஽ ൌ ൤݀ ൌ ∅150μ݉ ܰ ൌ 30 ܴܲܯ ଵܶ ൌ 80°ܥଶܶ ൌ 70°ܥ ݒ ൌ 5.0
݉݉
ݏ ݖሺݐሻ ൌ 150ߤ݉൨ 2-37 
The minimum set of design variable for the width and height of a PED printed PCL filament 
are presented in equation 2-38.  
ߖ௉ா஽ ൌ ሾܽ ൌ 255 ߤ݉ ܾ ൌ 163 ߤ݉ ሿ 2-38 
Figure-2-26 presents photographs of the printed PCL pattern (left), replica molded channels 
in PDMS substrate with red dye in network for visualization. Microscope images of a channel 
cross-section and top view of two parallel channels presented on the right.  
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Figure 2-26: Minimum channel depth and height fabricated by precision extrusion 
deposition/replica molding process is 255µm and 163µm respectively.  
2.2.6.4 Fabrication of microfluidic network with variable channel cross-section width and 
heights 
Process parameters are either (1) maintained constant throughout a build cycle to produce 
the same set of design variables from the beginning to the end of the printed pattern or (2) adjusted 
dynamically over the build cycle to produce variable cross-sectional width/heights throughout the 
printed geometric pattern. Maintaining constant process parameters from the beginning to the end 
of the build cycle produces geometric pattern variation without controlled variation of the cross-
sectional width/height. Figure 2-27 presents photographs of the printed PCL pattern and replica 
molded channel network on the surface of a PDMS substrate. Channel network is flooded with 
green dye for visualization.  
 
Figure 2-27: PCL pattern printed by precision extrusion deposition (left) and network on surface 
of PDMS substrate flooded with green dye for visualization (right).  
63 
 
Programmed variation in the set of process parameters fabricates a range of printed filament 
widths along the tool path. Consequently, the channel network produced from replica molding the 
printed pattern includes variable cross-sectional width and depth.  This ability allows for fabrication 
of multiple channel cross-sectional geometries in a single fabrication/replica molding step.  Process 
parameters can be programmed in a single build cycle to fabricate channel cross-sections from 387-
1052µm wide and 267-400µm deep, as presented in figure 2-28. 
 
Figure 2-28: Channel cross-section with (W) and depth (D) for variable extruder RPM.   
Further capability to vary the geometric pattern and channel cross-section width/depth is 
illustrated in figure 2-29.  
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Figure 2-29: Microfluidic network on the surface of a PDMS substrate flooded with green dye 
for visualization. Network pattern and variable cross-sectional geometries produced during 
precision extrusion deposition of PCL pattern. Fabricated in a single step of replica molding.   
2.3 Multi-nozzle deposition and freeze casting of hierarchical scaffolds 
2.3.1 Purpose of method 
An engineered 3-dimensional scaffold with hierarchical porosity and multiple niche 
microenvironments is produced using a combined multi-nozzle deposition - freeze casting 
technique. We present a process to fabricate a scaffold with improved interconnectivity and 
hierarchical porosity. The scaffold is produced using a two-stage manufacturing process which 
superimposes a printed porous alginate network and a directionally frozen ceramic-polymer matrix. 
The combination of two processes, multi-nozzle deposition and freeze casting, provides 
engineering control of the microenvironment of the scaffolds over several length scales; including 
the addition of lateral porosity and the ratio of polymer to ceramic microstructures. The printed 
polymer scaffold is submerged in a ceramic-polymer slurry and subsequently, both structures are 
directionally frozen (freeze cast), superimposing and patterning both microenvironments into a 
single hierarchical architecture. An optional additional sintering step removes the organic material 
and densifies the ceramic phase to produce a well-defined network of open pores and a homogenous 
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cell wall material composition. The techniques presented in this contribution address processing 
challenges, such as structure definition, reproducibility and fine adjustments of unique length 
scales, which one typically encounters when fabricating topological channels between longitudinal 
and transverse porous networks.  
Well defined scaffold architectures and niche microenvironments are recognized 
mechanisms to direct cell behavior towards a functionalized tissue engineered product (Cao et al., 
2006; Chu, Orton, Hollister, Feinberg, & Halloran, 2002; Tsuruga, Takita, Itoh, Wakisaka, & 
Kuboki, 1997; Zmora, Glicklis, & Cohen, 2002). Features of the in vitro culture environment are 
derived from native tissue and parametric studies of cell response to engineered scaffolds (Mills, 
Frith, Hudson, & Cooper-White, 2011; Muschler, Nakamoto, & Griffith, 2004). Microarchitecture 
such as pore size, geometry, and interconnectivity are tuned for maximum cell infiltration (F. P. 
Melchels et al., 2010a; Silva et al., 2006) and to produce substrate and diffusion conditions to 
promote stable phenotype proliferation (Griffon, Sedighi, Schaeffer, Eurell, & Johnson, 2006; 
Karageorgiou & Kaplan, 2005a; Spiteri, Pilliar, & Kandel, 2006) as well as multi-lineal 
differentiation (Chatrchyan et al., 2011; G. M. Sun & Gerecht, 2009). Manufacturability and 
reproducibility of the microarchitecture depend on automated control of independent scaffold 
properties (Nakamura, Iwanaga, Henmi, Arai, & Nishiyama, 2010; W. Sun & Chang, 2008). 
Gradient and hierarchical structures within 3-dimensional scaffolds selectively stimulate cell 
behavior by structural, mechanical, and chemical cues(Doran, Mills, Parker, Landman, & Cooper-
White, 2009; Irimia & Toner, 2009; Ranucci, Kumar, Batra, & Moghe, 2000; Ridley et al., 2003). 
Unique niche microenvironments are combined in a single scaffold to model coupled physiological 
structure and support multiple stable phenotypes. As in osseous tissue, compact and cancellous 
bone are complementary microenvironments which work together to counterbalance applied 
stresses to maintain integrity of the tissue and house a network of blood vessels and nerves(Lutolf 
& Hubbell, 2005; Turner & Burr, 1993). A combination of artifacts and porosity covering sub-
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micron and micro length scales are necessary to mimic 3-dimensional extracellular 
matrices(Holzwarth & Ma, 2011; Karageorgiou & Kaplan, 2005b) Therefore a combination of 
processing techniques and manufacturing expertise is necessary to fabricate multiple niche 
environments in a single scaffold. 
Structure definition, reproducibility and fine adjustments of the microstructure on several 
length scales within the scaffold are challenges typically encountered with current processing 
techniques when engineering and fabricating a 3-dimensional set of niche microenvironments 
(Panoskaltsis, Mantalaris, & Wu, 2005). The objective of this work is to present a two stage 
processing technique to produce hierarchical porosity in a 3-dimensional scaffold. The two 
processing steps are (1) scaffold printing by solid freeform fabrication (SFF) and subsequent (2) 
directional freezing (freeze casting).  
First, sodium alginate (Alg) and a cross-linking solution are simultaneously extruded using 
a multi-nozzle deposition (MND) printing system to produce a 3-dimensional porous scaffold of 
rigid hydrogel filaments (W. Sun, Chang, Emami, & Wu, 2010; W. Sun, Chang, & Nam, 2008). 
Second, the printed MND network is placed in a cylindrical mold, submerged in chitosan-
hydroxyapatite (CS-HA) slurry and placed on a cooling plate for directional freezing (Meghri et 
al., 2010; Wegst, Schecter, Donius, & Hunger, 2010).  Lyophilization after freeze casting removes 
ice from the Alg filaments as well as from the CS-HA composite, leaving transverse pore channels 
and open longitudinal lamellae through the scaffold, parallel and perpendicular to the cooling 
surface, respectively. After lyophilization, the scaffold’s architecture is hierarchical and the 
material composition is a heterogeneous combination of the printed porous scaffold and the freeze-
cast polymer-ceramic composite.  An optional additional sintering process incinerates the organic 
material and densifies the ceramic phase to produce a homogenous material composition with a 
well-defined network of open pores.  In an unsintered scaffold, the alginate scaffold provides a 
secondary physical environment for cell adhesion, migration, and mass transport into the scaffolds. 
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The heterogeneous material combination of rigid (CS-HA) and soft (Alg) substrates are expected 
to support multiple phenotypes simultaneously. Controlled cell seeding by substrate preference and 
microenvironment stiffness may produce a stable 3-dimensional engineered co-culture (Pelham & 
Wang, 1998; Yeung et al., 2005). The sintering incinerates the embedded Alg scaffold and the 
polymer phase of the CS-HA scaffold to produce a denser, stiffer and stronger HA-scaffold. An 
open network of lateral pores is produced from the embedded Alg scaffold. Sintering and not 
sintering each result in unique scaffold material compositions and properties, both of which can be 
used for scaffold guided tissue engineering.   
The combination of the fabrication processes presented in this work offers unique 
engineering control of two hierarchical structures in the Alg scaffold and CS-HA lamellae, which 
together extend in three mutually orthogonal directions within the scaffold. Pores of the freeze-cast 
CS-HA scaffold are predominantly aligned parallel to each other, have closed cell walls and 
therefore exhibit limited interconnectivity, thus offering limited scope for lateral diffusion and 
biological mobility within the matrix. The orientation of the freeze-cast porosity is restricted to the 
direction normal to the cooling plate because it is templated by the ice crystals which grow parallel 
to the temperature gradient. Transverse porosity connecting neighboring lamellae and the surface 
of the scaffold is scares and irregular.  The combination of scaffold printing and freeze casting 
allows for the creation of additional, lateral porosity in the CS-HA matrix to enhance diffusion and 
serve as a niche microenvironment coupled with the lamellae. The created scaffold thus has a 
hierarchical structure with interconnected porosity in all three mutually orthogonal directions.   
The combined process enables engineering control of two distinct niche microenvironments 
and structures coupled in a hierarchical scaffold over several length scales; including lamellar 
spacing and embedded alginate filament diameter. This novel material is proposed for applications 
in scaffold guided tissue engineering, 3-dimensional co-culture, especially for macroscopic 
scaffolds where natural convection is not a sustainable mechanism for diffusion.  
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2.3.2 Description of method 
Two independent fabrication techniques are combined to embed an engineered 3-
dimensional support structure in a highly organized uni-directional freeze-cast scaffold. After 
sintering and polymer burnout, the resultant ceramic scaffold has porosity that is (1) template by 
the ice crystals during freeze casting and (2) embedded Alg filaments produced by printing. For 
scaffold preparation, porous Alg scaffolds are immersed in the CS-HA slurry under vacuum in a 
cylindrical mold for directional solidification. The wet Alg structure is rinsed with CS-HA slurry 
to allow the slurry to penetrate the printed scaffold before the CS-HA soaked structure is transferred 
to a mold filled with CS-HA slurry and exposed to a vacuum to remove any entrapped bubbles 
from the structure before freeze casting. After freeze casting, the sample is lyophilized to sublimate 
the ice-phase which templates porosity within both the printed Alg filaments and the freeze-cast 
polymer-ceramic scaffolds. At this point, the scaffold is heterogeneous, hierarchical and able to 
support cell viability. An additional processing step, sintering, removes the Alg scaffold and the 
CS-binder phase, opening pores that connect the longitudinal porosity of the freeze-cast scaffold, 
while creating a homogenous, purely ceramic HA cell wall material with increased strength. For 
sintering, the scaffolds are held at a temperature of 1250°C for 1 hour. The result is a ceramic 
scaffold with ice-templated longitudinal and Alg-templated transverse pores. Process flow to 
fabricate three pore structures (1) lamellae, (2) porous printed scaffold and (3) a combination of the 
former porosities is presented in figure 2-30.   
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Figure 2-30: Process flow to fabricate lamellae, porous scaffold, or a combined heterogeneous 
porosity using directional freeze casting with lyophilization, multi-nozzle deposition, or a 
combined process respectively. Each manufacturing method produces a unique scaffold and pore 
network structure. Photograph of printed scaffold and freeze cast slurry. Lamellae in freeze cast 
slurry align with direction of freeze front velocity through ceramic slurry during directional 
freezing.  
2.3.3 Step 1. Scaffold printing by multi-nozzle deposition (MND)  
Solid freeform fabrication by Multi-Nozzle Deposition (MND) of biological material and 
matrix by engineered fluid dispensing produces well-defined 3-dimensional patterns through layer-
by-layer deposition; including hydrogel scaffold laden with viable cells(Chang, Emami, Wu, & 
Sun, 2010; S. Khalil & Sun, 2009b; Nair et al., 2009; Snyder et al., 2011), single wall carbon 
nanotubes(Yildirim, Yin, Nair, & Sun, 2008), and magnetic nanoparticles(Buyukhatipoglu et al., 
2010a).  MND material delivery system is a network of multiple independently operated micro-
nozzles integrated with the motion system and controlled by the MND system’s computer aided 
manufacturing software. Alg and cross-linker are loaded into separate material reservoirs; each 
connected to its own pneumatic printing micro-nozzles. Micro-nozzles are mounted on a high 
precision positioning system to transport the dispensing tip during the extrusion process to produce 
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pre-defined patterns. Both printing micro-nozzles are oriented to extrude to the same point so that 
the two solutions come into contact at the capillary tip to produce a cross-linked hydrogel scaffold 
and maintain the printed pattern. Figure 2-31 presents a system schematic and the set-up of the 
MND system.   
 
Figure 2-31: Multi-nozzle deposition system pipeline and schematic.  
Deposition head is mounted to the motion system above a level stationary substrate. The 
flow rate of material from the nozzle is controlled by the dispensing pressure and outlet tip 
diameter. The geometric pattern of the printed material is fabricated by the programmed tool path. 
The rate material is deposited along the tool path determines the cross-sectional area of the printed 
structure. The cross-sectional area is a function of the flow rate process parameters and the 
printhead speed.  Figure 2-32 presents an illustration of the MND printhead with a single nozzle 
printing a filament.  
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Figure 2-32: Schematic of extruding nozzle with process parameters and design variables called 
out. Nozzle moved from left to right in depiction. Nozzle is continuously extruding polymer 
solution (shown as green) through capillary tip. Flow is driven by pneumatic pressure from 
compressed air reservoir regulated to a pre-determined dispensing pressure. Nozzle travels 
parallel to printing substrate to pattern polymer.  
The cross-section is modeled as an ellipse. The height of the ellipse can be no greater than 
the height of the outlet tip above the substrate. The relationship of printed cross-section takes two 
cases: (1) In the case the width of the printed filament is greater than the height, than the height is 
equal to the process parameter for the height of the tip above the substrate. (2) In the event the 
height is greater than the width, gravity will cause the not yet cross-linked solution to flow and the 
final height will be less than the elevation of the tip above the substrate. The second case is not as 
controllable as the first case. Therefore, printed width will be greater than printed height.  Figure 
2-32 presents the effect of decreasing the elevation of the printhead outlet (from left to right) on 
the printed filament height and width.  
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Figure 2-33: Schematic of printed filament cross-section generalized as an ellipse and defined by 
a major and minor axis. The minor axis will be equal to the capillary tip elevation, unless the 
elevation is greater than the capillary tip diameter.  
2.3.3.1 Definition of MND process parameters and design variables 
MND system performance is defined by a set of geometric design variables to assemble 
multiple materials in 3-dimensional space with controlled deposition along a pathway and 
width/height of the extruded filament. Design variables, ߖெே஽, are a function of the process 
parameters, ߗெே஽,௜.  The system is reproducible within the operating thresholds of the process 
parameters. Process parameters for each material are independently controlled by unique nozzles 
and are automated to vary over the time course of the build cycle to fabricate gradient structures or 
multiple sets of design variables.  Equation 2-39 presents the design of the variables ߖ , as a 
function of the process parameters ߗ, where each nozzle is described as its own indicy ݅, and as a 
variable over the course of the build cycle and therefore a function of time ݐ. 
ߖெே஽,௜ሺݐሻ ൌ ݂൛ߗெே஽,௜ሺݐሻൟ 2-39 
The MND system’s fabrication objectives define the design variables. The fabrication 
objective is a 3-dimensional built biological system using multiple materials with specific macro-
scale (10-3 – 10-1 m) pathways of material deposition and micro-scale (10-5 – 10-3 m) cross-sectional 
width/height of the deposited material. The macro-scale pathway of material deposition is 
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controlled by the motion system to be repeatable to less than 10µm. Micro-scale width, ܿ, and 
height, ݀, of the printed cross-section define the set of design variables. Each cross-section is 
fabricated by a unique nozzle, as indicated by the indicy ݅ in equation 2-40. 
ߖெே஽,௜ሺݐሻ ൌ ሾܿ௜ ሺݐሻ ݀௜ ሺݐሻ ሿ 2-40 
Process parameters are defined by the system’s hardware and software configuration. MND 
controllable process parameters are dispensing tip diameter, ܦ, dispensing pressure, ܲ, printhead 
speed, ݒ, temperature of material delivery system, ܶ, and height of the dispensing tip above the 
printing substrate, ݖ. Each of the material delivery system’s nozzles are independently controlled 
with their own set of process parameters, except for temperature. A single thermal enclosure 
surrounds all nozzles. The pressure printhead speed, and height are automated and tunable during 
a build cycle. The diameter of the dispensing tip, is selected from a prefabricated set of tips and 
cannot be changed dynamically during a build cycle.  Material parameters characterize the rheology 
during MND system operation. The concentration of solute or additives, ܰ, to the printing solution 
is included in the set of process parameters.  
ߗெே஽,௜ሺݐሻ ൌ ሾܦ௜ ௜ܲሺݐሻ ܰ ݒ௜ሺݐሻ ܶ ݖ௜ሺݐሻ ሿ 2-41 
Derived parameters assist in analytical characterization of the system. Derived parameters 
are not directly controlled by the operator and are not the specific performance objective of the 
process. Table 2-3 presents the MND system’s design, derived, material, and process parameters.  
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Table 2-3: Multi-Nozzle Deposition (MND) system design, derived, material, and process 
parameters 
Symbol Description Operating Threshold Parameter 
Type 
࡭ Cross Sectional Area of Printed 
Filament 
 Derived 
ࢉ Major Axis of Printed Ellipse  Design 
ࡰ Dispensing Tip Diameter 100 150 200
250 330 410					ߤ݉ 
Process 
ࢊ Minor Axis of Printed Ellipse  Design 
࢏ Index to identify a specific nozzle   - 
࢓ Mass Flow Rate   Derived 
ࡺ Solute or Additive Concentration  Process 
ࡼ Dispensing Pressure ൐ 40.0 psi Process 
ࡽ Volumetric Flow Rate  Derived 
࢜ Printhead Speed ൐ 15.0 mm/s Process 
ࢀ Temperature of Material Reservoir 0-4°C Process 
࢚ Time   - 
ࢠ Height of Tip Above Printing 
Substrate 
100ߤ݉ ൑ ݖ ൑ ܦ Process 
࣋ Material Density  Material 
ࢸࡹࡺࡰ The set of MND design variables   ࢹࡹࡺࡰ	 The set of MND process parameters 
for each nozzle.  
 - 
 
2.3.3.2 Motion System 
Motion is discretized into three mutually orthographic directions by Parker Daedal’s 400XR 
three axis high precision linear motor system. Gemini digital servo drives apply torque, velocity 
and encoder tracking to each of the three linear slides. Each drive is controlled by a 6K4 
Computroller controller. All controllers communicate with Parker’s Motion Planner automation 
software through the serial port SR-232. The displacement, speed, acceleration, and deceleration 
along each of the three linear slides is programmable as individual commands or a complete 
program. Displacement and bidirectional repeatability resolution are +/-10µm and +/-1.3µm, 
respectively.  
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2.3.3.3 Multi-nozzle deposition system 
The material delivery system is mounted to a high precision positioning system to deposit 
material on a stationary substrate placed underneath the tool path. Each of the four EFD pneumatic 
microvalve nozzles are independently controlled using automation software for dispense and hold 
during a build cycle. Nozzle actuation and the 3-dimensional tool path are both defined in the same 
Parker Motion Planner software program. Each nozzle is plumbed a dedicated material reservoir. 
Microvalve controller is pressurized to 70-80psi using a compressed air cylinder (AirGas) to actuate 
the valve. Material reservoir is pressurized to 0.1-40.0 psi to induce a desired flow rate through the 
extruder when the valve is open during printing.  The dispensing tip fastened to the nozzle outlet 
determined the approximate width of the printed filament. The tip is selected from a set of 
prefabricated EFD steel capillary tips.  
Configuration options for the nozzle are flexible between build cycles using a bracket 
mounting system for each nozzle, but cannot be adjusted during the build cycle. Options include: 
(1) nozzles are mounted adjacent to one another or at an angle or (2) pointed to extrude to the same 
point. Layer-by-layer printing achieves 3-dimensional scaffold architecture by stacking structures 
printed. After the structure is printed, the nozzle tip is raised and a second layer is printed on the 
first. To begin, a second layer is printed on top of the first. The programmed trajectory of the second 
layer is at 0-90 configuration to the first. This forms a grid structure or pores and extruded material.  
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Figure 2-34: Multi-nozzle configuration of nozzles mounted side-by-side for controlled 
sequential deposition (top row) and two nozzle oriented to the same point for individual or 
simultaneous extrusion (bottom row).  
2.3.3.3.1 Printhead speed selection for a set of design variables 
MND printing  is a controllable engineering process. A given set of MND process 
parameters produce a specific filament diameter; which can theoretically be varied from 250µm - 
800µm. A derived model for the printed filament width as a function of the MND process 
parameters and measured mass flow rate is presented. The derived model is a tool to define the 
MND process parameter for deposition head speed to fabricate specific filament widths. The mass 
flow rate from the material delivery system is equal to the mass flow rate of substrate accumulation. 
Further, the mass flow rate is gnerally equal to the material density and volumetric flow rate at any 
given point in the process, presented in equation 2-42.  
൬݀݉݀ݐ ൰௙௥௢௠	௠௔௧௘௥௜௔௟	ௗ௘௟௜௩௘௥௬ ௦௬௦௧௘௠ ൌ ൬
݀݉
݀ݐ ൰௦௨௕௦௧௥௔௧௘ ௔௖௖௨௠௨௟௔௧௜௢௡ ൌ ߩ௜ܳ௜ 2-42 
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The working solution is modeled as an incompressible fluid. The change in density of the 
working solution is neglected between the pressurized material delivery system and ambient 
substrate accumulation, presented in equation 2-43.  
ߩ௙௥௢௠	௠௔௧௘௥௜௔௟	ௗ௘௟௜௩௘௥௬ ௦௬௦௧௘௠ ൌ ߩ௦௨௕௦௧௥௔௧௘ ௔௖௖௨௠௨௟௔௧௜௢௡ 2-43 
The flow rate from the material delivery system is equal to the MND deposition head speed 
ݒand cross-sectional area of the printed filament ܣ, presented in equation 2-44.  
ܳ௙௥௢௠	௠௔௧௘௥௜௔௟ ௗ௘௟௜௩௘௥௬ ௦௬௦௧௘௠ ൌ ݒܣ 2-44 
Conservation of mass between the MND material resevoir and ambient substrate (equation 
2-42), constant density (equation 2-43) and volume flow rate from the material delivery system 
(equation 2-44) are combined for equation 2-45.   
ݒܣ ൌ ݉ ߩ⁄  2-45 
The density of the working solution is a function of the concentration of solute, ܰ, added to 
distilled water, presented in equation 2-46.  
ߩ ൌ 1 ൅ ܰ  2-46 
Where ρ is the density of the working solution and ܰ is the percentage of solute added to 
distilled water in mass per volume. The cross-section of the printed filament is modeled as an 
ellipse. The major and minor axis of the printed filament are parallel and perpendicular to the 
printing substrate respectively, presented in equation 2-47.  
ܣ ൌ ߨܿ݀4  2-47 
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The design variable for the printed filament height, or minor axis, is equal to the MND 
process parameters for the height of the dispensing tip over the substrate, equation 2-48.  
݀ ൌ ݖ 2-48 
The design variable for the width of a MND printed filament is defined by combining 
equation 2-45, 2-4, 2-47, and 2-48, as presented in  equation 2-49.  
ܿ ൌ 4݉ߨ݀ݒሺ1 ൅ ܰሻ 2-49 
The mass flow rate of two working solutions, alginate (Alg) and alginate blended with 
hydroxylapatite particles (Alg-HA) is experimentally measured. The MND micro-nozzle valve is 
opened and the extruded material is collected and weighed. The mass flow rate is determined from 
the measured weight and time using equation 2-50. The MND dispensing tip diameter and length, 
solute concentration of the working material, dispensing pressure, and temperature are constant 
during mass flow measurements.  
 ܯܽݏݏ	ܨ݈݋ݓ	ܴܽݐ݁ ൌ 	݉ ൌ ݂ ሺܦ,ܰ, ܲ, ܶሻ ൌ ௠೘ೌ೟೐ೝ೔ೌ೗ ೎೚೗೗೐೎೟೐೏ ೏ೠೝ೔೙೒ ೐ೣ೟ೝೠೞ೔೚೙௧೙೚೥೥೗೐ ೔ೞ ೚೛೐೙  2-50 
The minimum applied dispensing pressure to extrude 6% alginate through a 250µm 
diameter capillary tip is 15 psi. This dispensing pressure yields the smallest feasible mass flow rate 
of both materials; 6% Alg and 6% Alg-HA. Mass flow rate increases from 0.25/0.26 mg/s at 15 psi 
to 0.61/0.62 mg/s at 30 psi for Alg and Alg-HA respectively. Mass flow rate results in figure 2-35. 
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Figure 2-35: Experimental measurements of Alg and Alg-HA MND system mass flow rate 
through a 250µm capillary tip. 
The effect of dispensing pressure and printhead velocity on the printed filament width is 
studied using the experimentally determined mass flow rates (equation 2-50) and derived model 
(equation 2-49).  A graphical presentation of equation 2-49 and experimental results are presented 
in figure 2-36. Results are applicable to Alg and Alg-HA working solution using the partial set of 
MND process parameters including  a ∅250ߤ݉ tip positioned 200µm above substrate with a 
dispensing pressure of either 15 or 30psi.  
 
Figure 2-36: The effect of dispensing pressure and printhead velocity on the theoretical printed 
filament diameter of 6.0% alginate and blended alginate-hydroxylapatite extruded through a 
∅250µm capillary tip positioned 200ߤm above the printing substrate.  
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The design variable set for Alg and Alg-HA printing is defined to be a width and height of 
250µm and 200µm are presented in equation 2-50.  
ߖெே஽,௜ ൌ ሾܿ௜ ሺݐሻ ߤ݉ ݀௜ ሺݐሻ ߤ݉ ሿ  
ߖெே஽,௜ ൌ ሾ250 200 ሿ ൌ ݂൛ߗெே஽,௜ൟ 2-51 
Table 2-4 presented the printhead velocity to fabricate the set of design variables presented 
in equation 2-51.  
Table 2-4. MND printhead velocity to fabricate 250µm filament width of either 6.0% alginate 
(Alg) and blended alginate-hydroxylapatite (Alg-HA) extruded through a ∅250µm capillary tip 
positioned 200ߤm above the printing substrate. 
Material Printed Filament Width Dispensing Pressure Printhead Velocity
Alg ܿ ൌ 250 μm ܲ ൌ 15 psi ݒ ൌ 5.0	mm/s
Alg 250  30  11.9 
Alg-HA 250 15 4.8
Alg-HA 250  30 11.7  
 
Either dispensing pressure is theoretically capable of producing the set of design variables. 
The lower dispensing pressure is used in the experimental work to limit shear stress on the working 
material. This consideration for mechanical perturbations during printing is critical for future cell-
laden Alg or Alg-HA printing. 
 
ߗெே஽,௜ ൌ ሾܦ௜			μ݉ ௜ܲሺݐሻ ݌ݏ݅ ܰ ݒ௜ሺݐሻ ݉݉ ݏ⁄ ܶ Ԩ ݖ௜ሺݐሻ			ߤ݉				ሿ  
ߖெே஽,௜ ൌ ሾܿ௜ ሺݐሻ ߤ݉ ݀௜ ሺݐሻ ߤ݉ ሿ  
ߖெே஽,௜ ൌ ሾ250 250 ሿ ൌ ݂൛ߗெே஽,௜ൟ 
ൌ ݂ ൝
ܣ݈݃
ܣ݈݃ ൅ ܪܣ
ܥܽܥ݈ଶ
ൡ ൌ ݂ ൝൥
250 15.0 6%
250 15.0 6% ൅ 50݉݃ ݉ܮ⁄
400 1.0 10%
5.0 െ 200
5.0 െ 200
5.0 െ 200
൩ൡ 2-52 
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2.3.3.3.2 Alginate cross-linked with CaCl2 
Alginate (Alg) for MND printing is prepared from alginic acid sodium salt from brown 
Algae (Sigma Aldrich Corp., St. Louis, MO) in distilled water to a final concentration of 6.0% 
(w/v). The cross-linking solution for MND printing is prepared from calcium chloride ACS grade 
(BDH) in distilled water to a final concentration of 10% (w/v). MND process parameters are set to 
∅250 and Ø400µm dispensing tip and 15.0/1.0 psi for Alg and CaCl2 solutions respectively. 
Nozzles are oriented to the same point and extruded simultaneously to cross-link Alg or Alg-HA 
during 3-dimensional scaffold printing. Printhead speed is set to 5.0 mm/s and the height of the tip 
above substrate (and height increment between layers) is 200µm. The scaffold is a 20-layer stack 
of square waves. The scaffold is a single unbroken extruded filament printed to form a network of 
struts and interstitial pore space. A design model is programmed to a square wave with 20.0 mm 
center-to-center filament spacing. A complete scaffold consists of 20 layers, where consecutive 
layers are mutually orthogonal, with 200µm between layers. Figure 2-37 presents a 20-layer Alg 
scaffold respectively printed using MND. The set of process parameters to fabricate the results 
presented in equation 2-53. Printed filament width is measured to be 275µm. The target printed 
filament width being 250µm.  
ߗெே஽,௜ ൌ ሾܦ௜	ߤ݉ ௜ܲሺݐሻ ݌ݏ݅ ܰ ݒ௜ሺݐሻ݉݉/ݏ ܶ °ܥ ݖ௜ሺݐሻ	μ݉			ሿ  
൤ ܣ݈݃ܥܽܥ݈ଶ൨ ൌ ቂ
250 15.0 6%
400 1.0 10%
5.0 െ 250
5.0 െ 250 ቃ 2-53 
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Figure 2-37: Porous 20-layer scaffold fabricated by Multi-Nozzle Deposition (MND).  Scaffold 
photographed from (A) top, (B) front (C) 4x magnification of top view, and (D) 20x 
magnification top view of a pore. 
2.3.3.3.3 Alg-HA blend cross-linked with CaCl2 
Native alginate’s surface chemistry prohibits substantial cell attachment (K. Y. Lee & 
Mooney, 2012). Additives, such as HA particles, enable cell anchorage and cell-material (Wei & 
Ma, 2004). Alg and calcium chloride cross-linking solution is prepared as previously described. 
Alg-HA blend is prepared from HA (Trans-Tech Inc., Adamstown, MD) in Alg solution to a final 
concentration of 50 mg/mL. Alg-HA and calcium chloride cross-linking solution are loaded into 
separate nozzles. Figure 2-38 presents a 20-layer Alg scaffold respectively printed using MND. 
The set of process parameters to fabricate the results presented in equation 2-54. Printed filament 
width is measured to be 244µm. The target printed filament width being 250µm. 
ߗெே஽,௜ ൌ ሾܦ௜	ߤ݉ ௜ܲሺݐሻ ݌ݏ݅ ܰ ݒ௜ሺݐሻ݉݉/ݏ ܶ °ܥ ݖ௜ሺݐሻ	μ݉			ሿ  
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൤ܣ݈݃ ൅ ܪܣܥܽܥ݈ଶ ൨ ൌ ൥
250 15.0 6% ൅ 50݉݃݉ܮ
400 1.0 10%
5.0 െ 200
5.0 െ 200	൩ 2-54 
 
 
Figure 2-38: Porous 3-dimensional scaffold fabricated by Multi-Nozzle Deposition (MND). The 
20-layer 6% Alg (Alg) with 50 mg/mL Hydroxyapatite (HA) scaffold fabricated by the following 
set of MND process parameters: 15 psi dispensing pressure, 250µm/12.7mm diameter/length 
capillary, and 5.0mm/s printhead speed.   
2.3.3.3.4 Fibrin scaffold from MND printing of fibrinogen and thrombin  
Fibrin glue is composed of two agents; fibrinogen and thrombin. Fibrinogen is the base and 
thrombin is the cross-linker.  When mixed together, thrombin converts the fibrinogen into fibrin 
much like the body’s natural clotting cascade. The proportion of thrombin to fibrinogen affects the 
material properties of the resultant fibrin construct and cross-linking time. Thrombin and fibrinogen 
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supplied by Advanced Technologies and Regenerative Medicine (ATRM) from EVICEL Fibrin 
Sealant (Human) (Omrix Therapeutics). 
Cross-linking time is of critical importance to layer-by-layer manufacturing of fibrin 
scaffold. Without sufficient cross-linking time during the addition of layers, the scaffold’s 
formability is not sufficiently stable for layer-by-layer fabrication. During this work, minimum 
thrombin dilution to stably gel the construct to minimize detoeriation of macro- and micro- scale 
patterning are investigated. The lower limit of the process window for thrombin dilutions is set by 
minimum cross-linking time. The thrombin dilution may be increased from this limit to tune the 
material properties of the printed fibrin for structural and biomimetic design cues.  
Cross-linking time is a function of fibrinogen and thrombin concentration. ATRM and 
Drexel timed the cross-linking of fibrin (EVICEL™ Fibrin Sealant (Human), Omrix Therapeutics) 
using a serial dilution of thrombin. The time to print a single layer is 0.5-1.0 minutes, therefore the 
fibrin must be cross-linked in under 0.5 minutes for layer-by-layer manufacturing techniques. The 
results of the experiment are presented in Table 2.   
Table 2-5: Estimated cross-linking time for a series of thrombin 
Dilution Thrombin (mL) PBS (mL) Cross-linking time (minutes) 
1:16.67 0.30 4.70 0.5 
1:125 0.04 4.96 4.0 
1:625 0.01 4.99 15.0 
The 1:16.37 dilution of thrombin cross-linked the fibrinogen in 0.5 minutes. Less dilute 
thrombin solutions took longer than 0.5 minutes to cross-link. The 1:16.67 thrombin dilution is the 
minimum dilution for use in fibrin printing, more dilute solutions gel too slowly for fibrin printing. 
Nozzles are oriented to the same point and extruded simultaneously to cross-link fibrinogen and 
thrombin during scaffold printing. The design model used for previous Alg 20-layer scaffold 
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printing is used again for Alg-HA scaffold. The set of MND process parameters are presented in 
equation 2-55.  
ߗெே஽,௜ ൌ ቂܦ௜			μ݉ ௜ܲሺݐሻ ݌ݏ݅ ܰ ݒ௜ሺݐሻ ݉݉ݏ ܶ °ܥ ݖ௜ሺݐሻ	μ݉			ቃ  
ቂܨܾ݅ݎ݅݊݋݄݃݁݊ܶݎ݋ܾ݉݅݊ ቃ ൌ ቂ
150 2.0 ܰ݋ ܦ݈݅ݑݐ݅݋݊
150 2.0 1: 16.67
5.0 െ 200
5.0 െ 200	ቃ 2-55 
 
Figure 2-39:  Multi-layer fibrin scaffold printed by multi-nozzle deposition of thrombin and 
fibrinogen. Macroscopic photograph of dual nozzle printing fibrin (A,B) and light microscope of 
4-layer scaffold (C,D).  
 Cells-laden fibrinogen is prepared and printed a one layer series of intersecting circles and 
lines. The set of MND process parameters are presented in equation 2-56. Printing formable single 
layer structures of cell-laden fibrin is feasible. Further analysis of cell survival and function post-
printing is left to future work.  
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ߗெே஽,௜ ൌ ቂܦ௜			μ݉ ௜ܲሺݐሻ ݌ݏ݅ ܰ ݒ௜ሺݐሻ ݉݉ݏ ܶ °ܥ ݖ௜ሺݐሻ	μ݉			ቃ  
ቂܨܾ݅ݎ݅݊݋݃݁݊ ൅ ܥ݈݈݁ݏ݄ܶݎ݋ܾ݉݅݊ ቃ ൌ ൤
150 2.0 ܰ݋ ܦ݈݅ݑݐ݅݋݊ ൅ 1.0 ൈ 10଺
150 2.0 1: 16.67 	
5.0 െ 200
5.0 െ 200 ൨ 2-56 
 
 
Figure 2-40: Cell-laden polymer printed to form an intersecting line (top) and line (bottom) by 
multi-nozzle deposition of cell-laden fibrinogen and cross-linking agent thrombin. Process 
parameters defined as 250µm diameter capillary tip, 8 psi dispensing pressure, printhead speed 10 
mm/s.  Materials include 1.0E106 mesenchymal stem cells / mL fibrinogen.   
2.3.3.4 Temperature control system 
2.3.3.4.1 Rationale and description  
Temperature control system is designed to prevent the viscosity of a thermally cross-linking 
printing solution from increasing during a build cycle. Partial curing due to uncontrolled ambient 
temperature conditions increases material viscosity. Consequently, material formability becomes a 
function of the amount of time the material has been exposed to gel-inducing temperature 
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environment. Partial gelation diminishes reproducibility of the printed results. Complete curing 
causes the material delivery system to occlude and prevents further deposition. Therefore, the 
working material visacosity is stabilized using temperature control. All components of the multi-
nozzle material delivery sub-system are housed in a thermal enclosure with temperature control. 
The temperature control system includes a thermal enclosure, vortex tube, compressed air 
reservoir, and thermometer. The nozzles and material reservoir are placed in the thermal enclosure 
and mounted to the stage on the motion system. Air passes from the compressed air cylinder, 
through the vortex tube, and the cold air stream enters the thermal enclosure to cool the working 
material. Hot air stream from the vortex tubes is vented to the ambient environment. The MND 
printing operator visually monitors the thermometer and manually increases or decreases the flow 
rate from the air cylinder to cool or warm the thermal enclosure during printing.  Figure 2-41 
presented the components of the temperature control system.  
 
Figure 2-41: Temperature control system schematic mounted around material delivery system.  
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2.3.3.4.2 Matrigel thermally cross-linked 
A promising extracellular matrix is a gelatinous protein mixture Matrigel, which imporves 
in vitro biomimetic cell function through bioactive factors and essential macromolecules (Dutta & 
Dutta, 2010; Kleinman & Martin, 2005; Moghe et al., 1996). However, existing printing techniques 
are unable to dispense cell-laden Matrigel because the devices operate above the material’s gelation 
temperature. Matrigel thermally cross-links above 4ºC, and this occludes an ambient temperature 
dispensing capillary and prevents further extrusion. A novel temperature controlled printing system 
is presented in this work to pattern Matrigel and leverage both biological cues from Matrigel matrix 
and physical cues from physiologically derived cell patterning to improve biomimetic function of 
in vitro tissue analog (Allen, Khetani, & Bhatia, 2005; Nahmias, Schwartz, Hu, Verfaillie, & Odde, 
2006).  Printing technology allows researchers to leverage geometric positioning and proximity of 
specific biologics to bring functional abilities to cell aggregates (Barron, Wu, Ladouceur, & 
Ringeisen, 2004; Ciocca, De Crescenzio, Fantini, & Scotti, 2009; Murray, Garcia-Godoy, & 
Hargreaves, 2007). In this work, cells are printed in square wave form to ensure nutrient and drug 
diffusion to the core of the extruded filament, apply structural cues to cells, and quality control over 
equal dispensing for each sample.  
The feasibility of temperature controlled cell printing depends on cell viability after the 
mechanical and thermal stress of printing.  Prior to patterning cell-laden Matrigel and further study 
of printed structures, cell survival and viability 48 hours after printing is studied.  Human mammary 
epithelial of the cell line M10 (ATCC) are cultured in the Alpha Modification of Eagle's Medium 
supplemented with 10% (v/v) fetal bovine serum and 1% (v/v) penicillin streptomycin. Cells are 
rinsed with PBS, trypsinized, and counted using exclusion dye Trypan Blue and hemocytometer. 
Once counted, cells are with the gelatinous protein mixture Basement Phenol Red-free Matrigel 
(BD Bioscience) over ice to prevent gelation. Cells are homogenously distributed throughout the 
Matrigel using a gentle tapping technique with minimal pipetting to a concentration of 1.0×106 cells 
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per mL. Final printing solution is 50% cells and 50% Matrigel (v/v) solution. The cell-laden 
solution is stored on ice for 5-10 minutes prior to printing to prevent gelation. After printing, the 
viability of cells is qualitatively assessed using the fluorescence based Live/Dead 
Viability/Cytotoxicity Kit for mammalian cells. Printed constructs were screened using 
fluorometric indicators of the commercially available Live/Dead kit for live (green) and dead (red) 
cells. Figure 2-42 presents the fluorescent images of cells less than 30 minutes and 48 hours after 
printing.  Process parameters are presented in equation 2-57. 
ߗெே஽,௜ ൌ ሾܦ௜	ߤ݉ ௜ܲሺݐሻ ݌ݏ݅ ܰ ݒ௜ሺݐሻ ݉݉ ݏ⁄ ܶ Ԩ ݖ௜ሺݐሻ		ߤ݉			ሿ  
ܯܽݐݎ݈݅݃݁ ൅ ܥ݈݈݁ݏ ൌ ൤150 12.3 50% ൅ 1.0 ൈ 10଺ ݈݈ܿ݁ݏ݉ܮ െ 2 െ		൨ 2-57 
 
Figure 2-42: Human mammary epithelial cells embedded in Matrigel labeled (A) less than 30 
minutes and (B) 48 hours after printing. 
Necrotic effects of the process are not quantitatively observed in the printed cells. 
Temperature controlled printing yielded high cell survivability and viable cells remained 48 hours 
later. Minimal cell proliferation is observed, which is to be expected due to cell encapsulation.  
After observing cell survive the printing process, the authors printed a square wave of cell-
laden Matrigel. The pattern has a high surface area to volume ratio for cell/drug contact during 
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pharmacokinetic studies. Human mammary epithelial of M10 cell line were prepared in a Matrigel 
matrix as described previously and printed using the process parameters presented in equation 2-
58.  Cell arrangement post-printing is qualitatively evaluated using fluorescence based Live/Dead 
Viability/Cytotoxicity Kit for mammalian cells (Molecular Probes).  
ߗெே஽,௜ ൌ ሾܦ௜	ߤ݉ ௜ܲሺݐሻ ݌ݏ݅ ܰ ݒ௜ሺݐሻ ݉݉ ݏ⁄ ܶ Ԩ ݖ௜ሺݐሻ ߤ݉						ሿ  
ܯܽݐݎ݈݅݃݁ ൅ ܥ݈݈݁ݏ ൌ ൤250 12.3 50% ൅ 1.0 ൈ 10଺ ݈݈ܿ݁ݏ݉ܮ 10.0 2 200൨ 2-58 
 
 Figure 2-43:  (Left) photograph of printed construct and (right) fluorescent image of 
cells in printed construct. 
2.3.4 Step 2. Embed scaffold in ceramic slurry  
MND printed 20-layer scaffolds of both alginate (Alg) and alginate-hydroxylapatite (Alg-
HA) are fabricated as previously described in sections 2.3.3.3.2 and 2.3.3.3.3 respectively. The 
printed scaffold is moved to an absorbent towel to drain cross-linking solution from pore space. 
Then, printed scaffold is submerged in ceramic slurry under vacuum to remove air trapped in 
solution.  The ceramic slurry is prepared from chitosan (CS) solution for freeze casting is prepared 
by diluting 2.4% (w/v) chitosan (low molecular weight, Sigma Aldrich Corp, St. Louis, MO) in 
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100 mL of 1% (v/v) acetic acid in doubly distilled water. To completely dissolve the CS, the 
solution is rolled on a bottle roller for at least 24 hours. Subsequently, 10g of HA (Trans-Tech Inc., 
Adamstown, MD) is added to 10 mL of CS solution to obtain the CS-HA slurry. The printed 
scaffolds are rinsed with CS-HA slurry before being transferred to a cylindrical PTFE mold, which 
is filled with the CS-HA slurry and sealed by a copper bottom plate.  Any remaining bubbles from 
the submerged structure of the mold are removed by exposing the filled mold to a vacuum.   
2.3.5 Step 3. Freeze casting and lyophilization 
Scaffold microarchitecture and material properties of freeze-cast scaffolds are correlated to 
material composition and processing parameters (Hunger, Donius, & Wegst, 2012, 2013).  To begin 
freeze-casting, the mold with printed scaffold immersed in CS-HA slurry is placed with its copper 
bottom atop a cold finger. The mold is immersed in a liquid nitrogen bath (Wegst et al., 2010). The 
cooling rate applied by the cold finger is regulated with a PID-controller that is attached to a 
thermocouple at the top of the cold finger and a band heater just below it to counteract the liquid 
nitrogen cooling.  The directional freezing of a polymer-ceramic slurry in a cylindrical mold results 
in a highly aligned assembly of lamellar pure ice crystals, between which the polymer-ceramic 
phase is concentrated. The applied freezing rate, which can be carefully controlled, determines the 
sample cooling rate as well as the velocity of the freezing front within the mold, and through it the 
ice crystal thickness and lamellar spacing within the freeze-cast composite scaffold.  The samples 
of this study are frozen at a cooling rate of 10°C per minute until completely solidified, removed 
from the PTFE mold and transferred to a lyophilizer (FreeZone 4.5, Labconco, Kansas City, MO), 
where they are held for at least 48 hours to remove the ice phase. 
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Figure 2-44: Schematic of freeze-casting system, reproduced from Wegst et. al. (Wegst et al., 
2010) and freeze cast CS-HA scaffold after lyophilization to sublimate ice phase. Front view (top 
right) presents the outside surface of the scaffold. No significant porosity to exchange gas or 
liquid between the core of the scaffold and ambient environment is evident. Section view (bottom 
right) of the same scaffold present lamella network; orthographic to the cooling plate. Lamellae 
are open pores in scaffold formed when ice phase is sublimated during lyophilization.  
2.3.5.1 Scanning electron microscope characterization 
Scanning electron microscopy is performed at high vacuum with a Zeiss Supra 50VP SEM 
(Carl Zeiss Microscopy, LLC, Thornwood, NY) at an accelerating voltage of 6 kV and a working 
distance of 4 to 6 mm. All investigated specimens were sputter coated with a 5 nm thick layer of 
platinum-palladium to provide a conductive path during imaging.  
2.3.5.2 MND printed scaffold embedded in freeze cast scaffold 
Combining the printing with the freeze-casting process superimposes the embedded 
transverse Alg network with a scaffold in which the lamellae are longitudinally aligned to produce 
a hierarchical microarchitecture with a heterogeneous cell wall material composition.  The size and 
spacing of the uni-directional lamellae network is controlled by the rate of freezing.  The embedded 
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Alg network remains in the polymer-ceramic composite after freeze drying. These filaments 
produce a regular lateral porosity, which is orthogonal to the longitudinal lamellae. The longitudinal 
lamellae are in plane with the imaged cross-section. The lateral pores, created by the Alg filaments, 
are normal to the imaged cross-section. Figure 2-45 presents images of a cross-section of such CS-
HA-Alg scaffold without sintering. Regular pores, two along the top row and two along the bottom 
row, are visible in the SEM. An Alg filament is emerging from a pore in the upper right corner and 
extends across the scaffold cross-section.   
 
Figure 2-45: (A-C) CS-HA and CS-HA-Alg (D-F) scaffolds after freeze casting (no sintering) 
and then sectioned longitudinally. (A, D) Photographs of cross-section of scaffold to expose a 
longitudinal view of lamellae network and side view of embedded Alg scaffold. (B, E) 4 x 
magnifications of A and D, respectively. (C,F) 10 x magnifications of A and D, respectively. 
Arrows in E and F point to Alg filaments protruding from section. 
2.3.5.3 Sintering CS-HA matrix 
Sintering removes the embedded Alg as well as the CS binder from the CS-HA matrix to 
produce open pores, while a monolithic HA-ceramic scaffold with increased stiffness and strength 
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is created (Ruys et al., 1995). Figure 2-46 presents SEM micrographs of un-sintered and sintered 
freeze-cast CS-HA scaffold.  
 
Figure 2-46: SEM micrographs of un-sintered (left) and sintered (right) freeze cast CS-HA. 
Sintering incinerated CS and sinters HA particles. 
The embedded MND network templates the transverse pore network within the lamellar CS 
scaffold, resulting in hierarchical, porosity. The lamellar structure is maintained after sintering and 
thus provides high stiffness and strength while providing longitudinal porosity for cell migration, 
innervation and vascularization as well as the transport of nutrients or metabolic waste. Further, 
through the initial incorporation of the printed Alg scaffold, there exist transverse pores in the 
structure, which result in a network of pores between and through the ceramic lamellae. Two sets 
of mutually orthogonal pores are superimposed because of the combined process. Unidirectional 
lamellae extend longitudinally through the cylindrical scaffold. Sintering incinerates CS and Alg 
components of the scaffold leaving HA. After sintering, scaffolds sectioned longitudinally and 
presented in figure 2-47. 
The structure of each scaffold component can be independently varied to produce a 
hierarchy of microenvironments within a single scaffold and enhanced diffusion. An SEM 
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micrograph of a longitudinal section of the composite scaffold after sintering with a binary inset of 
an Alg templated pore is presented in figure 2-46. Images are converted to 8-bit and analyzed using 
the Image J (NIH) Analyzed Particles routine.  The average pore cross-sectional area is 
13,731 µm2 +/- 1984 µm2 with an average major axis of 163µm +/- 28 µm and average minor axis 
of 115 µm +/- 17 µm.  
 
Figure 2-47: SEM of longitudinal section view of CS-HA-Alg, scaffold produced by the 
combined process after sintering, to expose lateral porosity produced by embedded porous 
scaffold. (A) Far field view of several Alg pores and (B) close view of single pore (bottom). Inset 
are binary images of A and B to show of pore produced by embedded Alg scaffold. Scale bar is 
100µm.   
2.3.6 Cell attachment to printed substrates after 24 hrs  
Because Alg, CS-HA and CS-HA-Alg could be substrates within the scaffold, when the 
scaffold is not sintered, each substrate is evaluated for cell viability after 24 hours. Mouse 
osteoblasts from bone marrow of the 7F2 cell line (ATCC) are cultured in alpha minimum essential 
medium (Sigman et al.) supplemented with 2mM l-glutamine (Sigma Aldrich Corp., St. Louis, 
MO), 1mM sodium pyruvate without ribonucleosides and deoxyribonucleosides (Sigma Aldrich 
Corp., St. Louis, MO) and 10% (v/v) fetal bovine serum (Gibco). A suspension of 106 7F2 cells / 
mL of complete cell culture medium is placed in a non-adherent culture dish with 0.5 g Alg, CS-
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HA or CS-HA-Alg substrate (n=3). After 24 hours, the substrate is rinsed 3 times with fresh 
medium and then stained with Live/Dead Viability/Cytotoxicity Kit (Molecular Probes) according 
to manufacturer specified protocol to examine the substrate for viable and adherent cells. Figure 2-
47 presents live cells and dead cells attached to variable substrate materials after 24 hours. Alg 
shows significantly less viable cells than the other substrates.   
 
Figure 2-48: 7F2 cells seeded on variable material substrates; CS-HA-Alg scaffold produced by 
the combined process without sintering (A-C), freeze cast CS-HA (D-F), and printed Alg (G-I). 
Fluorescent image of live and dead stain (A,D,G), binary image of live cell signal (BE,H), and 
binary image of dead cell signal (C,F,I).   Scale bar is 100µm.  
Fluorescent images for CS-HA, and CS-HA-Alg are analyzed by ImageJ (NIH) to quantify 
the area live and dead cells occupy in culture, as presented in figure 2-48. The number of live cells 
are significantly greater than dead cells for CS-HA containing substrates. The Alg substrate has 
less live cells and more dead cells than both the CS-HA and CS-HA-Alg substrates. 
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Figure 2-49: Area live and dead cells occupy on variable material substrates; scaffold produced 
by the combined process without sintering CS-HA-Alg, freeze cast CS-HA, and printed Alg.  
2.3.7 Discussion 
The objective of this work is to present a processing technique to produce an engineered 
hierarchical architecture with lateral and longitudinal porosity.  Without sintering, the freeze-cast 
scaffold conjugates two niche material microenvironments in a single engineered CS-HA-Alg 
scaffold. With sintering, the scaffold couples two open pore networks of the lamellae, longitudinal, 
and transverse network templated by the printed 3-dimensional alginate scaffold. Sintering 
increases scaffold stiffness and strength. Mass transfer and cell mobilization in sintered and un-
sintered scaffolds offer advantages for a variety of tissue engineering applications and in vitro cell 
culture.  
The two-step processing technique offers several advantages.   It overcomes the limitation 
of many freeze-cast scaffolds which offer only a limited or no lateral diffusivity between adjacent 
pores and the scaffold surface.  Two porous networks are super-imposed by combining the two bio-
98 
 
additive manufacturing techniques (1) SFF using a MND system to print a 3-dimensional porous 
scaffold and (2) directional freeze casting and lyophilization to fabricate lamellae and directional 
porosity in a CS-HA matrix.   
Engineering process control over both the lamellae network and 3-dimensional porous 
scaffold is due to the independence of each of the two fabrication techniques - MND and freeze 
casting. Engineering analysis of the MND process parameters, including the flow rate and printhead 
velocity, defines the manufacturing expertise required to fabricate a pre-determined filament 
diameter. Freeze casting process parameters include the rate of cooling, possible additives and the 
position of the cooling probe; in this work a cylindrical mold of CS-HA-Alg is placed on a flat 
cooling plate. The set of processing parameters used during fabrication determines the lamellar 
thickness and spacing as well as the shape of the longitudinal pores. The set of parameters used 
during fabrication engineer a controlled set of traverse and longitudinal microenvironments; the 
Alg filament diameter and lamellae. Consequently, sintering incinerates Alg leaving an open 
network of pores templated by the embedded printed scaffold.  The combined freeze casting and 
MND fabrication technique retains independent process control of porosity in 3 directions by 
combing the lamella and MND network. 
The combined MND and freeze casting process produces a hierarchical microarchitecture. 
In addition to the sub-micron scale of the lamellae, the embedded MND network produces an 
average pore cross-sectional area of 13,731 µm2 +/- 1984 µm2 with an average major axis of 
163µm +/- 28 µm and average minor axis of 115 µm +/- 17 µm.  Lamellae and MND network are 
mutually orthogonal and cover 3-4 orders of magnitude, sub-micron lamellae to 100 µm MND pore 
diameter.  Before sintering, the CS-HA-Alg is a heterogeneous material. Material stiffness and 
surface chemistry are significant factors in phenotype-specific function through cell-material 
interaction(Bhumiratana et al., 2011; Genes, Rowley, Mooney, & Bonassar, 2004; Pek, Wan, & 
Ying, 2010) After sintering, the Alg and CS are removed, leaving a network of open pores and 
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homogenous HA material composition. The diameter of the printed filament is significantly larger 
than the quantified lateral pore size after directional freeze casting and sintering. This is attributed 
to shrinkage of the ceramic scaffold during sintering.  
Both the CS-HA and CS-HA-Alg, maintain viable cells for 24 hours after cell seeding. After 
rinsing, the cells remain attached to CS-HA containing substrates. Mouse osteoblasts attach to CS-
HA containing substrates after 24 hours. Alg is not cytotoxic but cannot support cell viability. 
Mouse osteoblasts did not adhere to the Alg substrate due to the material’s surface chemistry (K. 
Y. Lee & Mooney, 2012).  It is the CS-HA component of the CS-HA-Alg scaffold which supports 
cell growth, specifically the HA particles(Wei & Ma, 2004).  
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CHAPTER 3: FABRICATION OF HETERO-CELLULAR MICROFLUIDIC DEVICE 
AND APPLICATION 
In this chapter, hetero-cellular microfluidic devices are constructed from a channel network 
fabricated by the precision extrusion deposition/replica molding process previously described. 
Cell-laden microfluidic devices are adventageous for the following environmental and structural 
factors (1) forced convection through a cell-laden matrix, (2) cell to interstitial fluid volume, (3) 
cell seeding, and (4) residence time of drug or other soluble cues. We investigate two types of cell-
laden devices; the first with a 3-dimensional channel networks fully embedded in a PDMS substrate 
and the second a channel network on the surface of the PDMS substrate for cell printing directly 
into device channels. Fully embedded networks are leak-resistant with simplified construction 
methods.  However, surface channel networks are partially exposed; which allows for controlled 
cell seeding by multi-nozzle deposition throughout the network. Hetero-cellular arrangement 
throughout the microfluidic device improves the in vitro model’s biomimetic attributes and hold 
promise to increases in vitro model fidelity. A hetero-cellular microfluidic device to model human 
liver is designed, fabricated and applied to study the effect of hetero-cellular arrangement on 
radioprotective drug efficacy.  
3.1 Final construction of a cell-laden microfluidic device  
3.1.1 Rationale 
The precision extrusion deposition of a PCL pattern followed by replica molding produces 
a 3-dimensional interconnected channel network embedded in a PDMS substrate. The process has 
the following advantages: (1) channel network is sealed in PDMS, meaning no additional cover 
component is required to construct the device and (2) the geometric pattern of the channel network 
and their cross-sectional width/height are achieved by tuning automated process parameters. In this 
work, we construct a complete microfluidic device using an embedded channel network, inject cells 
and test the maximum flow rate using a programmable syringe pump.  The objective is to present 
the precision extrusion deposition/replica molding process as a viable and potentially advantageous 
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fabrication method for leak-resistant 3-dimensional microfluidic devices.  The leak-resistant claim 
comes from no requirement for a cover, as the network is embedded. Perfusion occurs through 
capillary tips inserted from the surface to the open channels.   
 
Figure 3-1: Microfluidic device without fluid (left), with blue fluid perfusion (center) and with 
red fluid perfusion (right). 
3.1.2 Description of method 
Cell-laden microfluidic device is fabricated by (1) precision extrusion deposition and replica 
molding of microfluidic network, (2) fix capillary tips to inlet and outlet, (3) plumb with silicone 
tubes to pump, and (4) sterilize and inject cell-laden solution.  
 
Figure 3-2: Step-by-step fabrication process to produce a cell-laden microfluidic device with 
channel network embedded in a PDMS substrate.  
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3.1.2.1 Step 1. Precision extrusion deposition and replica molding of microfluidic network  
This step requires the same considerations as those presented in section 2.2 description of 
the precision extrusion and replica molding process.  
3.1.2.2 Step 2. Fix capillary tips to inlet and outlet   
Capillary or syringe tips are used to clear PCL pattern embedded in the PDMS substrate 
during the fabrication process. Add a droplet of lubricant, water is sufficient, to the PDMS surface 
prior to puncturing in the surface to minimize PDMS tearing. A prefabricated steel 250-350µm 
inner diameter capillary tip is used for inlet and outlet. The tip size is selected to fit in silicone tube 
without leakage or additional means of fastening.   
 
Figure 3-3: Printed PCL pattern embedded in PDMS with 350µms inner diameter steel capillary 
tips inserted through PDMS to PCL pattern. Capillary tips serve as inlet/outlet of device. No 
additional ports or cover needed. 
3.1.2.3 Step 3. Plumb with silicone tubes to pump  
Silicone tubes inserted over the capillary tips are plumbed back to syringe pump. A 
prefabricated 250-350µm inner diameter capillary tip is also inserted into the other end of the 
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silicone tube. Luer lock housing molded around the tip mates to a luer lock syringe. Fluid is loaded 
into the syringe and diffused through microfluidic device using a programmable syringe pump.  
3.1.2.4 Step 4. Sterilize and inject cell-laden solution 
Sterilization by autoclave or 70% ethanol rinse prepare the microfluidic device for cell 
culture. The cell population is expanded in tissue culture dishes with cell culture medium as 
specified by cell provider. To prepare a cell solution for injection, first collect the cell pellet by 
trypsin and centrifugation. Next, re-suspend cell pellet in less than the estimated volume of the 
channel network.  Aseptically load solution in sterile syringe. Fix a 25-350µm capillary tip to the 
end of the syringe and directly inject solution into microfluidic network. Inject slowly to minimize 
additional perturbation to cells. Store device in incubator overnight to allow for cell attachment.  
Cell attachment to the channel walls of the microlfuidic device is observed using a human 
hepatocyte cell line and fluorescence based kit. Human hepatocytes of the HepG2 cell line (ATCC) 
are cultured in Eagle’s Minimum Essential Medium base medium (ATCC) supplemented with 10% 
(v/v) fetal bovine serum (FBS) (Invitrogen) and 1% (v/v) antibiotic/antimycotic (Invitrogen). Cells 
are maintained at 32ºC and 5% CO2 for less than 3 passages after thawing prior to experiment. 
Microfluidic device is sterilized and cells are injected as described. After 12 hours, the cell-laden 
device is connected to a programmable syringe pump and perfused 1.0 mL/hr for 3.0 hours. The 
estimated volume of the microfluidic network is less than 0.5 mL; this estimate is based on the 
volume injected from a syringe to fill the network after the device’s final construction.  After 
perfusion, cells are fixed with 70% ethanol and stained using fluorescence based Live/Dead 
Viability/Cytotoxicity Kit for mammalian cells (Molecular Probes).  
Figure 3-4 presents a light microscope image of the channels (left) and fluorescent image of 
one region of the light microscope image to show the cells in the channel (right). Cells labeled 
green and red are visible in the fluorescent image. The kit labels live cells (cells with an intact 
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membrane) green and dead cells (cells with a ruptured membrane) red. Cells were fixed to preserve 
their location and enhance visualization prior to staining. Necrosis caused by the environment or 
cell seeding process would be rinsed away before fixation or staining. The appearance of both green 
and red fluorescent probes in the image means not all cells were fixed or fixation was incomplete. 
However, the location of the cells in the channel is apparent. The green probe is further proof the 
cells were able to attach and survive in the PDMS microfluidic channel for the overnight static 
incubation and 3 hour perfusion periods.  
 
Figure 3-4: Image of microfluidic device under 4x magnification (left)  and fluorescent image of 
cells labeled with green and red Fluorochrome (right).  
Figure 3-5 presents a section of the microfluidic network with cells. The figure shows the 
same view field four times to compare channels/cells and two focal planes. Light microscope 
images of the channel network (A,C) present the channel network and fluorescent images of labeled 
cells (B,D). Cells are present in the channels after dynamic perfusion for 3 hours. Two focal planes, 
one near field (A,B) and far field (C,D) demonstrate the microfluidic network is 3-dimensional 
with perfusion and cells throughout the network of channels. 
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Figure 3-5: Cell seeded in the channels of the microfluidic device adhere to the walls of 
channels. Cells adhere to channels on multiple levels.  
3.1.3 Leak resistance during forced convection  
Connectivity of the open network channels from the inlet and outlet are deomstrated by the 
perfusion of fluid through the microfluidic device. Figure 3-6 presents a time lapse photo sequence 
of PDMS microfluidic device being perfused. Each frame contains a top (left) and front (right) 
view of the device.  The leak resistance of a fully constructed microfluidic device is evaluated using 
a programmable syringe pump. Syringes are filled with water colored with food die. Perfusion rate 
was maintained at 2.0 mL/min for 10 minutes. No leaks were observed from the insertion points of 
the capillary tips. Figure 3-7 presents a 30 second time-lapse set of images to show perfusion of 
1.0mL of fluid across the microfluidic device without leakage. Yellow arrows in the intial and final 
photograph call attention to the beginning and ending position of the second hand.  
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Figure 3-6: Time lapse photo sequence of PDMS microfluidic device being perfused. Each frame 
contains a top (left) and front (right) view of the device.  
 
Figure 3-7: Controlled perfusion of microfluidic device by programmable syringe pump. Figure 
presents time lapse photographs of 30 seconds of 2 mL/min perfusion. The clock face behind the 
microfluidic device counts through 30 seconds. Yellow arrows in frames 1 and 9 point out the 
initial and final location of the second hand. The final volume perfused after 30 seconds is 1 mL. 
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3.2 Cell printing in channels of a microfluidic device 
3.2.1 Rationale 
In this work, multiple cell-laden solutions are selectively assembled through an open 
channel network using multi-nozzle printing. The objective is to fabricate a cell-laden microfluidic 
device with controlled arrangement of multiple cell types between the inlet and outlet of the device.  
3.2.2 Definition of method 
The combined SFF patterning and replica molding process produces a cell-laden 
microfluidic device with channel designed to biomimic liver physiology and flow design. First, 
microfluidic channel pattern is designed from in vivo liver structure. Second, microfluidic pattern 
is printed using precision extrusion deposition. PDMS is cured against the PCL pattern in a single 
step of replica molding to produce PDMS substrate. PCL pattern is cleared from PDMS, which 
leaves a network of open channels. The PDMS microfluidic chip is plasma treated to decrease 
surface energy for  homogenous surface wetting during printing. Cell-laden matrix is directly 
printed into the channels using direct cell writing system. Cell-laden microfluidic chip is sealed and 
cell culture medium is perfused to deliver nutrients and remove waste using a programmable 
syringe pump.   Figure 3-8 pesents the process to fabricate the cell-laden microfluidic device with 
controlled cell arrangement in microfluidic channels by cell printing.  
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Figure 3-8: Step-by-step fabrication process to produce a cell-laden microfluidic device 
leveraging cell printing for controlled assembly of cells and matrix material in the device channel 
network.  Channels are on the surface of PDMS substrate. Cover with ports aligned to channel 
network inlet/outlet also required to seal system.  
3.2.2.1 Step 1. Precision extrusion deposition and replica molding of microfluidic network  
This step requires the same considerations as those presented in section 2.1.2, the description 
of the precision extrusion and replica molding process.  
3.2.2.2 Step 2. Design and fabricate device cover   
The microfluidic device’s cover serves the following role: (1) closes channels open on the 
surface of the PDMS substrate, (2) includes ports to fasten hosing from the syringe pump to the 
channel network and (3) is of sufficient surface area to create a seal against leakage. The surface 
area of the cover is sufficient to close all open channels on the surface of PDMS substrate plus at 
least a 1.0 cm border for sealing. The location of ports on the cover is mapped to the inlet and outlet 
of microfluidic network. The cover is made of either glass or PDMS. Holes through the cover and 
the attachment of ports depends on the cover material. All cover ports are flat bottom nano-ports 
(UpChurch Scientific). For the glass cover, through holes are made using a diamond tip bit and a 
hand drill. Ports are attached over the holes using adhesive with a gasket, following the 
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manufacturer’s direction. For the PDMS cover, ports are glued to a petri dish with water soluble 
adhesive.  PDMS is prepared 10:1 base to elastomer and poured in the dish around the ports as a 5-
10mm deep pool. After PDMS has cured, the cover is peeled away from the petri dish, cut to size 
using a scalpel and washed with warm soap and water. The cover, either glass or PDMS, is sterilized 
by autoclave.  
3.2.2.3 Step 3. Plasma surface treatment  
Plasma surface treatment oxidizes the PDMS substrate methyl groups to form silanol groups 
(Whitesides, Ng, Gitlin, & Stroock, 2002). The wettability of cross-linking solution and printed 
alginate matrix is controllable and homogenous on post-plasma treated surface. PDMS substrate is 
placed in RF plasma chamber (Harrick Plasma) for 90 seconds less than 2 minutes prior to printing.  
 
Figure 3-9: Effect of 90 second air plasma treatment on homogeneity PDMS substrate wettability 
3.2.2.4 Step 4. Cell printing in channels 
Cell printing by multi-nozzle deposition produces explicitly designed 3-dimensional 
patterns of cell-laden matrix in microfluidic device (W. Sun et al., 2010; W. Sun et al., 2008). The 
material delivery system is mounted to a high precision positioning system to print the cells into 
microfluidic channels. The design input model for cell printing tool path is reproduced from PED 
model programmed to fabricate the PCL pattern used to template the open network of channels. 
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Figure 3-10 presents system configuration for direct cell writing system aligned to PDMS substrate 
to print cells into microfluidic channels. 
 
Figure 3-10: PDMS substrate positioned under bioprinter printhead to directly deposit cells and 
matrix into microfluidic channels.  
 
Figure 3-11:  Time lapse photographs of MND system extrusion of alginate into sinusoid channel 
network on the surface of a PDMS substrate.  
The volume of dispensed material is controllable by manufacturing process parameters. A 
set of fully defined direct cell writing process parameters produces a unique volume dispensed per 
unit surface area of channel. Process parameters can be varied independent of printed pattern to 
produce patterns of extruded filaments of variable diameter. The volume dispensed per unit area of 
substrate is a function of the flow rate and speed of material delivery system. The flow rate through 
the nozzle is a function of the capillary tip diameter and length, material viscosity, and dispensing 
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pressure. The matrix viscosity is a function of the material and cells concentration, which are 
selected for to support cell growth after printing. Dispensing tip is selected from a set of 
prefabricated tips and fixed to material delivery system before printing. Dispensing pressure and 
speed of material delivery system can be adjusted during printing and tuned to create variable 
filament diameters. Figure 3-12 presents matrix extruded through 150µm nozzle tip at 5psi with 
variable speeds of material delivery system. Equation 3-1 presents the MND process parameters.  
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Figure 3-12: Bioprinting variable filament width using the manufacturing process parameters. 
Dispensing pressure 5psi, dispensing tip diameter 150µm and variable traveling speed. 
Photographs with measured filament width presented on left. Plot of measured filament width as 
a function of programmed printhead speed on right.  
Cell-laden matrix is prepared and loaded into multi-nozzle deposition (MND) direct cell 
writing system and printed.  Human hepatocytes of the HepG2 cell line (ATCC) are cultured in 
Eagle’s Minimum Essential Medium base medium (ATCC) supplemented with 10% (v/v) fetal 
bovine serum (FBS) (Invitrogen) and 1% (v/v) antibiotic/antimycotic (Invitrogen). Cells are 
maintained at 32ºC and 5% CO2 for less than 3 passages after thawing prior to experiment. Alginate 
matrix prepared from 6.0% (w/v) alginic acid sodium salt from brown algae (Sigman et al.) in 
deionized water is sterilized by serial filtration through 0.2µm mesh (VWR). Cells are mixed with 
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alginate for final concentration of 2.0x106 HepG2 cells per mL aqeuous alginate solution. Prior to 
printing, channels are flooded with 5.0% (w/v) calcium chloride (Sigman et al.) in deionized water 
cross-linking solution. Cell viability post-printing is qualitatively evaluated using fluorescence 
based Live/Dead Viability/Cytotoxicity Kit for mammalian cells (Molecular Probes). Two-color 
discrimination by the fluorescent probes enthedium calcein AM and ethidium homodimer-1 labels 
live cells as green and dead cells as red. Samples were analyzed using a DM RIB inverted 
microscope (Leica) with UV source. Images of all cells were captured electronically by Insight 
4.0Mp Monochrome digital camera (Spot Insight) and manufacturer provided imaging software. 
Cells are fluorescently labeled after printing to demonstrate their position. Figure 3-13 presents 
hepatocytes-laden alginate printed into microlfuidic channels fabricated by the combined preciison 
extrusion depostion and replica molding process. The set of MND process parameters for direct 
cell writing are presented in equation 3-2.   
ߗெே஽,௜ ൌ ሾܦ௜		μ݉ ௜ܲሺݐሻ ݌ݏ݅ ܰ ݒ௜ሺݐሻ ݉݉/ݏ ܶ Ԩ ݖ௜ሺݐሻ		ߤ݉			ሿ  
൤ܣ݈݃ ൅ ܥ݈݈݁ݏܥܽܥ݈ଶ ൨ ൌ ൥
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Figure 3-13: Hepatocytes in alginate printed into channels labeled with the Live/Dead stain and 
photographed under phase contrast (top row) and fluorescent (bottom row) microscope.  
Fluorescent imaging confirmed viable hepatocytes were printed into microfluidic channels 
on PDMS chip. No necrotic effects of the process on the healthy cells is qualitatively observed in 
the healthy cells. Cell printing enables control over geometric pattern and specific area of cell-laden 
matrix in channels. Further, cell printing by multi-nozzle deposition automates 3-dimensional 
deposition relative to (1) global coordinate space and (2) the other working solution being printed. 
The methods to arrange the discrete working solutions in microfluidic channels include any or a 
combination of the following: 
 Direct all nozzles at a single point and extrude concurrently. Control the volume 
fraction of each solution by the selection of process parameters for each nozzle.  
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 Direct all nozzles to a single point and selectively open and close each valve while 
tracing the microfluidic channel trajectory. Produce an alternating pattern of 
homogenous phenotypes, support material, or scaffolding throughout the network. 
 Open one valve while tracing the microfluidic channel trajectory, then re-trace the 
microfluidic channel trajectory with another valve open. Produce a layered structure in 
the channel, with the second layer in contact with fluid and therefore any soluble cues or 
drugs, before the shielded layer.  
 
Figure 3-14: Single and dual nozzle printing into channel to control the arrangement of multiple 
materials throughout the microfluidic network.  
Hepatocytes are seeded into channels using multi-nozzle deposition for direct cell writing 
of two different cel types. The purpose is to demonstrate control over the arrangement of discrete 
cell types throughout the channel network. Hepatocytes are prepared as previously described. 
However, before printing cell-laden solution is split into two equal volumes. One volume is stored 
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in 37°C water bath. The other volume is repeatedly frozen/thawed between -210°C liquid nitrogen 
and 37°C water bath to lyse cells. Each solution (healthy and lysed) is loaded into separate nozzles 
and printed into alternating channels of a square wave network. Live/Dead staining after printing 
fluorescently labels the lysed and healthy cells red and green respectively. Imaging of the cells after 
printing demonstrates the position of each cell solution after multi-nozzle deposition. Figure 3-15 
presents the two types of cells printed into alternating channels of the microfluidic device. Equation 
3-3 presents the set of process parameters for MND direct cell writing of both cell types. Multi-
nozzle deposition successfully assembled healthy cells (green) and lysed cells (red) in alternating 
channels of the network. The damage to the lysed cells is not a consequence of the printing process 
of channel environment. Cells were purposely lysed prior to printing for imaging purposes. 
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Figure 3-15: Controlled cell seeding of two cell types by multi-nozzle bioprinting. Two 
fluorescently labeled cells (red and green) are printed in alternating channels.  
3.2.2.5 Step 5. Add cover and align ports to channel inlet/outlet   
Manually align inlet/outlet of channel network on PDMS substrate with ports on cover and 
place cover. Plasma surface treatment on PDMS substrate improves substrate/cover seal.    
3.2.2.6 Step 6. Secure in bracket  
Align holes in bracket’s cover with inlet/outlet ports on the microfluidic device’s cover and 
place the device in bracket. Secure the bracket with screws. Manually tighten screws to achieve a 
seal with the minimal amount of compression to PDMS components.   
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3.2.2.7 Step 7. Plumb with silicone tubes to pump 
Cell-laden PDMS microfluidic chip and PDMS cover fitted with nano-port assemblies 
(Upchurch Scientific) secured together by polycarbonate brace to form a microfluidic circuit. 
System perfused by programmable syringe pump (Next Era) and flow tested to 10µL/hr with media.   
 
Figure 3-16: Photograph of cell-laden microfluidic device in bracket with silicone tubes to inlet 
and outlet (left) plumbed to programmable syringe pump (right).  
3.2.3 Discussion 
The objective of this work is to fabricate a cell-laden microfluidic device by combined solid 
freeform patterning and replica molding with direct cell writing into channels. MND for direct cell 
writing defines a set of process parameters to control over cell to fluid volume ratio and 
arrangement of cell types. Precise volumes of fluid in a microfluidic device are transported through 
microfluidic device through continuous network of channels up to a flow rate of 10µL/hr.  
Cell seeding is controlled by direct cell writing of cell-laden matrix into microfluidic 
channels. SFF manufacturing by MND for direct cell writing traces channel pattern to dispense 
cell-laden matrix into channels. The direct cell writing process has multi-nozzle capability to 
pattern different types of biologics within a single microfluidic device during a single printing 
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episode. The direct cell writing motion system has the capability to move in 3-dimensional space 
to layer and pattern biologics. MND for direct cell writing is a feasible biofabrication method to 
introduce hierarchical patterning of cell/biologics densities or cell types throughout the depth of 
the chip, in addition to the planar patterning, to cell arrangement throughout a microfluidic device. 
Direct cell writing process produces manufacturing control of volume of printed material 
per unit area of substrate and therefore control of cell to interstitial fluid volume ratio. The diameter 
of the extruded cell-laden filament is a function of the nozzle diameter, feed rate (dispensing 
pressure), matrix viscosity, and travel speed of the material delivery system. In this work, we used 
150µm capillary tip. Remaining process parameters were derived from previous work printing 
alginate using direct cell writing process to produce threshold minimum filament diameter, as it is 
the limiting case. The filament diameter can be increased by increasing the volume of material 
dispensed per unit area of substrate. This can be accomplished by increasing dispensing rate, 
decreasing matrix viscosity, or decreasing travel speed of the material delivery system. Since the 
cross-section of the microfluidic channel has been characterized, operator produce a cell to 
interstitial fluid ratio close to one by tuning direct cell writing process parameters.  The process 
allows for independent control over the filament cross-section and pattern.    Printed pattern and set 
of process parameters manufactures a unique 3-dimensional cell-laden construct.  
3.3 Effect of hetero-cellular microfluidic device on radioprotective drug efficacy 
3.3.1 Rationale for study 
Advancements in multi-nozzle deposition and microfluidic technology enables controlled 
spatial deposition of several cell types in a single microfluidic network with reproducible 
engineering process control.  Such techniques are leveraged to study the impact of co vs. mono-
culture on drug efficacy. The objective of this study is to determine the effect of an engineered co-
culture on the radioprotective efficacy of the pro-drug amifostine on human liver cells in a 
microfluidic device. Tissue engineering applications of this work include the biomimetic co-culture 
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design and in vitro drug discovery platforms.  Research tasks include (1) design and fabrication of 
a built biological model of native human hepatic niche, (2) identify a radiation source and exposure 
to model of extraplanetary radiation and (3) experimentally compare the radioprotective effect of 
drug on liver’s parenchymal cells type in mono- and co-culture with epithelial cells.  
The built biological model of liver tissue leverages multi-nozzle deposition bioprinting and 
microfluidic technology. Multi-nozzle deposition bioprinting enables controlled arrangement of the 
cells in the microfluidic device. The arrangement of cells in the device determines the sequence of 
drug-cell interactions and consequently, if the drug is in active or in-active form. Each cell type is 
contained in a separate chamber within the microfluidic device. Chambers are connected by a 
microfluidic network perfused with cell culture medium. The arrangement of the chambers and 
uni-directional flow through the device separates drug-cell type interactions chronologically and 
by phenotype. The effect of drug’s interaction with epithelial cells is effected through soluble cues 
when the drug flows from the epithelial chamber into the hepatocyte chamber. The residence time 
of the drug in each chamber is controlled using a programmable syringe pump.    
3.3.2 Model design and fabrication 
High fidelity in vitro models are achieved through advanced manufacturing and 
environmental controls. The cell model design objective is a predetermined geometric pattern to 
achieve sufficient diffusion for cell viability and biomimetic hetero-cellular arrangements.  A 
biomimetic environment and transient control after fabrication is achieved using engineered 
devices to deliver prescriptive amounts of physiologically relevant physical, soluble, and biological 
stress (P. J. Lee, Hung, & Lee, 2007; Tourovskaia, Figueroa-Masot, & Folch, 2005). These 
deliberate environmental components are meant to enhance culture’s function beyond the activity 
of a single cell type aggregate to synergistic and cooperative activity of multiple cell types (Dash 
et al., 2009; Gebhardt et al., 2003).  The microfluidic model in this study physically segregated 
each cell type into separate chambers of a microfluidic system. The transient interaction between 
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compartments of the device, and therefore cell types, is controlled by the flow rate of the pump. In 
this study, we model the radio protective drug efficacy on human liver using a co-culture of 
hepatocyte and epithelial cells. Each cell type is relegagated in discrete compartment of a 
microfluidic device and serially connected. Soluble cues, such as drug, are carried throughout the 
body in the cariovasular system’s lumen. Nutrients and drugs diffuse from the lumen, through an 
epithelial cell lining and into the trabeular space of the lumen network where the parenchymal cells 
are positioned. From the blood stream drug first contacts the epithelial cell lining of ther lumen, 
then the hepatocytes in the functional unti of the tissue. Therefore, in the in vitro microfluidic model 
the drug passes through the epithelial cell comparment and then the heptocyte compartment.  Figure 
3-17 presents the biofabrication process to print two cell types in a microlfuidic device using MND 
for direct cell deposiiton.  
 
Figure 3-17: Method to assemble a co-culture microfluidic system with controlled cell seeding 
and dynamic perfusion through an array of cell model compartments. Macro- and micro- cell 
patterning in the chip controlled by cell printing.   
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Two immortalized cell lines are co-cultured in the co-culture environment. Human hepatic 
carcinoma cells of the cell line HepG2 (ATCC) and human mammary epithelial of the cell line 
M10 (ATCC) are cultured in the Alpha Modification of Eagle's Medium supplemented with 10% 
(v/v) fetal bovine serum and 1% (v/v) penicillin streptomycin. Half volume of culture medium is 
changed every other day. Cultures are maintained 37oC and at 5% carbon dioxide. Cell culture 
medium and supplements purchased from Invitrogen unless otherwise noted. Separate cell-laden 
solutions of epithelial and hepatocytes are created in an identical manner. Cells are rinsed with 
PBS, trypsinized, and counted using exclusion dye Trypan Blue and hemocytometer. Once counted, 
cells are mixed with the gelatinous protein mixture Basement Phenol Red-free Matrigel (BD 
Bioscience) over ice to prevent gelation. Cells are homogenously distributed throughout the 
Matrigel using a gentle tapping technique with minimal pipetting to a concentration of 1.0×106 cells 
per mL. Final printing solution is 50% cells and 50% Matrigel (v/v) solution. The cell-laden 
solution is stored on ice for 5-10 minutes prior to printing to prevent gelation.  
All components of printing system to come in contact with cell-laden material is flushed 
with 70% ethanol three times and dried overnight under UV light for sterilization in laminar flow 
laboratory hood (NuAir). A 150μm diameter flexible precision dispensing tip (EFD) is fixed to the 
end of a 3mL luer lock tip syringe (BD Syringe). Vortex cooling from compressed the air cylinder 
cools temperature controlled enclosure to 2.0ºC +/-2.0ºC. Once temperature is stably within target 
range, the cell solutions are loaded into their respective nozzles.  Extrusion pressure is set to 12.3 
Pa. The height of the dispensing tip above the PDMS substrate is set to 200µm. Hepatocyte 
constructs are printed first, one at a time for each PDMS substrate, followed by epithelial cell 
constructs. Each cell construct is printed in their own compartment of their own dedicated PDMS 
substrate. After printing, a cover is added to seal the open channels. Cover and substrate secured in 
a bracket.  Tubes connect ports on the cover to network cell-laden compartment to each other, to a 
source of fresh cell culture medium and to a drain. The flow rate through the system is set to 
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30µL/hr. All devices are stored 37°C and 5% CO2. The set of MND process parameters are 
presented in equation 3-4. Figure 3-17 presents the biofabrication process to print two cell types in 
a microlfuidic device using MND for direct cell deposiiton. Figure 3-18 presents photographs of 
the fully assembly cell-laden microfluidic device prepared for the study.  
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Figure 3-18: Microfluidic chip containing cell-laden constructs serially connected to biomimic in 
vivo pathogenesis. 
3.3.3 Experimental design 
The pro-drug drug amifostine must be metabolized to active form to effect radiation 
shielding on cells and genetic material. The metabolizing tissue is epithelial, which is chosen 
because its bio-signature is more suited to metabolizing amifostine, as compared to the target tissue. 
The target tissue is hepatocytes, which is chosen for its sensitivity to radiation and because as a 
monoculture it less capable of converting amifostine to active form.  In this study, we serially 
connect epithelial constructs and hepatocytes and introduce amifostine to observe cell function after 
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printing and environmental control provided by the microfluidic platform. Figure 3-19 is a 
schematic of the dual micro-fluidic set-up.   
 
Figure 3-19: Method to study the effect mono- vs. co-culture microfluidic devices, 
radioprotective treatment and radiation on population fraction of genetically healthy vs. mutated 
HepG2 cells.  
Amifostine enters the microfluidic system through a nano-port above the metabolizing 
tissue, which is the epithelial construct. Amifostine is in its inactive WR-2721 form (Aydemir, 
Sevim, Celikler, Vatan, & Bilaloglu, 2009). Epithelial cells secrete alkaline phosphatase, which is 
capable of activating the drug by stripping the amifostine of its phosphate group. Alkaline 
phosphatase in the epithelial cells de-phosphorylated the amifostine and convert the drug to active 
WR-1065 form. Dynamic perfusion forces the converted drug to the target tissue, which is the 
hepatocyte construct. The alkaline phosphatase activity in the hepatocyte is much less than the 
metabolizing construct. The drug metabolized to active form by the metabolizing construct protects 
the target tissue from radiation damage. The single tissue model is only the target tissue and does 
not include the metabolizing tissue.  
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Figure 3-20: Schematic representation of the biomimetic pathogenesis of amifostine metabolism 
using dual tissue microfluidic device 
3.3.3.1 Ground model of extraplanetary radiation exposure. 
Radiation treatment was administered by the University of Pennsylvania School of 
Medicine Department of Radiation Oncology using a 137Cs gamma -ray source with a dose rate of 
86 cGy per minute. Irradiated samples were exposed to a 2 Gy dose over 1.72 minutes. Hepatocyte 
constructs remained sealed in microfluidic chip during exposure. Only select hepatocyte constructs 
are exposed to radiation, however all biological samples in this experiment are transported to 
treatment facility and remain outside incubated environment for an equal amount of time.  
3.3.3.2 Radioprotective drug treatment by pro-drug amifostine 
Anti-radiation treatment is perfusion of the radioprotective agent amifostine (Sigman et al.) 
through the cellular construct both before and after radiation exposure. Powder amifostine is mixed 
with culture medium to final concentration of 1mM amifostine. Amifostine is perfused through the 
constructs at a rate using a multi-channel programmable syringe pump (New Era Pump Systems) 
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for three hours prior to radiation exposure and for two hours after exposure. Equation 3-5 presents 
a selection method for the volumetric flow rate through the microfluidic device, ܳ, as a function of 
the the geometric parameter for chamber volume, ܸ, and design variable for residentce time, ݐோ.  
ܳ ൌ ܸݐோ 3-5 
The residence time of the drug in each chamber is 3 hours. The chamber volume is measured 
from the empty as-built microlfuidic chip.  The volumetric flow rate is determined to be 30 μL/hr. 
3.3.3.3 Radiation damage by micronuclei count 
Micronuclei count quantified radiation damage of samples. After anti-radiation treatment is 
complete, cells are recovered from Matrigel matrix using BD MatriSperse Cell Recovery Solution 
(BD Bioscience) and plated on tissue treated polystyrene culture plates (Corning) for in culture 
medium with 3μg/mL permeable mycotoxin Cytochalasin B (Sigman et al.) to block cytoplasm 
division. After 72 hours cells are fixed in 50% (v/v) Methanol solution, genetic material is labeled 
with the fluorescent probe DAPI Nuclear Counter stain (Molecular Probes), and examined. 
Samples were analyzed on a Zeiss Axioplan fluorescence microscope. Images of all cells were 
captured electronically using a Sensys charge-coupled device (CCD) camera (Photometrics Ltd.) 
and the MacProbe computer software developed by Applied Imaging. All samples were coded and 
scored blind. Cells are qualitatively sorted into three categories (1) mono-nucleated (2) bi-nucleated 
without micronuclei and (3) bi-nucleated with micronuclei.  Figure 3-21 presents categories of cells 
prepared for micronuclei count. Only bi-nucleated cells with micronuclei are considered damaged. 
The results of the count are presented as a percentage of radiation damage cells determined by the 
number of bi-nucleated cells with micronuclei relative to total number of bi-nucleated cells.   
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Figure 3-21: Classification of cells post-radiation (A) mono-nucleated (B) bi-nucleated without 
micronuclei (C) bi-nucleated with micronuclei.  
3.3.4 Effect of radiation, drug and hetero-cellular culture on drug efficacy 
HepG2 cells contained in a mono-culture microfluidic device are irradiated without 
radioprotective drug treatment. The effect of radiation on the population fraction of HepG2 cells 
with genetic mutation is compared to non-irradiated HepG2 also contained in a mono-culture 
microfluidic device. Each cell is categorized as healthy or genetically mutated based on a 
micronuclei count. The population fraction of genetically mutated vs healthy HepG2 cells for 
irradiated (2 Gy Radiation) and non-irradiated (0 Gy Radiation) devices is presented in figure 3-
22. The 2 Gy radiation treatment is not the exclusive cause of genetic mutation for HepG2 cultured 
in the presented microfluidic device. Non-irradiated HepG2 present micronuclei and are therefore 
categorized as genetically mutated. Radiation exposure increases the population fraction of 
genetically mutated cells by 22.1% from 3.6% to 25.7%. Consequently, the population of healthy 
cells decreases from 96.4% to 74.3% after 2 Gy radiation exposure.  
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Figure 3-22: Effect of 2 Gy gamma radiation on population fraction of genetically mutated vs. 
healthy HepG2 cells in mono-culture microfluidic device without radioprotective drug treatment.  
HepG2 cells contained in a mono-culture microfluidic device are irradiated with and without 
radioprotective drug treatment. Each cell is categorized as healthy or genetically mutated based on 
a micronuclei count. The population fraction of genetically mutated vs healthy HepG2 cells after 
radiation with (1mM Drug) and without (0mM Drug) radioprotective drug treatment is presented 
in figure 3-23. Radioprotective drug decreases the population fraction of genetically mutated cells 
by 19.1% from 25.7% to 6.6%. Consequently, the population of healthy cells increases from 74.3% 
to 93.4% with radioprotective drug treatment.  
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Figure 3-23: Effect of 1 mM radioprotective drug on population fraction of genetically mutated 
vs. healthy HepG2 cells in mono-culture microfluidic device after 2 Gy gamma radiation 
exposure.  
HepG2 and M10 cells contained in a co-culture microfluidic device are irradiated with 
radioprotective drug treatment. The effect of co-culture with M10 cells on the population fraction 
of HepG2 cells with genetic mutation after radiation and radioprotective drug treatment is 
compared to HepG2 cells in a mono-culture microfluidic device. The population fraction of 
genetically mutated vs healthy HepG2 cells for mono- vs. co-culture microfluidic devices is 
presented in figure 3-24. HepG2 present genetic mutations in mono- and co-culture environments. 
Co-culture of HepG2 with M10 cells decreases the population fraction of genetically damaged cells 
from 6.6% in mono-culture to 3.3% in co-culture devices.   
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Figure 3-24: Effect of mono- and co-culture microfluidic device on population fraction of 
genetically mutated vs. healthy HepG2 cells exposed to 2 Gy gamma radiation and treated with 
1mM radioprotective drug.  
3.3.5 Discussion 
The space environment causes a physiological and pathological change in biological 
behavior, which must be characterized for NASA to prepare appropriate health systems 
requirements. A new method of bio-printing and bioreactor design is offered in this research work. 
The solution is tailored to accommodate pharmaceutical testing using human derived cellular 
material in exotic environments, like space. Specifically, to create high fidelity tissue analogs to 
study multi-cellular metabolism of anti-radiation medication for long term space flight. 
Microfluidics were designed and manufactured to study the drug metabolism and radiation 
shielding in a hetero-cellular environment. The radioprotective benefits of the pro-drug amifostine 
were fully realized by incorporating hetero-cellular arrangement througut a micrlofluidic system.  
The single organ model was not a complete or accurate representation of the conversion of drug to 
active form, and consequently modeled diminished drug efficacy as diminished radiation shielding.  
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The co-culture condition is a more authentic representation of in vivo pathogenesis and 
tissue function. The single tissue model gives the false conclusion amifostine is not an effective 
radioprotective agent. Microfluidics were used in this work to control and organize the transient 
interactions between two cell types. A metabolizing organ and target organ were serially connected 
in microfluidic chip and dynamically perfused with the anti-radiation drug amifostine. The 
metabolizing organ converts the drug to active form by producing the enzyme alkaline phosphatase, 
which strips the drug of phosphates. The active form of the drug then perfuses the target organ and 
shields the organ from radiation damage. The micronuclei count demonstrates the active form of 
the drug is an effective form of radioprotection. The percentage of radiation damaged cells for the 
dual organ is 3% compared to 4% for non-irradiated controls. Without the metabolizing tissue, less 
of the drug is converted to active form and less radiation protection is observed. The percentage of 
radiation damaged cells for the single organ is more than twice the dual organ. Table 3-1 
summarizes the experimental variables and results of the presented study.  
Table 3-1. Effect of culture condition, radiation exposure and radioprotective drug treatment on 
percentage of genetically mutated hepatocytes.  
Culture 
Condition 
Radiation 
Exposure 
Radioprotective 
Treatment
Mutated 
Cells 
Assessment 
Co-Culture 2 Gy 1 mM Drug 3.0 % Healthiest 
Mono-Culture 0 0 3.6 %  
Mono-Culture 2 Gy 1mM 6.6 %  
Mono-Culture 2 Gy  0 25.7 % Most Damaged 
The instances of radiation damage for the single organ model are twice that of the non-
irradiated control. However, this is because the drug is not converted to active form. The 
metabolizing organ represents cooperate and synergistic relationship between cell types in the 
human body. The dual organ model demonstrates the radioprotective benefits of amifostine by 
metabolizing the drug as would happen in vivo conditions.  
131 
 
Radioprotective benefits of amifostine would not have been observable without the dual 
organ culture environment. The simpler single organ model would have falsely underestimated 
benefits of amifostine. The microfluidic platform provides researchers a portable tool to study 
synergistic coupled behavior between various cell types. The dynamic perfusion provides control 
over the transient interaction and dynamic effluent collection to understand effect of environmental 
stress on tissue and organ level function. The microfluidic platform is an improved vetting 
technique for drug discovery and fundamental characterization of cell behavior.  
The organization and patterning of the cells is controlled by cell printer. Printing technology 
allows researchers to leverage geometric positioning and proximity of specific biologics to bring 
functional abilities to cell aggregates (Barron et al., 2004; Ciocca et al., 2009; Murray et al., 2007). 
Physicians and researchers study in vivo tissue composition and cellular orientation to characterize 
critical mechanisms of tissue and organ systems (Alini et al., 2008; Gabbay et al., 2006). This body 
of knowledge defines healthy tissue; which can then be used as a template to conceptually design 
functional tissue from basic biological building blocks. Bio-modeling is the engineered 
combination of physical components into a specific spatial construction in a flexible digital 
workspace. Additionally, biologics are spatially organized to allow nutrient diffusion to the core of 
a matrix and subvert cell death due to hypoxia. Automation of dispensing control also ensures 
consistent material allocation for each sample.   
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CHAPTER 4: DEVELOPMENT OF A SYNCHRONIZED MULTI-MATERIAL 
BIOPRINTING SYSTEM 
4.1 Rationale and fabrication 
4.1.1 Rationale 
The previously presented multi-nozzle deposition system (MND) leverages discrete nozzles 
to dispense separate phenotypes, cross-linking solution, and support material during SFF of 
hydrogel scaffolds. Each nozzle extruded a homogenous cell-laden filament. Multiple nozzle 
produce hierarchical environments. In this work, we design, fabricate and characterize a novel 
synchronozed multi-material bioprinting (SMMB) system to improve the resolution of the MND 
system. The novel deposition system combines aquesous solutions into a single outlet stream 
without mixing. The deposition head is mounted to motion system with independently controlled 
movement in the x-, y-, and z-direction. The deposition head extrudes the heterogenous assembly 
of materials along a pre-programmed 3-dimensional tool-path. The objective of the multi-input 
microfluidic printhead is to improve the resolution of the bioprinter by packaging multiple 
phenotypes in a single filament. 
The snynchronized multi-material bioprinter’s novel deposition head fabricates both (1) 
hetereogenous filaments printed into geoemtric patterns defined using automation software and (2) 
heteregenous nano-liter droplets with variable volume from 200-600nL and shape (torus droplets 
or solid sphereical droplets). Figure 4-1 presents the block diamgram of the synchronized multi-
material bioprinter integrated with the multi-nozzle deposition cell printer for temperature 
controlled geometric patterning of heterogeneous cell-laden filaments to build 3-dimensional 
scaffolds or controlled cell seeding in the channels of a microfluidic device.   
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Figure 4-1: Block diagram of the synchronized multi-material bioprinter (SMMB) which 
integrates a deposition head for controlled heterogeneous extrusion with multi-nozzle deposition 
(MND) system.  
The design of the heterogeneous filament extruded by the SMMB is controlled by the 
channel network in the deposition head. Figure 4-2 presents several networks design to package 
multiple materials in a 1-dimensional array prior to printing. Figure 4-3 is a photograph of the 
fabricated SMMB deposition head perfused with three different solutions laden with die for 
visualization purposes.  
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Figure 4-2: Microfluidic network layouts for homogenous, heterogeneous, axisymmetric, and 
asymmetrical combination of up to three materials.  
 
Figure 4-3: As-built Simultaneous Multi-Material Print head perfused with 3 inputs to produce 5 
discrete streams in the outlet channel. 
4.1.2 Fabrication of SMMB deposition head 
SMMB deposition head packages multiple fluid streams into a single heterogeneous array. 
Each material enters the deposition head through its own inlet port. The design of the channel 
network defines the flow path of each material to collect in a pre-determined arrangement in a 
single combined flow outlet channel. Figure 4-4 presents the PCL pattern and flow design 
schematic as well as a photograph of the fabricated PDMS SMMB deposition head.   
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Figure 4-4: Multi-inlet microfluidic design and fabricated printhead.   
The channel network is embedded in a PDMS substrate. Embedding the channel network 
circumvents the need for an additional cover components and prevents leakage. Step 1 is the design 
and fabrication of the channel network embedded in PDMS by the two stage process precision 
extrusion deposition and replica molding, process is described in section 2.2. Step 2 is shaping the 
outlet to a point using a blade. Step 3 is to insert a steel capillary tip in to the outlet channel. Step 
4 is insert capillary tips into inlet ports. Silicone tubes are attached to the inlet tips and plumbed 
back to the material reservoir placed in a syringe pump.  
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Figure 4-5: SMMB deposition head construction in four steps from left to right: Step 1: Design 
and fabricate channel network. Step 2: Shape outlet. Step 3: Insert capillary tip into outlet. Step 4: 
Inset capillary tips into each inlet and connect silicone tubes.  
The channel network is a 3-dimensional interconnected set of features which include vertical 
channel perpendicular to the rest of the network, bifurcations and arch structures. These are 
necessary for the following reasons:  
 Channel bifurcations: Produce axisymmetric material arrays using a single inlet for each 
channel.  
 3-dimensional arch structures: Cross material channels without mixing.  
 Channels perpendicular to the flow network: Material inlets ports without crossing other 
channels or producing arches. 
Channel network is fabricated using a printed PCL template. The PED system’s capability 
to fabricate 3-dimensional structures is the limiting technology to produce features in the channel 
network. Here we present the PED system’s capability to fabricate vertical filaments and arches to 
be used for the SMMB deposition head. Figure 4-6 presents the PED printing vertical filaments, 
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filaments perpendicular to the printing substrate. The rest of the SMMB deposition head channel 
template is parallel with the printing substrate. 
 
Figure 4-6: View of PED system printing SMMB deposition head design to be replica molded. 
PED tool path includes z-direction perpendicular to the printing substrate to fabricate vertical 
filaments. Red arrows point to vertical filaments.  
Figure 4-7 presents a photograph of PED system printed PCL arch structures. The purpose 
of the arch is to provide clearance for a second channel to pass under the arch. In this way, more 
complex material arrays become feasible.  The inconsistent cross-section and shape of the arch 
does not diminish the feature’s ability to provide clearance for another channel underneath, and 
therefore successfully enable materials channel to cross without mixing within the SMMB 
deposition head network.  
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Figure 4-7: PED system printed PCL arches for possible use in SMMB deposition head. Arches 
identified by red arrows.  
4.2 SMMB process parameters, material properties and design variables 
SMMB system performance is defined by a set of geometric design variables to assemble a 
set of materials in a heterogeneous array as a single extruded filament and print that filament to 
produce a programmed geometric pattern. Design variables, ߖௌெெ஻, are a function of the geometric 
parameters of the SMMB deposition head,ߕௌெெ஻, process parameters, ߗ	ୗ୑୑୆, and material 
properties, Φௌெெ஻.  The system is reproducible within the operating thresholds of the process 
parameters.  Process parameters are automated and can be adjusted dynamically during the build 
cycle period to fabricate gradient structures and multiple design variables in a single printed 
construct.  Equation 4-1 defines design variables as a function of the geoemtric parameters, process 
parameters and material properties.  
ߖௌெெ஻ሺݐሻ ൌ ݂ሼߕௌெெ஻, ߗௌெெ஻ሺݐሻ, ߔௌெெ஻ሺݐሻሽ 4-1 
The SMMB system’s fabrication objectives define the design variables. The fabrication 
objective is a 3-dimensional built biological system using thermally extruded polymer with specific 
macro-scale (10-3 – 10-1 m) pathways of material deposition and micro-scale (10-5 – 10-3 m) cross-
sectional width/height of the polymer. The macro-scale pathway of material deposition is controlled 
by the motion system to be repeatable to less than 10µm. Micro-scale design variables to 
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characterize the printed filament’s cross-section are controlled by system’s process parameters. The 
size of the printed filament are independently controllable and automated to be varied over the build 
cycle to transform throughout the construct. Each material is combined in a single outlet of the 
deposition head. The volume fraction of each material and the width of a single material or 
combination of material streams are designed to mimic in vivo conditions. Reaction time between 
solutions in the deposition head determines chemical reactions prior to extrusion to induce a 
particular amount of partial cross-linking prior to extrusion. Equation 4-2 defines the set of design 
variables as the printed filament’s cross-sectional width, ܿ,  and height, ݀, reaction time between 
solution in the printhead, ݐ௥, width of a combination of material stream i and j, ݓ௜௝, and volume 
fraction of material i to material j, ߛ௜௝ .   
ߖௌெெ஻ሺݐሻ ൌ ሾܿሺݐሻ ݀ሺݐሻ ݐ௥ ሺݐሻ ݓ௜௝ሺݐሻ ߛ௜௝ሺݐሻ ሿ 4-2 
Process parameters are defined by the system’s hardware and software configuration. Each 
material is prepared and loaded into its own independently controlled programmable syringe pump. 
Material is pumped from its reservoir, through its own SMMB inlet port, into the combined outlet 
channel and extruded as part of a single heterogeneous filament onto the printing substrate. SMMB 
controllable process parameters are the flow rate of each material, ܳ, printhead speed, ݒ, height of 
the dispensing tip above the printing substrate, ݖ, and height between build cycles, ݀௭. All 
parameters are automated and tunable during a build cycle. During the course of the build cycle, 
process parameters can be adjusted to fabricate multiple sets of design variables in a single 
construct. Equation 4-3 defines the set of independently tunable system process parameters.    
ߗௌெெ஻ሺݐሻ ൌ ሾܳ௜ሺݐሻ ݒሺݐሻ ݖሺݐሻ ݀௭ሺݐሻሿ 4-3 
The set of design variables for a heterogeneous multi-material printed filament require the 
flow through the deposition head be laminar and incompressible. The criteria to define laminar 
flow is Reynolds number, which coorelates the inertial forces of the system’s hardware and channel 
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geometry with viscous forces in the fluid. The criteria for incompressible flow is Mach number. 
The Mach number couples the inertial forces to the material’s compressibility. Equation 4-4 defines 
the set of material properties to describe material rheology as density, ߩ௜, absolute viscosity, ߤ௜, 
and kinematic viscosity, ߥ௜, and material compressibility as material bulk modulus, ܧ௜.   
ߔௌெெ஻ሺݐሻ ൌ ሾ ܧ௜ ߤ௜ ߥ௜ ߩ௜ሿ 4-4 
Geometric parameters are designed to maintain laminar flow and restrict shear stress in the 
flowing fluid to maintain threshold precentages of viable cells in printed constructs.  Parameters 
are measured using photographs of the as-built system evaluated using the image processing 
software ImageJ (NIH). Geometric parameters require changes to system’s parts or configuration 
and remain constant from build cycle to build cycle. The set of SMMB geometric parameters are 
all specific to the combined flow outlet channel cross-section width, ܽ, and height, ܾ, and total 
length from where the individual streams combine to where they are dispensed to the ambient 
environment, ܮ. The total length is divided into the length inside PDMS deposition head, ܮ௉஼, and 
capillary tip length, ܮ஼். The combined flow outlet channel cross-section shape coefficient, ߱, 
defines the combined flow as either a half or full ellipse. Equation 4-5 presents the set of geometric 
parameters.  
ߕௌெெ஻ ൌ ሾ ܽ ܾ ܮ ܮ஼் ܮ௉஼ ߝ ሿ 4-5 
Table 4-1 presents the geometric, process, material, design, and derived parameters. Derived 
parameters assist in analytical characterization of the system. Derived parameters are not directly 
controlled by the operator and are not the specific performance objective of the process.   
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Table 4-1. Synchronized multi-material bioprinter (SMMB) system design variables, derived, 
geometric, material, and process parameters. 
Symbol Description Process Window Parameter 
Type 
࡭	 Cross-sectional area of printed 
filament  
-  Derived 
࡭ࢉ Cross-sectional area of SMMB 
deposition head outlet channel 
 Derived 
ࢇ SMMB deposition head channel 
cross-section width  
 - Geometric 
࢈ SMMB deposition head channel 
cross-section height 
 - Geometric 
ࢉ Printed filament width   - Design 
ࢊ Printed filament height   - Design 
ࡰ SMMB deposition head outlet 
channel diameter 
  
ࡰࢎ Hydraulic diameter   ࡱ࢏ Material bulk modulus  Material ࡸ SMMB deposition head combined 
outlet channel total length 
 Geometric 
ࡸ࢖ࢉ SMMB deposition head combined 
outlet channel length inside PDMS  
 Geometric 
ࡸ࡯ࢀ SMMB deposition head outlet 
capillary tip length 
 Geometric 
ࡹ Mach number  Derived 
ࡽ Net volumetric flow rate SMMB 
deposition head outlet  
 - Derived 
ࡽ࢏ Individual material flow rate into 
SMMB deposition head 
1.67 ൈ 10ିଷ ൑ 		ܳ௜ 		൑ 2.00 mL/min 
Process 
ࡾࢋ Reynolds number  Derived 
ࡾࢋ࢒ Maximum Reynolds number for 
laminar flow in a closed channel  
2300 Derived 
࢚ Time -  
࢚࢘ Reaction time between materials in 
SMMB deposition head 
- Design 
࢜ SMMB printhead speed 0.1 ൑ ݒ ൑ 15.0 ݉݉ ݏ⁄  Process 
࢜ࢊ SMMB material deposition speed  Derived ࢜ࢠ Fluid speed in SMMB deposition 
head 
 Derived 
࢝࢏࢐ Width of a combination of material 
stream i and j 
 Design 
ࢠ Height of SMMB deposition 
system outlet above printing 
substrate 
100 ൑ ݖ ൑ 1000	ߤ݉ Process 
ࣆ࢏ Material absolute viscosity  Material 
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cont’d    
Symbol Description Process Window Parameter 
Type 
ࣇ࢏ Material kinematic viscosity  Material ࣋࢏ Material density  Material ࢽ࢏࢐ Volume fraction of material i to 
material j 
 Design 
࣓ Channel cross-section shape 
coefficient 
Full Ellipse ߱ ൌ 4 
Half Ellipse ߱ ൌ 2 
Geometric 
ળ Cell survival  Design 
ࢷࡿࡹࡹ࡮	 SMMB geometric parameters   ࢶࡿࡹࡹ࡮ SMMB material parameters - Geometric ࢸࡿࡹࡹ࡮ SMMB design variables - Design  ࢹࡿࡹࡹ࡮ SMMB process parameters - Process 
 
4.2.1 Design parameters definition 
The set of design parameters is specifically defined for a three material flow pattern. The 1-
dimensional array of solutions analyzed in this work is symmetric about the longitudinal axis of 
the printhead.  A schematic of the flow is shown in figure 4-8. Each solution and its flow rate are 
numbered, beginning at the longitudinal axis of the outlet channel and moving out radially. In this 
analysis there are three solutions. Each solution is independently controlled by its own dedicated 
programmable syringe pump. 
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Figure 4-8: SMMB deposition head with three fluid inputs combined in a single outlet stream to 
be extruded as a single heterogeneous filament. Flow schematic and photograph of fully 
developed three material flow through fabricated deposition head.  
In this case solution 1 and 2 are cell-laden. Solution 3 is a cross-linking solution. The set of 
design parameters for the axisymmetric 3-material array, where the outer most solution is a cross-
linking solution are presented in equation 4-2 (reporduced below).  
ߖௌெெ஻ሺݐሻ ൌ ሾܿሺݐሻ ݀ሺݐሻ ݐ௥ ሺݐሻ ݓ௜௝ሺݐሻ ߛ௜௝ሺݐሻ ሿ  
 ܿ	   Total width of the heterogeneous printed filament 
 ݀    Total height of the heterogeneous printed filament 
 ݐ௥      Gelation time in the device 
 ߛ௜௝     Biomimetic ratio of the two cell-laden solutions 
 ݓ௜௝	   A target width of solution 1 and 2 (excluding solution 3, the cross-linker) 
The design variables and geometric parameters for the three material input axisymmetric 
design is presented in figure 4-9. Extruded material is not presented in the figure 4-9 graphic, 
therefore the width/height of the combined material outlet channel (represented as ܽ and ܾ 
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respectively in geoemtric parameter set) are equal to the total width/height of the heterogenous 
filament (represented as ܿ and ݀ respectively in the design variable set) .  
 
Figure 4-9: Schematic of geometric and process parameters for synchronized multi-material 
deposition head.  Each material flows in through a port in the top of the SMMB and is combined 
in a single outlet channel at the bottom.  
4.2.1.1 Volume fraction of each material 
System requirements determine the fluid is incompressible. Consequently, the volume 
fractions of the solutions are a function of the flow rate. Equation 4-6 through 4-8 define the volume 
fraction of solutions to the flow rate.  
ߛଵ,ଶ ൌ ߛଶ,ଵିଵ ൌ ܳଵܳଶ 4-6 
ߛଵ,ଷ ൌ ߛଷ,ଵିଵ ൌ ܳଵܳଷ 4-7 
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ߛଶ,ଷ ൌ ߛଷ,ଵିଵ ൌ ܳଵܳଷ 4-8 
4.2.1.2 Width of each material in combined flow 
The three material input axisymmetric design schematic presented in figure 4-9 defines the 
design variables for the width of the solution as a function of the geometric parameters of the 
SMMB deposition head channel. The width each individual material stream is presented in equation 
4-9 through 4-11.  
ݓଵ ൌ 2ݔଵ 4-9 
ݓଶ ൌ ሺݔଶ െ ݔଵሻ 4-10 
ݓଷ ൌ ܽ ൅ ݔଵ െ ݔଶ 4-11 
The width of a combination of adjacent materials is presented in equation 4-12 and 4-13.  
The total width of all the materials is equal to the width of the fabricated channel. 
ݓଵ,ଶ ൌ 2ݔଶ 4-12 
ݓଶ,ଷ ൌ ܽ െ ݔଵ 4-13 
4.2.1.3 Reaction time between materials in outlet channel 
The duration of chemical reactions, including cross-linking, between adjacent materials in 
the combined flow outlet channel is the controllable design parameter named reaction time. The 
reaction time is a function of the length of the combined flow outlet channel, material’s flow rate 
and the cross-sectional area the material occupies in the channel, equation 4-14.  
			න ݀ݐ
௧ೃ
଴
ൌ න ܣ௖
௅
଴
൬෍ ܳ௜
ଷ
௜ୀ଴
൰
ିଵ
݀ܮ 4-14 
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The flow rate and cross-sectional area a material occupies is constant throughout the length 
of the channel. Equation 4-13 is integrated to define the reaction time as a function of a material’s 
geometry and process parameters, equation 4-15. 
ݐோ ൌ ܣ௖ܮܳଵ ൅ ܳଶ ൅ ܳଷ 4-15 
The average velocity of the combined flow is a function of the total cross-sectional area and 
net volumetric flow rate and the individual material cross-sectional are and individual flow rate, 
presented in equation 4-15. The cross-sectional area of the capillary tip inserted in the outlet and 
outlet channel embedded in the PDMS deposition head are the equal.  
ܮ
ݐோ ൌ
ܳଵ ൅ ܳଶ ൅ ܳଷ
ܣ௖ ൌ
ܳଵ
ܣଵ ൌ
ܳଶ
ܣଶ ൌ
ܳଷ
ܣଷ 4-16 
4.2.2 Controllable process parameters operating thresholds 
Process parameters for simultaneous multi-material print head integrated with the bioprinter 
are flow rate for each input, print head speed over substrate, height of print head above printing 
substrate, and displacement in z. The set of bioprinter process parameters are as follows: 
ߗௌெெ஻ሺݐሻ ൌ ሾܳ௜ሺݐሻ ݒሺݐሻ ݖሺݐሻ ݀௭ሺݐሻሿ  
The hardware limitation of the New Era Pump Systems programmable syringe pump defines 
the maximum and minimum flow rates for the as-fabricated system, equation 4-18.  
1.67 ൈ 10ିଷ ݉ܮ݉݅݊ ൑ ܳ௜ ൑ 2.00
݉ܮ
݉݅݊ 4-17 
The hardware limitation of the Parker Motion System linear slides defines the maximum 
and minimum print head speed for x, y, and z direction, as presented in equation 4-18.  
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0.1 ݉݉ݏ ൑ ݒ ൑ 10.0
݉݉
ݏ  4-18 
Thresholds for process parameters are driven from hardware limitations are the set presented 
in equation 4-19. 
ߗ௉ ൌ
ۏ
ێێ
ێێ
ۍ1.67 ൈ 10ିଷ ൑ ܳ௜ ൑ 2.00 ݉ܮ݉݅݊
0.1		 ൑ 	 ݒ௣ 		൑ 10.0					 ݉݉ݏ
100 ൑ ݖ ൑ 2000 ߤ݉
0.1 ൑ ݀௭ ൑ 50 ݉݉ ے
ۑۑ
ۑۑ
ې
 4-19 
 
4.3 System requirements and material selection criteria 
Flow through the deposition head must be laminar, incompressible and fully developed to 
successfully arrange multiple fluid streams in a heterogeneous array.  Process limitations are 
defined by characterizing operating windows which maintain laminar, incompressible and fully 
developed flow through the SMMB deposition head channel network.  
Table 4-2. System requirements for printing heterogeneous material filament with controllability 
using SMMB deposition head.  
Requirement Criteria Process Window 
to maintain requirements 
Laminar Flow Reynolds Number 
Inertial Forces 
Hardware Limitations 
Channel Geometry 
⟷ Viscous Forces 
Incompressible Mach Number 
Inertial Forces 
Hardware Limitations 
Channel Geometry 
⟷ Compressibility Forces 
Fully Developed  Channel Length ⟷ Channel Hydraulic Diameter 
Cell Viability Shear Stress Thresholds 
Inertial Forces 
Hardware Limitations 
Channel Geometry 
⟷ Viscous Forces 
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Streamlines maintained by the flow due to viscous forces define laminar flow and prevent 
mixing. The criteria to analyze laminar flow is Reynolds number. The Reynolds number relates the 
inertial forces of the system’s hardware and channel geometry with viscous forces in the fluid. The 
Reynolds number criteria defines the set of viscosities which can and cannot be successfully printed 
without mixing. The criteria for incompressible flow is Mach number. The Mach number couples 
the inertial forces to the material’s compressibility. The Mach number criteria defines the set of 
densities and bulk modulus which can and cannot be successfully printed without compression. 
Fully developed flow is assumed for the outlet channel length is significantly greater than the 
channel’s hydraulic diameter.  
4.3.1 Inertial and viscous thresholds coupled by Reynolds number 
The synchronized multi-material deposition head combines multiple material inputs into a 
single combined material outlet. The volume fraction of each constituent material is controllable 
by the manufacturing process parameters. The volume fraction of each material is preserved even 
if each constituent material mixes in the outlet channel. However, distinct hierarchical structures in 
the extruded combined flow are present and their shape controllable if the materials do not mix. 
The criteria to define the mixing behavior of a flowing fluid is the Reynolds number, which relates 
the inertial to viscous forces in a flowing fluid.  
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Figure 4-10: Heterogeneous filament produced at deposition tip because streamlines are 
maintained in laminar flow process window. Viscous forces are sufficient to prevent mixing due 
to inertial forces in the flowing fluid. Each calibration at the top of the photograph is 500µm 
apart.      
The ratio of inertial to viscous forces quantifies the relative influence of both forces on the 
flow pattern of a fluid (Rott, 1990). Three distinct flow regimes are defined as (1) inertial force 
dominant, (2) viscous force dominant and (3) transitional. Viscous force dominant flow, or laminar 
flow, maintains streamlines without mixing. Inertial force dominant flow, or turbulent flow, has 
chaotic motion with mixing and flow instabilities. Transient flow does not reliably present the 
predictable streamlines of laminar flow or the full mixing of turbulent flow. The Reynolds number 
in a closed channel defines each of the three flow regimes as a function of the ratio of inertial to 
viscous forces.  The Reynolds number is a function of the average fluid speed, hydraulic diameter 
of the channel and kinematic viscosity of the fluid. Each regime is presented in equation 4-20.  
ܴ݁ ൌ ݅݊݁ݎݐ݈݅ܽ	݂݋ݎܿ݁ݏݒ݅ݏܿ݋ݑݏ	݂݋ݎܿ݁ݏ ൌ
ܸܦ௛
߭ ൌ ൝
ܴ݁௟ ൏ 2300 ܮܽ݉݅݊ܽݎ
ܴ݁௟→௧ 2300 ൏ 4000 ܶݎܽ݊ݏ݅݁݊ݐ
ܴ݁௧ ൐ 4000 ܶݑݎܾݑ݈݁݊ݐ
ൡ 4-20 
Process windows for the synchronized multi-material bioprinter system are designed to 
maintain a Reynolds number less than 2300 to preserve laminar flow and prevent mixing. The 
criteria to maintain laminar flow is a function of the known maximum ratio of inertial to viscous 
forces for laminar flow (maximum laminar Reynolds number for closed channel) and variable 
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which define the Reynolds number. The ratio of inertial to viscous forces required which define the 
upper limit of non-mixing or inertial dominant flow is presented in equation 4-21.  
2300 ൐ ܴ݁ ൌ ܸܦ௛߭  4-21 
The inertial forces in the deposition system are a function of the maximum and minimum 
force generated by the syringe pump and cross-sectional area of the outlet channel. The viscous 
forces are a material property. The maximum and minimum force generated by the syringe pump 
and cross-sectional area of the outlet channel are known. The maximum allowable Reynolds 
numbers is 2300 to prevent mixing. Therefore, a selection criteria for material rheology is presented 
to preserve laminar flow by maintaining a ratio of inertial to viscous forces less than 2300, equation 
4-22.  
߭ ൐ ܸܦ௛2300 4-22 
Equation 4-22 is algebraically manipulated and combined with the maximum laminar flow 
Reynolds number in equation 4-21 to present the kinematic viscosity as a function of Reynolds 
number and inertial forces, equation 4-21. Average fluid speed is a function of the flow rate and 
channel cross-sectional area. The cross-sectional area is the outlet channel where the material inlets 
combine and mixing is of concern.  The number of inlet channels combining in the outlet channel 
effects the total flow rate as each inlet channel is plumbed to its own programmable syringe pump. 
Therefore the hardware limitations only apply to a single inlet stream and the maximum possible 
flow rate is incrementally raised with the addition of inlet streams.  
ݒ௭ ൌ
∑ ܳ௜௡௜ୀଵ
ܣ  4-23 
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The maximum and minimum flow rate are defined by the hardware limitations of the 
programmable syringe pump. The hardware limitation of the New Era Pump Systems 
programmable syringe pump defines the maximum and minimum flow rates for the as-fabricated 
system.  
1.67 ൈ 10ିଷ ݉ܮ݉݅݊ ൑ ܳ௜ ൑ 2.00
݉ܮ
݉݅݊ 4-24 
The outlet channel is a capillary tip with a circular cross-section. The hydraulic diameter is 
proportional to the ratio of the cross sectional area to the perimeter. The hydraulic diameter for a 
capillary tip is equal to the diameter of the tip.  
ܦ௛ ൌ 4ܣܲ ൌ ܦ 4-25 
Tips are purchased a prefabricated set of steel capillary tips.  
ܦ௠௜௡ ൌ 150 ߤ݉
ܦ௠௔௫ ൌ 2000ߤ݉ 4-26 
The cross-sectional area of the capillary tip outlet is a function of the diameter.  
ܣ ൌ ߨܦ
ଶ
4  4-27 
Combining equation 4-3, 4-4 and 4-9 to define the kinematic viscosity as an explicit function 
of the total flow rate in the outlet of all the combined inlet materials and the hydraulic diameter.  
߭ ൐ 4ܴ݁௟ߨ
∑ ܳ௜௡௜ୀଵ
ܦଶ  4-28 
The syringe pump produces a flow rate and inertial forces on the working solution.  The 
maximum and minimum inertial force caused by the system is defines by the hardware limitation 
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of the pump and the hydraulic diameter of the cross-section. The hydraulic diameter of a capillary 
tip is the diameter.  Maximum and minimum fluid velocity defined in equation 4-29 and 4-30.  
ݒ௭,௠௜௡ ൌ ቆ ܳܦ௛ଶቇ௠௜௡
ൌ ∑ ܳ௠௜௡
ଷ௡ୀଵ
ܦ௖,௠௔௫ଶ ൌ 2.09 ൈ 10
ିହ ݉
ݏ  4-29 
ݒ௭,௠௔௫ ൌ ቆ ܳܦ௛ଶቇ௠௔௫
ൌ ∑ ܳ௠௔௫
ଷ௡ୀଵ
ܦ௖,௠௔௫ଶ ൌ 4.44
݉
ݏ  4-30 
The maximum inertial force produced by the programmable syringe pump through the outlet 
channel is defined by the hardware limits and the geometry of the channel.  The maximum and 
minimum kinematic viscosity to maintain laminar flow is defined in equation 4-31 and 4-32.  
ߥ௠௔௫ ൌ
4	ܦ௖,௠௜௡ ݒ௭,௠௔௫
ߨܴ݁௟ ൌ 3.69 ൈ 10
ି଻ܿܵݐ 4-31 
ߥ௠௜௡ ൌ 4ܦ௖,௠௔௫ ݒ௭,௠௜௡ߨܴ݁௟ ൌ 2.31 ൈ 10
ିଵଵܿܵݐ 4-32 
Selection criteria for the working material rheology to maintain laminar flow in the 
combined flow outlet channel is presented in equation 4-33. 
߭ ൌ
ە
۔
ۓ ൏ 2.31 ൈ 10
ିଵଵܿܵݐ → ܰ݁ݒ݁ݎ ܮܽ݉݅݊ܽݎ	ܨ݈݋ݓ
2.31 ൈ 10ିଵଵ ൏ ߭ ൏ 3.69 ൈ 10ି଻ܿܵ → ܸ ൌ ܳܦ௛	 ൐
4߭
ߨܴ݁௟
൐ 3.69 ൈ 10ି଻ܿܵݐ → ܣ݈ݓܽݕݏ ܮܽ݉݅݊ܽݎ	ܨ݈݋ݓۙ
ۘ
ۗ
 4-33 
Material rheology, flow rate and capillary diameter are tuned to maintain laminar flow 
through print head capillary tip. Hardware limitation for maximum and minimum flow rate and 
capillary diameter bound inertial forces of flowing fluid. Working solution rheology bounds 
viscous forces of the system. Kinematic viscosity increases linearly with alginate density in solution 
from 0.94 and 1.69 cSt for 0.1 and 0.75 g/L respectively (Gomez-Diaz & Navaza, 2003). Kinematic 
viscosity of water decreases linearly with temperature from 1.00 and 0.65 cSt for 20ºC and 40ºC 
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respectively. The rheology of calcium chloride cross-linking solution and buffer solutions are 
approximated as water.  
4.3.2 Inertial and incompressible thresholds coupled by Mach number 
The material properties are a function of the inertial forces in the system to maintain 
subsonic flow The Mach number defines a criteria to determine the significance of compressibility 
in a flowing fluid. The Mach number is the ratio of inertial to compressive forces in a fluid (Shajii 
& Freidberg, 1996).  
ܯ ൌ ݅݊݁ݎݐ݈݅ܽ ݂݋ݎܿ݁ݏܿ݋݉݌ݎ݁ݏݏܾ݈݅݅݅ݐݕ ݂݋ݎܿ݁ݏ 4-34 
The Mach number characterizes the effect of compressibility as negligible (incompressible) 
and significant (compressible), as shown in equation 4-35. Negligible compressible effects are less 
than 5% change in density per volume, equation 4-36.  
ܯ ൌ			 ൝			
ܯ ൏ 0.3 ܵݑܾݏ݋݊݅ܿ ܫ݊ܿ݋݉݌ݎ݁ݏݏܾ݈݅݁
0.3 ൏ ܯ ൏ 0.8 ܵݑܾݏ݋݊݅ܿ ܥ݋݉݌ݎ݁ݏݏܾ݈݅݁
0.8 ൏ ܯ ൏ 1.2 ܶݎܽ݊ݏ݋݊݅ܿ ܥ݋݉݌ݎ݁ݏݏܾ݈݅݁
ൡ 4-35 
ܯ ൏ 0.3 → ݀ߩܸ݀ ൏ 5% 4-36 
The circumstances which define the range of inertial forces in the system are determined by 
the hardware limitation of the programmable syringe pump and cross-sectional area of the channel. 
The acoustic velocity expressed with Hook’s Law is a function of the material modulus and density, 
equation 4-37.  
ܯ ൌ ݒ௭ܿ ൌ
݂݈ݑ݅݀ ݏ݌݁݁݀
ݏ݌݁݁݀ ݋݂ ݏ݋ݑ݊݀ ൌ
∑ ܳ௜௡௜ୀଵ
ܣ ට
ߩ
ܧ 4-37 
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The criteria for subsonic incompressible flow defines the inertial to compressive ratio for 
the system (equation 4-36) and closed form analytical definition for Mach number (equation 4-37) 
combine to produce equation 4-38.  
0.3 ൐ ܯ ൌ ∑ ሶܳ௜
௡௜ୀଵ
ܣ௖ ට
ߩ
ܧ 4-38 
The maximum and minim fluid velocity are determined from the fundamental process and 
geometric parameters. The feasible set of bulk modulus is defined by the Mach number and system 
parameters. The minimum bulk modulus for subsonic flow under any flow rate is determined from 
the minimum fluid velocity, assuming one fluid stream (n=1). The minimum bulk modulus for 
subsonic flow under any flow rate is determined from the maximum fluid velocity, assuming three 
streams (n=3). Equation 4-39 and 4-40 present the minimum and maximum bulk modulus for 
incompressible flow through the SMMB deposition head.  
ܧ௠௜௡ 	൐ ߩ ቆ
∑ ሶܳ௜,௠௜௡ଵ௜ୀଵ
0.3ܣ௖,௠௔௫ ቇ
ଶ
ൌ ߩ ൬ ܸ0.3൰
ଶ
 4-39 
ܧ௠௔௫ 	൐ ߩ ቆ
∑ ሶܳ௜,௠௔௫ଷ௜ୀଵ
0.3ܣ௖,௠௜௡ ቇ
ଶ
ൌ ߩ ൬ ܸ0.3൰
ଶ
 4-40 
The selection criteria for a material based on bulk modulus and density to maintain 
incompressibility is presented in figure 4-12. The figure presents three regimes, subsonic SMMB 
deposition head operation under some flow and under all possible flow.  
155 
 
 
Figure 4-11: Material bulk modulus and density criteria for subsonic flow in printhead.   
The bulk modulus and density of common liquids presented in table 4-3 all fall in the 
subsonic printhead operation under all possible flow rate regime of figure 4-12. Compressibility is 
not considered a significant factor for common liquids in the SMMB deposition head. Flow through 
the channels is modeled as incompressible.  
Table 4-3: Bulk modulus and density of common liquids from published references.  
Material Temperature 
°C 
Density (࣋) 
1.0 kg/m3 = 1.0E-3 g/mL 
Bulk Modulus 
SI Units MPa 
Acetone 25 785 920 
Benzene 25 874 1,050 
Ethyl Alcohol 20 789 1,060 
Gasoline 16 737 1,300 
Glycerin 25 1259 4,350 
Kerosene 16 820 1,300 
Mercury - 13,590 28,500 
Petrol, natural 60 711 1,070 – 1,490 
Seawater 25 1025 2,340 
Water 20 1000 2,150 
156 
 
4.3.3 Control maximum shear stress to achieve permissible level of cell viability 
Shear stress in the flowing solution during printing inelastic and elastic defomration to the 
cell membrane, which diminishes the cell’s viability and phenotype stabilty post-printing. The 
effect of shear stress in the flowing fluid on cell viability is repoduced from a peer reviewed 
publication by Nair et. al. and is presented in equation 4-41 (Nair et al., 2009).  
ܥ݈݈݁	ܵݑݎݒ݅ݒ݈ܽ					
ߓ ൐ 90%
ߓ ൐ 80%
ߓ ൐ 70%
ߓ ൐ 60%
			
→
→
→→
				
൑
൑
൑൑
			
10 ݇ܲܽ
40 ݇ܲܽ
60 ݇ܲܽ
180 ݇ܲܽ
 4-41 
Shear stress in the SMMB head will be kept below a threshold levels to maintain a pre-
determined standard of cell viability. The maximum shear stress occurs in the smallest orifice, for 
the print head that is the capillary tip at the outlet. The generalized case of a Non-Newtonian fluid 
is presented in equation 4-42. 
߬௠௔௫ ൐ ܭ ൬݀ݑ݀ݔ൰
௡
 4-42 
The equation for the maximum shear stress of fully developed incompressible laminar flow 
through a capillary tip is presented in equation 4-43 (Nair et al., 2009).  
߬௠௔௫ ൐ ܭ ൬ 8ܳߨܦଷ൰
௡
 4-43 
Equation 4-43 is algebraically manipulated to explicity present the flow rate, equation 4-44. 
The flow rate is a combination of n individually controlled material inputs.   
෍ܳ௜,௠௔௫
௡
௜ୀଵ
൏ ߨܦ
ଷ
8 ൬
߬௠௔௫ሻ
ܭ ൰
ଵ/௡
 4-44 
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For a three material input design, the individual flow rate of any one material to induce a 
predetermined limit of cell damage is defined by equation 4-45.  
ܳ௜,௠௔௫ ൏ ߨܦ
ଷ
24 ቀ
߬௠௔௫
ܭ ቁ
ଵ/௡
 4-45 
Sodium alginate aqueous solution is the cell-laden delivery matrix material used during 
SMMB cell printing. The rheology of alginate and water are derived from literature and presented 
in table 4-4.   
Table 4-4: Sodium alginate aqueous solution and water consistency coefficient and index. 
Reference are 1(S. E. D. Khalil, 2005)  or 2 (Rezende, Bartolo, Mendes, & Maciel, 2009). 
Material Concentration 
w/v 
Consistency Coefficient 
(K     Pa sn   ) 
Consistency 
Index (n) 
Ref 
Sodium 
alginate 
aqueous 
solution 
1.0 % 0.610 0.66 1 
1.5 % 1.259 0.70 1 
2.0 % 2.010 0.78 1 
2.0 % 2 0.87 2 
3.0 % 8.587 0.76 1 
3.0 %   6 0.84 2 
5.0 % 28 0.84 2 
Water 30°C - 0.798 1 - 
 
The effect of the maximum allowable individual flow rate is calculated for several 
concentrations of sodium alginate and water using equation 4-45 and rheological properties 
presented in table 4-4. The SMMB hardware limit for the flow rate is 2.0 mL/min. Results are 
presented in table 4-5. The maximum hardware limit is significantly less than the flow limit to 
produce cell viability less than 90%. Theoretically, SMMB printed cell-laden models presents 
greater than 90% viability.  
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Table 4-5: Maximum individual flow rate through SMMB to maintain design specific cell 
viability, represented as a percentage of surviving cells.  
Cell 
Viability 
Maximum Individual Flow Rate (mL/min) 
Water Alg 1.0% Alg 1.5% Alg 2.0% Alg 3.0% Alg 5.0% 
൐ ૢ૙% 66.4 1.29×104 1.98×103 2.91×102 57.4 5.80 
൐ ૡ૙% 2.66×102 1.05×105 1.43×104 1.72×103 3.56×102 30.2 
൐ ૠ૙% 3.99×102 1.95×105 2.56×104 2.89×103 6.06×102 49.0 
൐ ૟૙% 1.20×103 1.03×106 1.23×105 1.18×104 2.57×103 1.81×102 
 
The effect of the flow rate on cell viability is experimentally evaluated using HepG2 cells 
(ATCC) in 0.5% (w/v) sodium alginate collected after printing using variable flow rates. After 
printing, cell viability is detected using metabolic indicator alamar blue. The fluorescent intensity 
after 4 hours is not significantly different for the control or any printed sample. The printing process 
and the selection of flow rate had no significant effect on the relative metabolic activity (linearly 
related to cell number), results presented in figure 4-13. Therefore, the SMMB depostion head is a 
feasible method to print live cells.  
 
Figure 4-12: Fluorescent intensity of Alamar blue after 4hrs of incubation with printed cell-laden 
samples and an un-printed control group.  
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4.4 Process parameters as a function of the design variables  
4.4.1 Cross-sectional area of a fully developed flow 
An individual material’s volume fraction of a cross-sectional area in the combined flow 
outlet is proportional to the fraction of the material’s flow rate over the total flow rate. The cross-
sectional area of an individual material, ܣ௜, as a fraction of the total channel cross-section, ܣ஼, is 
proportional to the material’s flow rate, ܳ௜, as a fraction of the total flow rate of ݊ individual 
material streams.  
ܣ௜
ܣ௖ ൌ
ܳ௜
∑ ܳ௜௡௜ୀଵ  4-46 
For a three input system with three independently controllable flow rates the fraction of the 
total cross-section area occupied by each material is presented in equation 4-47, 4-48 and 4-49.  
ܣଵ
ܣ௖ ൌ
ܳଵ
ሺܳଵ ൅ ܳଶ ൅ ܳଷሻ 4-47 
ܣଶ
ܣ௖ ൌ
ܳଶ
ሺܳଵ ൅ ܳଶ ൅ ܳଷሻ 4-48 
ܣଷ
ܣ௖ ൌ
ܳଷ
ሺܳଵ ൅ ܳଶ ൅ ܳଷሻ 4-49 
The average velocity of flow in the channel is the deposition velocity from the SMMB 
deposition head to the substrate. The deposition velocity, ݒௗ, is a function of the total flow rate and 
total cross-sectional area, as presented in equation 4-50. 
ݒௗ ൌ
ሺܳଵ ൅ ܳଶ ൅ ܳଷሻ
ܣ௖ ൌ
ܳଵ
ܣଵ ൌ
ܳଶ
ܣଶ ൌ
ܳଷ
ܣଷ  4-50 
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4.4.2 Area fraction as a function of internal geometry of multi-material outlet channel 
The cross-sectional area is specific to the size and shape of the channel cross-section. A 
generalized equation for the area of a circular, full or half elliptical cross-section is derived using a 
shape coefficient, major and minor axis. A full ellipse is four quadrants ሺ߱ ൌ 4ሻ  when the center 
of ellipse is mapped to the center of a Cartesian coordinate system. A half ellipse is two quadrants 
ሺ߱ ൌ 2ሻ when the center of ellipse is mapped to the center of a Cartesian coordinate system. Figure 
4-13 presents the schematic of the fully developed non-mixing flow through the combined outlet 
channel of the SMMB deposition head. The flow design is 3 material axisymmetric flow. The figure 
4-13 schematic presents the variable cross-section shapes and reference geometries utilized in the 
derived model 
 
Figure 4-13: Fully developed non-mixing flow through the combined outlet channel of 
theSMMB deposition head. Schematic presents variable cross-section shapes and reference 
geometries utilized in the derived model.  
For the generalized case of an elliptical cross-section the x- and y- coordinates of the 
perimeter are related by the major and minor axis, as presented in equation 4-51.  
ݔଶ
ܽଶ ൅
ݕଶ
ܾଶ ൌ 1 4-51 
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The standard form is algebraically manipulated to express the y coordinate on the perimeter 
of the ellipse as a function of the geometry and x-coordinate, as presented in equation 4-52.   
ݕ ൌ ܾܽඥܽଶ ൅ ݔଶ 4-52 
The area of a fraction of an ellipse bounded by i and j is the integration between two 
locations along the x-axis, , as presented in equation 4-53.   
ܣ௜௝ ൌ න ݕሺݔሻ݀ݔ
௫ೕ
௫೔
 4-53 
The definite integral is bounded by the geometric limits of the ellipse, as presented in 
equation 4-54.  
0 ൑ ݔ௜ ൏ ݔ௝ ൑ ܽ 4-54 
The area is for one quadrant of the cross-section. The area is multiplied by the number of 
quadrants to determine the total area. The number of quadrants is either 2 for a half ellipse or 4 for 
a full ellipse, as defined in equation 4-55.  
߱ ൌ 2, 4 4-55 
The area of an elliptical cross-section or fraction thereof partitioned symmetrically from the 
minor axis as shown in figure 4-13 is presented in equation 4-56. 
ܣ௜௝ ൌ ߱න ܾܽඥܽଶ ൅ ݔଶ ݀ݔ
௫ೕ
௫೔
 4-56 
Cartesian coordinates are converted to polar coordinates for the integration. The conversions 
are summarized as presented in equations 4-57, 4-58 and 4-59.  
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ݔ ൌ ܽ ݏ݅݊ ߠ 4-57 
݀ݔ ൌ ܽ ܿ݋ݏ ߠ ݀ߠ 4-58 
0 ൑ ߠ௜ ൏ ߠ௝ ൑ ߨ2 4-59 
The area in terms of polar coordinate is a combination of the area integral (eqaution 4-56) 
and cartesian to polar identities (equations 4-57, 4-58 and 4-59), as presented in equation 4-60.  
ܣ௜௝ ൌ ߱න ܾܽ ඥܽଶ െ ሺܽ ݏ݅݊ ߠሻଶ ሺܽ ܿ݋ݏ ߠሻ ݀ߠ
ఏೕ
ఏ೔
 4-60 
Equation 4-60 is simplified to equation 4-61.   
ܣ௜௝ ൌ ܾܽ߱න ඥ1 െ ሺݏ݅݊ ߠሻଶ ሺܿ݋ݏ ߠሻ ݀ߠ
ఏೕ
ఏ೔
 4-61 
Euclidean geometry’s Pythagorean Theorem defines a right triangle’s lengths and angles in 
the function presented in equation 4-62.   
1 െ ݏ݅݊ଶ ߠ ൌ ܿ݋ݏଶ ߠ 4-62 
The area function is simplified using Pythagorean Theorem is equation 4-63.  
ܣ௜௝ ൌ ܾܽ߱න ܿ݋ݏଶ ߠ ݀ߠ
ఏೕ
ఏ೔
 4-63 
Considering the following trigonometric identity from the Double-angle formula presented 
in equation 4-64. 
ܿ݋ݏଶ ߠ ൌ 12 ሺ1 ൅ ܿ݋ݏ 2ߠሻ  4-64 
The area function is simplified as presented in equation 4-65: 
163 
 
ܣ௜௝ ൌ ܾܽ߱2 න 1 ൅ ܿ݋ݏ 2ߠ ݀ߠ
ఏೕ
ఏ೔
 4-65 
The area function in polar coordinates is presented in equation 4-66: 
ܣ௜௝ ൌ ܾܽ߱2 ൤ߠ ൅
ݏ݅݊ 2ߠ
2 ൨ఏ೔
ఏೕ
 4-66 
The Double Angle Theorem is identified in equation 4-67: 
ݏ݅݊ 2ߠ ൌ 2 ݏ݅݊ ߠ ܿ݋ݏ ߠ 4-67 
Equation 4-66 and 4-67 are combined to form equation 4-68. 
ܣ௜௝ ൌ ܾܽ߱2 ሾߠ ൅ ݏ݅݊ ߠ ܿ݋ݏ ߠሿఏ೔
ఏೕ 4-68 
Polar and Cartesian coordinates are related by trigonometry derived from schematic shown 
in figure 4-13 and defined by equations 4-69, 4-70 and 4-71.  
ߠ ൌ ܽݏ݅݊ ݔܽ 4-69 
ݏ݅݊ ߠ ൌ ݔܽ 4-70 
ܿ݋ݏ ߠ ൌ ඥ1 െ ݏ݅݊ଶߠ ൌ ඨ1 െ ݔ
ଶ
ܽଶ ൌ
1
ܽඥܽଶ െ ݔଶ 4-71 
The area function in Cartesian coordinates is presented in equation 4-72: 
ܣ௜௝ ൌ ܾܽ߱2 ቂܽݏ݅݊
ݔ
ܽ ൅
ݔ
ܽଶ ඥܽଶ െ ݔଶቃ௫೔
௫ೕ
 4-72 
The area of a bounded portion of the cross-section is equation 4-73.  
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ܣ௜௝ ൌ ܾܽ߱2 ൭ܽݏ݅݊ ቀ
ݔ௝
ܽ ቁ െ ܽݏ݅݊ ቀ
ݔ௜
ܽ ቁ ൅
1
ܽଶ ൬ݔ௝ටܽଶ െ ݔ௝ଶ െ ݔ௜ඥܽଶ െ ݔ௜ଶ൰൱ 4-73 
The cross-section of material 1, 2 and 3 are defined as equation 4-74, 4-75 and 4-76. 
ܣଵ ൌ ܣ௖	ሺ0 ൑ ݔ ൑ ݔଵሻ ൌ ܾܽ߱2 ቀܽݏ݅݊ ቀ
ݔଵ
ܽ ቁ ൅
ݔଵ
ܽଶ ඥܽଶ െ ݔଵଶቁ 4-74 
ܣଶ ൌ ܣ௖ ሺݔଵ ൑ ݔ ൑ ܦଵ,ଶ2 ሻ	 
ܣଶ ൌ ܾܽ߱2 ቌܽݏ݅݊ ൬
ܦଵ,ଶ
2ܽ ൰ ൅
ܦଵ,ଶ
2ܽଶ ඨܽଶ െ
ܦଵ,ଶଶ
4 െ	ܽݏ݅݊ ቀ
ݔଵ
ܽ ቁ െ
ݔଵ
ܽଶ ඥܽଶ െ ݔଵଶቍ 
4-75 
ܣଷ ൌ ܣ௖	ሺܦଵ,ଶ2 ൑ ݔ ൑ ܽሻ	 ൌ
ܾܽ߱
2 ቌ
ߨ
2 െ ܽݏ݅݊ ቀ
ݓଵ,ଶ
2ܽ ቁ െ
ݓଵ,ଶ
2ܽଶ ඨܽଶ െ
ݓଵ,ଶଶ
4 ቍ 4-76 
4.4.3 Flow rate as a function of the design variable reaction time 
Equation  4-15 presents the reaction time as function of the outlet channel length, cross-
sectional area and flow rate, as previously presented. The deposition speed of material from the 
outlet is equal to the flow rate divided by the cross-sectional area, either for the total channel or a 
fraction of the channel a single material occupies. Equation 4-16 is algebraically manipulated to be 
an explicit function of reaction time, equation 4-77.  
ݐோ ൌ ܣ௖ܮܳଵ ൅ ܳଶ ൅ ܳଷ ൌ
ܣଵܮ
ܳଵ ൌ
ܣଶܮ
ܳଶ ൌ
ܣଷܮ
ܳଷ  4-77 
Equation 4-77 and equation 4-76, the area fraction of material three as a function of the 
geometric parameters, are combined to present the flow rate of material 3, the cross-linking 
solution, as a function of process and geometric parameters, equation 4-78.  
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ܳଷ ൌ ܾܽ߱ܮ4	ݐோ ቌߨ െ ܽݏ݅݊ ቀ
ݓଵ,ଶ
2ܽ ቁ െ
ݓଵ,ଶ
2ܽଶ ඨܽଶ െ
ݓଵ,ଶଶ
4 ቍ 4-78 
4.4.4 Flow rate as a function of the design variables 
The deposition speed of the combined material flow or portion of the flow are equal. 
Consequently the ratio of material 3 flow rate to cross-sectional area is equal to either (1) the same 
ratio of material 1 or 2 OR (2) the combination material 1 and 2, presented by equation 4-79.  
ܳଷ
ܣଷ ൌ
ܳଵ ൅ ܳଶ
ܣ௖ െ ܣଷ 4-79 
The design variable volume fraction defines the ratio of material 1 to material 2, derived 
from equation 4-6 to produce 4-80.  
ܳଵ ൌ ߛଵଶܳଶ 4-80 
The flow rate for a three inlet material axisymmetric array where each solution is 
independently controlled by a programmable syringe pump as a function of design variables and 
geometric is presented in equation 4-81, 4-82 and 4-83.   
ܳଵ ൌ ܾܽ߱ܮߛଵଶ2ሺ1 ൅ ߛଵଶሻݐோ ቌܽݏ݅݊ ቀ
ݓଵ,ଶ
2ܽ ቁ ൅
ݓଵ,ଶ
2ܽଶ ඨܽଶ െ
ݓଵ,ଶଶ
4 ቍ 4-81 
ܳଶ ൌ ܾܽ߱ܮ2ሺ1 ൅ ߛଵଶሻݐோ ቌܽݏ݅݊ ቀ
ݓଵ,ଶ
2ܽ ቁ ൅
ݓଵ,ଶ
2ܽଶ ඨܽଶ െ
ݓଵ,ଶଶ
4 ቍ 4-82 
ܳଷ ൌ ܾܽ߱ܮ2ݐோ ቌ
ߨ
2 െ ܽݏ݅݊ ቀ
ݓଵ,ଶ
2ܽ ቁ െ
ݓଵ,ଶ
2ܽଶ ඨܽଶ െ
ݓଵ,ଶଶ
4 ቍ 4-83 
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The behavior of variable volume fraction and material 1-2 width is studies using the 
dimensionless flow rate. Dimensionless variables for flow rate, total channel width and combined 
material width are presented in equations 4-84, 4-85 and 4-86.  
ܳ௜∗ ൌ
2ݐ௥ܳ௜
ܾܽܮ߱ 4-84 
ܽ∗ ൌ 1 4-85 
ݓଵ,ଶ∗ ൌ ݓଵ,ଶܽ  4-86 
The dimensionless flow rate are presented in equation 4-87, 4-88 and 4-89. The equations 
are plotted to grpahically present the dependence of design variables for volume fraction and the 
width of center two material streams in a three material axisymmetric flow design. A study of the 
effect of parametric changes to the volume fraction of two materials in a three material design (as 
previously described) on the set of flow rates using the derived model is presented in figure 4-15. 
A study of the effect of parametric changes to the combined width of the central two materials i a 
three material design (as previously described) on the set of flow rates using the derived model is 
presented in figure 4-16. 
ܳଵ∗ ൌ ߛଵଶሺ1 ൅ ߛଵଶሻ൮ܽݏ݅݊ ቆ
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Figure 4-14: Theoretical selection of the dimensionless flow rate to achieve a design-specific 
volume fraction of material 1 to 2, assuming a total of three material streams.  
 
Figure 4-15: Theoretical selection of the dimensionless flow rate to achieve a design-specific 
dimensional width of the internal two material streams.  
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4.5 Comparison of experimental and theoretical results 
Internal features of the heterogeneous array are constructed based on the design of the 
SMMB deposition head channel network and selection of the process parameter set. The design 
variables for the internal features can also be dynamically adjusted over the build cycle, as the 
process parameters can be tuned during fabrication. The width of individual or collections of 
adjacent material is one such controllable design variable. A parametric study swept through a set 
of flow rates to decrease the combined width of two materials in an axisymmetric combined outlet 
channel. Figure 4-16 presents photographs of the three material deposition head. From left to right, 
the flow rate of red material is increased, the flow rate of green and yellow is maintained constant. 
The combined width of green and yellow decreases from left to right. The volume fraction of green 
to yellow is maintained constant, as the flow rates are equal.  
 
Figure 4-16: Effect of flow rates on architecture of internal feature of heterogeneous flow. Flow 
rates are numbered from the longitudinal axis beginning with 1 and moving out radially. Flow 
rates are µL/s and diameter is the width of yellow and green measured in µm. 
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Experimental result and the derived model are compared in figure 4-17. The trend for 
theoretical and experimental results agree. Experimental results are quantified using ImageJ (NIH) 
analysis with the threshold color plug-in for pixel count. The derived collective width of the center 
two materials in a three material axisymmetric is calculated using equations 4-81, 4-82 and 4-83. 
The experimental results are directly measured from photogrpahs using the reference system 
presented in figure 4-9.    
 
Figure 4-17: Theoretical and experimental effect of volumetric flow rate on width of a 
combination of two adjacent longitudinally-centered materials in a three-material axisymmetric 
flow.   
The volume fraction of solution can be adjusted, while maintaining the combined width of 
the two solutions constant. Figure 4-18 presents photographs of the SMMB deposition channel 
during the volume fraction adjustments. In a second parametric study, the red flow rate is 
maintained constant and combined flow rate of yellow and green are maintained constant, but the 
volume fraction of yellow to green is adjusted. From left to right, the volume fraction of green is 
increased by increasing the proportion of green flow rate to yellow. The total flow rate of yellow 
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and green is constant. The volume fraction of red is constant throughout the study, as the proportion 
of red to the total flow rate is constant.  
 
Figure 4-18: Effect of flow rates on architecture of volume fraction of heterogeneous flow. Flow 
rates are numbered from the longitudinal axis beginning with 1 and moving out radially. Flow 
rates are µL/s and diameter is the width of yellow and green measured in µm.  
Experimental results are quantified using ImageJ (NIH) analysis with the threshold color 
plug-in for pixel count. The volume fraction defined by the derived model is presented in equation 
4-6 and experimental volume fraction from images is presented in equation 4-90.   
ߛଵଶ,௘௫௣௘௥௜௠௘௡௧௔௟ ൌ
∑݌݅ݔ݈݁௚௥௘௘௡
∑݌݅ݔ݈݁௬௘௟௟௢௪ 4-90 
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Results are compared in figure 4-19. The trend for theoretical and experimental results 
agree. Agreement is stronger for flow rate less than 0.05 mL/min, relatively weaker for 0.1 mL/min 
and again weaker for 0.25 mL/min.  
 
Figure 4-19: Theoretical and experimental effect of volumetric flow rate on volume fraction of 
two materials in a three-material flow.   
4.6 Advantages of SMMB 
Advantages include of the synchronized multi-material bioprinter (SMMB) include:   
1. Improves resolution of existing extrusion based bioprinting: Multiple materials are 
packaged as a heteregenous array in the SMMDH in a single combined outlet flow without mixing. 
The pattern of the materials across the combined flow cross-section and volume fraction of the 
materials are controllable design parameters. Existing bioprinting techniques leverage multiple 
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nozzles to place each material independently during a buidl cycle. The minimum feature size is 
constrained by the resolution of the nozzle and motion system hardware. The SMMDH addresses 
this challenge by combing multiple materials in a single printed filament, thereby decreasing the 
minimum feature size and improving the resolution of extrusion based bioprinters.  
2. Variable volume fraction and internal geomtry of the material array during the build 
cycle: The flow rate of each material is independently controlled using a programmable and can be 
varied during the build cycle. Consequently, the design variables for volume fraction is directly 
controllable by the user interface on the syringe pump. The internal arrangement of the materials 
is determineed by the design of the open network channel in the SMMDH and also the flow rate.   
3. Controlled chemical reactions for partial cross-linking prior to deposition to minimize 
fluid flow from the location the material is extruded: In addition to the constituent materials 
required in the design, we include cross-linking solution to fully or patrailly gel the aqeuous 
solution while it is still in the depositoin head. This is advantageous during extrusion as without 
the cross-linking the aqeuous solution will distort as it flows free from beng released from the outlet 
channel until it is cross-linked by the subsequent application of a cross-linking solution. Further, 
the residence time between the cross-linking and aqueous solutions in the deposiiton head is 
controllable according to the length of the combined outlet channel and flow rate of each material.  
4. Flexibility to fabricate heteregenous nano-liter droplets (torus droplets or solid 
sphereical droplets) or patterned filaments: The combined outlet flow is extruded along a 3-
dimensional tool path to fabricate either (1) nano-liter droplets or (2) patterned filaments, which 
with layer-by-layer fabrication produce 3-dimensional volumetric scaffolds. Nano-liter droplets are 
a more adapatable platform, as the droplet is simplier to design and can be used in many existing 
bioreactor designs. Heterogenous filaments are desirable for controlled cell seeding in the channels 
of microfluidic devices and for free-standing scaffold design for regenerative medicine and tissue 
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engineering applications. To fabricate droplets, the combined flow accumulated on the outlet tip of 
the SMMDH. The tip is cyclically dipped in a pool of cross-linking solution to produce a droplet 
on contact. The period of the cycle and flow rate determine the volume of the droplet. The relative 
flow rate of the materials determine the volume fraction of each constituent material. The cross-
linking time is a function of the aqueous solution being printed and cross-linking solution. Once 
the material accumulated on the outlet tip contacts the cross-linking pool, the accumulated material 
flows away from the tip as it is being cross-linked. There exists a set of printed material to cross-
linking solution concentration which the time required for cross-linking is slightly longer than the 
time it takes for the material to flow from the tip (leaving a hole in the center of the droplet). This 
forms a torus shape. There also exists a set of material concetrations where the cross-linking time 
is slightly less than the time it takes for the material to flow away from the tip and thereby there is 
no hole and the droplet is a solid sphereical shape. During heteregenous filament printing, the 
combined flow is extruded from the SMMDH mounted to a motion system on to a stationary 
substrate. The tool path patterned the extruded material layer-by-layer to build 3-dimensional 
volumetric structures of hetergenous filaments. Both the nano-liter droplet printing and 
heteregenous filament printing can be combined a single build cycle to fabricate various structures 
and artifacts.   
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CHAPTER 5: CHARACTERIZATION OF THE SYNCHRONIZED MULTI-MATERIAL 
BIOPRINTING SYSTEM AND APPLICATION 
5.1 Printing filaments and nano-liter droplets with SMMB   
SMMB system packages multiple materials in a heterogeneous array and deposits those 
materials along a pre-programmed 3-dimensional tool paths. The automation of this process offers 
two distinct opportunities for formability:  
(1) Heterogamous filaments: Layer-by-layer fabrication of a free-standing scaffold or 
controlled cell seeding in channels of a microfluidic device require deposited along a 
tool path. Multiple deposition heads can be simultaneously integrated in a single 
SMMB system. Multiple integrated deposition head offer the same benefit as multi-
nozzle printing; including supplemental cross-linking solutions or secondary 
heterogeneous set of materials.  
(2) Heterogeneous nano-liter droplets: The build cycle period defined by the SMMB 
motion system controls the frequency of an event to print droplets. Droplet volume is 
a controllable process parameter. 
 
Figure 5-1: Photographs of extrusion along a tool path to build a free-standing scaffold (left) and 
extrusion over a controlled build cycle to print droplets (right).    
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SMMB’s automated material delivery system and motion system produce both filaments 
and droplets.  SMMB scaffold printing improves the resolution of multi-nozzle deposition (MND) 
printing and offers the combined outlet channel as an opportunity for chemical reactions or mass 
species transfer during a controlled time interval. Partial or complete cross-linking is one method 
to leverage the combined outlet channel. SMMB droplet printing produces a simpler product than 
scaffold printing. However, printed droplets are a more accessible and adaptable technology. 
Droplets are simpler to design, fabricate and ensure sufficient nutrient diffusion to the cell-laden 
core. Droplets can also be used in many existing bioreactor platforms. In this work, printed co-
culture nano-liter droplets are the model of human liver to study the effect of microgravity on cell 
morphology and drug up-take using a rotary cell culture system.  
5.2 Printing heterogeneous filaments 
The synchronized multi-material bioprinter (SMMB) dispensing system is integrated with 
the existing multi-nozzle deposition (MND) system to continuously extrude heterogeneous 
filaments along a tool path. SMMB system performance to pattern a heterogeneous filament along 
a tool path is defined by a set of geometric design variables to control printed filament cross-
sectional width/height, reaction time in the outlet channel. Design variables, ߖௌெெ஻,஽, is defined 
by printed filament width, ܿ, and height, ݀, reation time, ݐ௥, and volume fraction of material i to 
material j, ߛ௜௝. The set of design variables are presented in equation 5-1.  The printed filament width 
and height, reaction time and volume fraction are a function of the process parameters, which are 
varied over the time course of the build cycle to produce hierarchial and gradient structures. The 
time variable, ݐ, denotes the parameter are adjustable over the course of the build cycle and 
consequenly non-static over the full dimensionalty of the built structure.  
ߖௌெெ஻,ிሺݐሻ ൌ ൣܿሺݐሻ ݀ሺݐሻ ݐ௥ ሺݐሻ ߛ௜௝ሺݐሻ ൧ 5-1 
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SMMB derived, geometric, material, and process parameters have been previously defined 
in section 4.2 definition of SMMB process parameters, material properties and design variables. 
Table 5-2 presents SMMB droplet printing variables. The set of design variables, geometric and 
process parameters are presented in table 5-1 and figure 5-2.   
Table 5-1. Synchronized multi-material bioprinter (SMMB) system design variables, derived, 
geometric, material, and process parameters to print a heterogeneous filament. 
Symbol Description Process Window Parameter 
Type 
࡭	 Cross-sectional area of printed 
filament  
-  Derived  
ࢇ SMMB deposition head outlet 
channel width 
-  Geometric 
࢈ SMMB deposition head outlet 
channel height 
 - Geometric 
ࢉ Printed filament width (parallel to 
printing substrate) 
- Design 
ࢊ Printed filament height 
(perpendicular to printing substrate) 
- Design 
ࡰࢉ SMMB deposition head capillary 
outlet channel diameter 
100 150 200
250 330 410					ߤ݉ 
Geometric 
࢔ Number of material streams - Design 
ࡽ࢏ Volume flow rate 1.67 ൈ 10ିଷ ൑ 		ܳ௜ 		൑ 2.00 mL/min 
Derived 
࢚ࡾ Reaction time between materials in 
the SMMB outlet channel 
- Design 
࢜ SMMB deposition head speed over 
printing substrate 
0.1 ൑ ݒ ൑ 15.0 ݉݉/ݏ Process 
ࢠ SMMB deposition head outlet 
height above printing substrate 
100 ൑ ݖ ൑ 1000	ߤ݉ Process 
࣋࢏ Material density - Material ࢸࡿࡹࡹ࡮,ࡲ Set of SMMB design variables to 
print heterogeneous filament 
 Design 
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Figure 5-2: Schematic of synchronized multi-material deposition head mounted to motion system 
printing heterogonous line with process control of the volume fraction of each material and 
internal architecture of printed filament.  
The flow from the printhead accumulates in an elliptical fiber on the substrate, as presented 
in equation 2-42 reprinted below.    
൬݀݉݀ݐ ൰௙௥௢௠	௠௔௧௘௥௜௔௟	ௗ௘௟௜௩௘௥௬ ௦௬௦௧௘௠ ൌ ൬
݀݉
݀ݐ ൰௦௨௕௦௧௥௔௧௘ ௔௖௖௨௠௨௟௔௧௜௢௡ ൌ ߩ௜ܳ௜  
Flow from the SMMB deposition system is combination of the flow rate of each material. 
An independently controlled three material case is presented in equation 5-2.   
൬݀݉݀ݐ ൰௙௥௢௠	ௌெெ஻	ௗ௘௣௢௦௜௧௜௢௡ ௦௬௦௧௘௠ ൌ෍ ܳ௜ߩ௜
௡
௜ୀଵ
ൌ ܳଵߩଵ ൅ ܳଶߩଶ ൅ ܳଷߩଷ 5-2 
The accumulation of material on the substrate along the tool path is defined by the cross-
sectional area of the printed filament and print head speed, equation 5-3.  
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൬݀݉݀ݐ ൰௦௨௕௦௧௥௔௧௘	௔௖௖௨௠௨௟௔௧௜௢௡ ൌ ݒሺܣଵߩଵ ൅ ܣଶߩଶ ൅ ܣଷߩଷሻ 5-3 
SMMB hardware is not capable of generating the inertial force required for compressible 
flow. The continuity model is augmented in favor of control volume analysis, equation 5-2 and 5-3 
combine to produce equation 5-4.   
ܳଵ ൅ ܳଶ ൅ ܳଷ ൌ ݒܣ 5-4 
The cross-section of the printed structure is modeled as an ellipse defined by a major axis 
(parallel to the printing substrate) and minor axis (perpendicular to the printing substrate), presented 
in equation 5-5.  
ܣ ൌ ߨܿ݀4  5-5 
The minor axis of the printed filament is controllable as long as it is greater than the major 
axis, as presented in section 2.3.3.3.1 printhead speed selection for a set of design variables. The 
SMMB printed filament width is a function of process parameters for flow rate, deposition head 
traveling speed and the height of the outlet above the printing substrate. The design variable printed 
filament width is an explicit function of process parameters in equation 5-6, a combination of 
equation 5-4 and 5-5.  
ܿ ൌ 4ߨݒݖ ሺܳଵ ൅ ܳଶ ൅ ܳଷሻ 5-6 
Equation 4-15 defines the total flow rate as a function of design parameter reaction length 
and the geometric parameters outlet channel length and cross-sectional area.  The deposition head 
traveling speed defined as a function of the geometric and design variables is presented in equation 
5-7, a combination equation 4-15 and  5-5.  The process parameter deposition head traveling speed 
as an explicit function of the (1) design variables printed filament cross-sectional width/height and 
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reaction time and (2) geometric parameters SMMB deposition head outlet channel cross-section 
width/height and channel length. Equation 5-7 is a predictive tool to define the deposition head 
traveling speed based on a set of design variables for the printed filament and the geoemtric 
parameters of the SMMB deposition head’s combined flow outlet channel.  
ݒ ൌ ܾܽܮܿ݀ݐோ 5-7 
Equation 5-7 is the general case of an elliptical outlet channel defined by the major and 
minor axis. The specific case of a capillary channel outlet is equation 5-8.  
ݒ ൌ ܦ௖
ଶܮ
ܿ݀ݐோ 5-8 
Heterogeneous printed filament in square wave pattern printed using bioprinter and a multi-
material deposition head with two inlet channels of red and green solution. Figure 5-3 presents a 
photograph of the printed alginate filament in square wave pattern (A) and binary contrast 
enhancement of green (B) and red (C) alginate are shown.   
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Figure 5-3: Heterogeneous printed filament in square wave pattern printed using bioprinter and a 
multi-material deposition head with two inlet channels of red and green solution. Schematic of 
the microfluidic network in multi-material deposition head depicts the red and green flows are 
combined in a single outlet channel. Bioprinter’s motion system carries the deposition head over 
the stationary substrate to produce the square wave pattern. Photograph of the printed alginate 
filament in square wave pattern (A) and binary contrast enhancement of green (B) and red (C) 
alginate are shown. 
5.3 Printing heterogeneous nano-liter droplets 
5.3.1 Description of process and variables 
The SMMB material delivery system’s flow rate controls the nano-liter volume which 
accumulates on the outlet of the outlet tip. The motion system introduces cyclic motion to dip the 
accumulated material in a cross-linking reservoir. The process is specifically suited for a chemically 
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cross-linking matrix; such as sodium alginate cross-linked with calcium chloirde.  Sodium alginate 
aqueous solutions of alginic acid sodium salt from brown algae (Sigman et al.) and cross-linking 
solution of ACS grade calcium chloride are prepared from distilled water, respectively. Alginate 
solution is loaded into SMMB material delivery system and cross-linking solution floods the 
reservoir pool positioned below the printing tip. SMMB deposition head outlet tip is lowered to 
less than 100µm above cross-linking pool. The programmable syringe pump extrudes alginate 
through the deposition head. The alginate accumulates on the tip, until contact with the cross-
linking reservoir. On contact, the droplet is released from the tip and gels to form an alginate pool 
in the cross-linking reservoir. The build cycle period, or time to printing one droplet, is adjusted 
using the process parameters to fabricate variable size droplets. Figure 5-4 presents a schematic of 
the process stages and figure 5-5 presents time-lapse photographs of one print cycle.  
 
Figure 5-4: Schematic of SMMB droplet printing process using two materials. 
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Figure 5-5: Time lapse photo of single build cycle printing droplet Process schematic for printing 
droplets using  
SMMB system performance to print nano-liter droplets is defined by a set of geometric 
design variables to control droplet size and volume fraction of the constituent materials. Design 
variables, ߖௌெெ஻,஽, is defined by reaction time in the SMMB deposition head combined outlet 
channel, ݐோ, droplet volume, ܸ ஽, and volume fraction of material i to material j, ߛ௜௝. The set of nano-
liter droplet design variables is presented in equation 5-9. 
ߖௌெெ஻,஽ ൌ ሾ ݐோ ஽ܸ ߛ௜௝ ሿ 5-9 
The complete set of SMMB process parameters are amended to print droplets to include the 
displacement and speed in the x-, y- and z-direction and the flow rate of each material input, as 
presented in equation 5-10.   
ߗௌெெ஻,஽ሺݐሻ ൌ ቎
݀௫
݀௬
݀௭
ܳ௜
ݒ௫ݒ௬ݒ௭
቏ 5-10 
SMMB derived, geometric, material, and process parameters have been previously defined 
in section 4.2 definition of SMMB process parameters, material properties and design variables. 
Table 5-2 presents SMMB droplet printing variables.  
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Table 5-2. Synchronized multi-material bioprinter (SMMB) system design variables, derived, 
geometric, material, and process parameters to print a heterogeneous nano-liter droplet. 
Symbol Description Process Window Parameter 
Type 
࡭	 Cross-sectional area of printed 
droplet 
-  Derived  
ࢊ࢞ Displacement in x-direction 100 ൑ ݀ ൑ 1000	ߤ݉ Process ࢊ࢟ Displacement in y-direction 100 ൑ ݀ ൑ 1000	ߤ݉ Process 
ࢊࢠ Displacement in z-direction 100 ൑ ݀ ൑ 1000	ߤ݉ Process ࡰࢉ SMMB deposition head capillary 
outlet channel diameter 
100 150 200
250 330 410					ߤ݉ 
Geometric 
ࡰࡼ Printed droplet diameter  Derived ࢔ Number of material streams - Design 
ࡽ࢏ Volume flow rate 1.67 ൈ 10ିଷ ൑ 		ܳ௜ 		൑ 2.00 mL/min 
Derived 
࢚࡮ Build cycle period, time to print 
one droplet 
- Derived 
࢚ࡾ Reaction time between materials in 
the SMMB outlet channel 
- Design 
࢜࢞ SMMB deposition head traveling 
speed in x-direction 
0.1 ൑ ݒ ൑ 15.0 ݉݉/ݏ Process 
࢜࢟ SMMB deposition head traveling 
speed in y-direction 
0.1 ൑ ݒ ൑ 15.0 ݉݉/ݏ Process 
࢜ࢠ SMMB deposition head traveling 
speed in z-direction 
0.1 ൑ ݒ ൑ 15.0 ݉݉/ݏ Process 
ࢂࡰ SMMB printed droplet volume - Design ࢽ࢏࢐ Volume fraction of i material to j 
material 
- Design 
࣋࢏ Material density - Material ࢸࡿࡹࡹ࡮,ࡰ Set of SMMB droplet printing 
design variables 
- Design 
ࢹࡿࡹࡹ࡮,ࡰ Set of SMMB droplet printing 
process parameters 
- Process 
  
5.3.2 Theoretical printed droplet volume and volume fraction 
The accumulation of material at the outlet of the SMMDH is a function of the flow rate 
through the printhead and the period of the build cycle. The build cycle period and flow rate are 
independent derived parameters, which can be independently tuned through process parameters to 
fabricate nano-liter droplets. The droplet volume of a two material SMMB printed droplet is a 
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function of the process parameter flow rate, design parameter volume fraction, and derived 
parameter build cycle period, as presented in equation 5-11.  
஽ܸ ൌ ܳଶሺ1 ൅ ߛଵଶሻݐ஻ 5-11 
The build cycle period is the amount of time material accumulates at the tip between 
dispensing droplets. The trajectory of the SMMB is discretized into several movements, each along 
a single axis, as presented in equation 5-12.  
ݐ஻ ൌ෍݀௜ݒ௜
ଷ
௜ୀଵ
ൌ ݀௫ݒ௫ ൅
݀௬
ݒ௬ ൅
݀௭
ݒ௭  5-12 
The printhead speed and distance in x- and y-axis are equal. Additionally, motion occurs in 
either the x- or y-axis and only as a single movement per build cycle. The variables for x- and y-
axis movement are combined into a single variable. Equation 5-13 and 5-14 present the process 
parameter for x- and y-axis speed and distance, respectively, as a single variable. 
ݒ௫௬ ൌ ݒ௫ ൌ ݒ௬ 5-13 
݀௫௬ ൌ ݀௫ ൌ ݀௬ 5-14 
 
The z-axis movement occurs twice for each build cycle; once to lift the SMMB tip away 
from the cross-linking reservoir and once to bring the SMMB tip back in contact with the reservoir 
to print droplet, as presented in equation 5-15.  
ݐ஻ ൌ ݀௫௬ݒ௫௬ ൅
2݀௭
ݒ௭  5-15 
The change in height in the z-direction (away from the cross-linking pool surface and then 
back to the surface) must be greater than the diameter of the droplet to prevent contact and 
uncontrolled dispense during the build cycle. The printed droplet is modeled as sphere to define the 
185 
 
minimum z-direction shift must be greater than the droplet diameter, defined as a function of the 
droplet volume, as presented in equation 5-16.   
݀௭ ൐ ඨ6 ஽ܸߨ
య
 5-16 
Droplet aggregation during printing due to repeated deposition on the same site is 
diminished by moving during the build cycle. This step is not mandatory if the reservoir is agitated 
causing the droplet to separate on their own. The minimum and maximum x- or y- direction 
displacement are zero and the hardware limit, as presented in equation 5-17.    
0 ൑ ݀௫௬ ൑ 1000 ߤ݉ 5-17 
Equations  5-11 and  5-15 combine to define the printed droplet volume as a function of the 
process parameters for flow rate, tool path length and deposition head traveling speed and design 
variables for the volume fraction of the two materials, as presented in equation 5-18.   
஽ܸ ൌ ܳଶሺ1 ൅ ߛଵଶሻ ቆ
݀௫௬
ݒ௫௬ ൅
2݀௭
ݒ௭ ቇ 5-18 
 
 
The theoretical effect of the process parameters and design parameter for volume fraction 
of material 1 to material 2 on the printed droplet volume are defined by equation  5-18. The effect 
of independent variable on the printed droplet volume are further examined in figure 5-6. The flow 
rate of material 2 and printed droplet volume are directly proportional. Further, the volume fraction 
is also directly proportional to the printed droplet volume. The distance along any of the three axis 
is proportional to the printed droplet volume, as it will increase build cycle period. The speed in 
any direction is inversely related to the printed droplet volume.  
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Figure 5-6: Theoretical effect of process parameters and design parameter for volume fraction of 
material 1 to material 2 on printed droplet volume.  
5.3.3 Printing heterogeneous droplet 
Material accumulates on the tip of the deposition head as a nano-liter droplet. Photographs 
of the accumulating droplet are analyzed for mixing. A homogenous droplets presents red coloring. 
The heterogeneous droplets presents both red and green coloring. The two colors are presented on 
discrete sides of the droplet. Figure 5-7 presents the droplet and color threshold images.  
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Figure 5-7: Photographs of red and green alginate accumulating on tip of deposition head as 
nanoliter droplet. Photographs are color threshold to present separate streams of red and green as 
heterogeneous   
5.3.4 Effect of cross-linking solution concentration on droplet formability 
The success of droplet formability requires the alginate gel in the cross-linking bath before 
dispersing in the bath due to the inertial force the printing process. The inertial forces of the flowing 
fluid degrades the droplet’s spherical structure before gelation, if the cross-linking concentration is 
low. Aqueous alginate solution will flow until sufficient time in contact with cross-linking solution 
causes gelation. Further, printed droplet solidity (torus or sphere) are generated by controlled the 
cross-linking time. Cross-linking time is a function of the alginate and calcium chloride 
concentration.  Cross-linking concentration is increased 0.2-1.0 g/mL calcium chloride in distilled 
water. Alginate concentration is constant 0.5% (w/v) throughout the study. The length of time 
required for cross-linking is inversely related to the concentration of the crossing solution, for a 
given concentration of alginate. Time lapse photography of the droplet dispensing into the cross-
linking pool present the effect of cross-linking solution concentration on formability of droplets 
and the ability to produce torus structures. Figure 5-8 presents alginate dispersed into 0.2 g/mL 
calcium chloride. The printed material flow away from the deposition point and degrades any 
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printed structure. Further perturbation of the cross-linking reservoir will cause the droplet to twist 
and lose all recognizable shape.  
 
Figure 5-8:  Time lapse photography of printed 0.5% (w/v) sodium alginate droplet in 0.2 g/mL 
calcium chloride cross-linking reservoir forming an unstable ring.  Each photograph is 0.06 
seconds apart. Calibration mark is 1 mm.   
Figure 5-9 presents alginate dispersed into 0.3 g/mL calcium chloride. The printed material 
flow away from the deposition point. The droplet is cross-linked before the structure completely 
degrades. However, the alginate had sufficient time to flow away from the deposition point, leaving 
a material void in the center of the printed structure. The results is a printed torus droplet.   
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Figure 5-9: Time lapse photography of printed 0.5% (w/v) sodium alginate droplet in 0.3 g/mL 
calcium chloride cross-linking reservoir forming a stable torus.  Each photograph is 0.06 seconds 
apart. Calibration mark is 1 mm.   
Figure 5-10 presents alginate dispersed into 0.5 g/mL calcium chloride. The printed material 
gels as it is deposited in the cross-linking reservoir. Material void in the center of the printed droplet 
is not apparent. The results is a printed spherical droplet.   
 
Figure 5-10: Time lapse photography of printed 0.5% (w/v) sodium alginate droplet in 0.5 g/mL 
calcium chloride cross-linking reservoir forming a stable solid droplet.  Each photograph is 0.06 
seconds apart. Calibration mark is 1 mm.   
Figure 5-11 presents alginate dispersed into 1.0  g/mL calcium chloride. The printed 
material gels on contact with the cross-linking bath. The printed material does not have sufficient 
time to sink into the cross-linking bath to form a sphere shape. The shallow disc is an unstable 
shape. Any perturbations to the cross-linking bath cause the shallow disc to twist and lose all 
recognizable shape. 
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Figure 5-11: Time lapse photography of printed 0.5% (w/v) sodium alginate droplet in 1.0 g/mL 
calcium chloride cross-linking reservoir forming a stable solid droplet.  Each photograph is 0.06 
seconds apart. Calibration mark is 2 mm.   
The feasible set of cross-linking concentration for printing 0.5% (w/v) sodium alginate 
range from 0.3-1.0% (w/v) calcium chloride. Alginate disperses into the cross-linking reservoir too 
quickly to gel for concentration less than 0.3%. Conversely, alginate gels too quickly in 
concentration greater than 1.0% to become submerged and cross-linked from all sides of the sinking 
droplet. Torus droplets (partial flow away from the deposition site) and spherical droplets (solid in 
appearance) are a consequence of the cross-linking concentration, as presented in figure 5-12. 
Further control of droplet solidity and symmetry may be controllable with a more in-depth study 
of the concentration.   
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Figure 5-12: Effect of cross-linking solution concentration on solidity of printed droplets. Two of 
the four process windows successfully fabricate stable droplets. The two extreme process 
windows, 0-0.30g/L and >1.00 g/L calcium chloride result in no shape.  
5.3.5 Comparison of theoretical and experimental printed droplet volume. 
The derived model of droplet volume as a function of the process parameters is compared 
to experimental results. Solution are prepared and loaded into the SMMB material delivery system 
syringe pump for controlled extrusion during the build cycle. In this work, sodium alginate aqueous 
solutions of alginic acid sodium salt from brown algae (Sigman et al.) and cross-linking solution 
of ACS grade calcium chloride are prepared from distilled water, respectively. Droplets are single 
material inlet 0.5% (w/v) sodium alginate printed into 0.5% (w/v) calcium chloride cross-linking 
solution. Sets of 200 individual droplets with volumes 200-600 nL are fabricated by SMMB in a 
single build. Figure 5-13 presents photographs of the printed droplets from each variable volume 
set.   
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Figure 5-13: Photographs of 20-30 individual droplets of variable volume 4printed droplet 
ranging from 200-600nL.   
Photographs of the printed droplets analyzed by ImageJ (NIH) color threshold plug-in. Each 
photograph is planar view of the droplets. Figure 5-14 presents photographs of the printed droplets. 
Area of each droplet measured using binary images.   
 
Figure 5-14: Photograph of 200 (A) and 600 (B) nL printed droplets. Outlines of binary contrast 
enhancement of 200 (C) and 600 (D) nL printed droplets using photographs A and B respectively.   
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Droplets are modeled as a sphere to estimate the printed volume from the measured area. 
The experimental volume is calculated from the measured area, equation 5-19. Equation 5-20 for a 
single material input is equation 5-18 amended for a single material defined by a single flow rate, 
equation 5-17. The derived model for droplet volume (equation 5-20) and calculated volume from 
experimental results (equation 5-19) are compared in figure 5-15. 
஽ܸ,௘௫௣௘௥௜௠௘௡௧௔௟ ൌ 43√ߨ ሺܣ௠௘௔௦௨௥௘ௗሻ
ଷ ଶ⁄  5-19 
஽ܸ,௧௛௘௢௥௘௧௜௖௔௟ ൌ ܳ ቆ݀௫௬ݒ௫௬ ൅
2݀௭
ݒ௭ ቇ 5-20 
 
Figure 5-15: Comparison of the theoretical and experimentally measured effect of the 
controllable process parameter. Printhead velocity refers to speed in the z-direction. No 
movement occurs in the x- or y-direction for this study.  
Each printed droplet volume set (200, 300, 500 and 600 nL) contains 200-300 individual 
droplets. The experimental printed droplet diameter is calculated from the measured droplet area, 
equation  5-21.  
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ܦ௉,௘௫௣௘௥௜௠௘௡௧௔௟ ൌ 2ඨܣ௠௘௔௦௨௥௘ௗߨ  5-21 
The probability distribution function of each measured printed droplet diameter is presented 
in figure 5-16. Distinct peaks for each droplet diameter are observed for each droplet volume set.  
 
Figure 5-16: Probability distribution function of printed droplet diameter  
The cumulative distribution function of the droplet circularity is directly measured from the 
binary photographs of fabricated result, figure 5-17. Circularity varied from 0.70 to 1.00 (fully 
circular) for all surveyed printed volumes. Droplets vary from 0.70-1.00 (completely circular) 
circularity.  The probability a printed droplet will be more than 0.90 circular increases as droplet 
volume increases from 200 to 600 nL.   
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Figure 5-17: Cumulative distribution function of printed droplet circularity for 200, 300, 500, 
and 600 nL volumes.  
5.4 Effect of model microgravity on hetero-cellular liver model 
5.4.1 Rationale for study 
5.4.1.1 Objective 
Gravitational forces or the lack thereof effect dispersion of interstitial fluids in the body, 
cell secretion and therefore biochemistry of tissues, gene expression, and volume of individual 
organelles (Baqai et al., 2009b; Khaoustov et al., 2001; Talbot et al., 2010a). NASA’s space life 
science enterprise studies cell function in microgravity to prepare clinical dosing requirements and 
pharmacological thresholds for long term manned space exploration. The objective of this work is 
to study the effect of co-culture and model microgravity using a printed hetero-cellular nano-liter 
droplet and rotary cell culture system. Printed hetero-cellular droplets are loaded into high aspect 
ratio vessels and conditioned to weightlessness using a rotary cell culture system to study drug 
metabolic rate in model microgravity. The effect of model microgravity on hepatocyte’s organelle 
size (including cell cytoplasm and nucleus), metabolic rate and drug up-take rate are presented. The 
effect of model microgravity and co-culture condition on urea concentration, metabolic rate and 
cell model stiffness are presented.    
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5.4.1.2 Preliminary results with mono-culture on collagen coated micro-carriers 
Preliminary work to study the effect of microgravity on human hepatic pharmacokinetics 
and function is conducted using a mono-culture cell model on collagen coated micro-carriers 
(Snyder J.E., 2012). Pharmacokinetics of the anti-nausea drug promethazine (PMZ) and the 
bioassay for cellular oxidation Alamar Blue are evaluated. Hepatic function is quantified by urea 
concentration. 3-dimensional hepatocyte aggregates experience simulated microgravity in a 
Synthecon Rotary Cell Culture System (RCCS). Pharmacokinetic rate and urea secretion are up-
regulated in model microgravity. RCCS as a ground model of microgravity up-regulates 
pharmacokinetic rate of PMZ metabolism and up-regulates urea secretion. Gravity had no observed 
effect on the amount a cell could metabolize. The saturation concentration of both drugs was same 
in both gravitation conditions, RCCS as a µG ground and 1G.  
Human hepatocytes of the HepG2 (ATCC) cell line are incubated with Cytodex collagen 
coated microcarrier beads in non-adherent plate. Average diameter of Cytodex bead is 225 µm +/-
25µm. After 24 hours in culture HepG2 adhere to microcarrier surface and begin to form 
aggregates. Figure 5-18 presents phase contrast images of HepG2 with microcarriers less than 1 hr 
and after 24 hours from cell seeding. HepG2-laden microcarriers are cultured in model µG and 1G.  
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Figure 5-18: Hepatocytes attached to the surface of collagen-coated spheres. 3D aggregates of 
HepG2 less than 1 hour after cell seeding 10x (A) and 24 hours after cell seeding 10x (B) 20X 
(C) 40X(D) 
The cell model is conditioned to microgravity using a ground model Synthecon rotary cell 
culture system (RCCS) to maintain the cell model in a state of perpetual freefall. Figure 5-19 is a 
schematic to introduce the operating principle of rotary cell culture as a model of microgravity. 
Contact forces signal the presence of a gravitational force. Perpetual freefall in a rotary cell culture 
system removes contact forces. Rotary cell culture is a ground model of microgravity and used to 
study the effect of no contact forces on cell models. Cell models are loaded into micro-spheres are 
loaded into high aspect ratio vessels (HARV) which are flooded with cell culture medium. 
Photograph of the Synthecon RCCS platform with four HARV filled with cell culture medium is 
presented in figure 5-20.  
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Figure 5-19: Presentation of rotary cell culture as a model of microgravity.  
 
Figure 5-20: Synthecon Rotary Cell Culture System (RCCS) with High Aspect Ratio (HARV) 
containing cell culture medium and cell models.  
RCCS rotation causes cell culture medium and the cell-laden micro-carriers to flow. Flow 
increases mixing and prevents local depletion of nutrients and drug and build-up of waste in the 
immediate vicinity of the model. 1G controls are incubated in HARV, but not rotated. To prove the 
results of the 1G vs. model microgravity experiment are caused by the diminished gravitational 
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force, and not local depletion drug, the 1G group is rotated horizontally at the same rpm as model 
microgravity group. In this way, both group experience mixing, but the cell model in the model 
microgravity group’s vertical configuration experience perpetual freefall; i.e. model microgravity 
conditioning. A cartoon depiction of the concern of static v. rotary culture on local depeltion if 
nutrients and drug is presented in figure 5-21.  
 
Figure 5-21: Cartoon depiction of RCCS HARV rotation to diminish the effect of local depletion 
of drug due to static conditions during drug-uptake study.  
Pharmacokinetics of two drugs are evaluated using RCCS and HepG2-laden microspheres 
(1) Promethazine (PMZ) and (2) Alamar Blue. PMZ (Sigman et al.) is drug commonly prescribed 
to astronauts for anti-nausea. PMZ concentration is determined by high performance liquid 
chromatography (Waters). Alamar Blue (AbD Serotec) is an oxidation redox indicator which 
fluoresces after being metabolized by live cells.   PMZ (0.10mg/mL) in cell culture medium is 
200 
 
loaded into HARV after cells have been in model microgravity for 24 hours. Cells in HARV 
metabolize and absorb the drug. Figure 5-22 presents pharmacokinetics of PMZ up-take in 
microgravity and 1G. PMZ concentration is 0.10mg/mL when loaded into the bioreactor. Cell 
metabolism and up-take of PMZ decreases the concentration throughout the 3 hour experiment. 
PMZ concentration decreases more quickly in model µG than 1G. PMZ concentration drops 7% 
more in model µG than 1G after 10 minutes, 22% more in model µG than 1G after 30 minutes, 
23% more in model µG than 1G after 1 hour, and 18% more in model µG than 1G after 2 hours. 
PMZ concentration is not statistically different after 3 hours.  
 
Figure 5-22: HepG2 cultured on microcarriers in RCCS after 24 hours metabolize PMZ to 
decrease concentration of drug. 
Alamar Blue (10% v/v) in cell culture medium is loaded into HARV after cells have been 
in model microgravity for 24 hours. After metabolize by cells, Alamar Blue fluoresces 530-560nm 
excitation and 590nm emission. Fluorescence increases throughout the 3 hour experiment as cells 
metabolize Alamar Blue. Without metabolism by the cells the drug will be undetectable by 
emission/excitation spectrum sampled. Figure 5-23 presents concentration of metabolized Alamar 
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Blue. Alamar Blue fluorescence increases more quickly in model µG than 1G until 3 hours 30 
minutes. Fluorescence is not significantly different after 6 hours.  
 
Figure 5-23: HepG2 in RCCS metabolize Alamar Blue to produce fluorescence proportional to 
cell number after 24 hours in RCCS. 
Drug half-life is determined from experimental results. Both PMZ and Alamar Blue half-
life are shorter in model µG than 1G. Figure 5-24 presents the half-life of each drug in model µG 
and 1G. PMZ half-life is 30.0 minutes earlier in model µG than 1G. Alamar Blue half-life is 8.4 
minutes earlier in in model µG than 1G. 
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Figure 5-24: Half-life of PMZ and Alamar Blue metabolized by HepG2 cultured on 
microcarriers in RCCS for 24 hours. 
Urea concentration is quantified after 24 hours in model µG and 1G. QuantiChrom Urea 
Assay Kit (BioAssay Systems, Hayward, CA) quantifies urea present in biological sample by 
absorbance measured at 405nm by Tecan Microplate Reader. Urea concentration in microgravity 
is compared to 1G controls. Figure 5-25 presents urea concentration after 24 hours in model 
microgravity and 1G. Urea concentration is 5.1mg/mL and 4.0mg/mL in model µG and 1G 
respectively. Hepatocytes secreted 22% more urea in in model µG than 1G.   
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Figure 5-25: Urea concentration of HepG2 cultured on microcarriers after 24 hours in RCCS.  
Ground model of microgravity up-regulates pharmacokinetic rate of PMZ metabolism and 
up-regulates urea secretion. Gravity had no observed effect on the amount a cell could metabolize. 
The saturation concentration of both drugs was same in model µG and 1G.  
Pharmacokinetic rate of drug metabolism by hepatocytes is up-regulated in model µG. 
HepG2 up-take PMZ more quickly in model µG than 1G. Concentration difference is maintained 
between 18-23% for much of the first 2 hours drug is introduced. Half-life of PMZ and Alamar 
Blue in model µG is 30 and 8 minutes shorter respectively in model µG than 1G. Hepatocyte’s 
capacity to metabolize drug is not effected by model µG. Saturation points for both drugs are not 
significantly different between model µG and 1G. No significant variance is observed after 3 hours 
with PMZ or after 6 hours with Alamar Blue respectively.  The number of hepatocytes in model 
µG and 1G are not significantly different. Cell number is determined from saturation fluorescence 
of Alamar Blue after 6 hours. Alamar Blue is an indicator of cell viability designed to monitor 
kinetic cell growth. Alamar Blue fluorescence is linearly proportional to cell number with 
correlation coefficient of 0.92 (data not shown). No significant difference in fluorescent after 6 
hours correlates to no significant difference in number of cells. Urea concentration is up-regulated 
in hepatocytes cultured in model µG for 24 hours. The number of cells in model µG and 1G are not 
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significantly different, according to Alamar Blue results. Therefore the amount of urea each cell 
secretes is up-regulated in model µG. Cell function and therefore biochemistry of culture and 
autocrine/paracrine signaling in model µG is observed to be quantitatively and temporally different 
than 1G.  
5.4.2 Model design and fabrication 
SMMB system enables fabrication of a hetero-cellular model of liver both (1) compatible 
with the existing RCCS platform and (2) capable of controlling the volume fraction of hepatocytes 
to endothelial cells. The biomimetic ratio of hepatocytes to endothelial cell in human liver sinusoid 
tissue is 7:1. Drag force on the droplet during RCCS culture is minimized by fabricating the 
minimum feasible droplet volume.     
The cell model is a set of SMMB printed 200nL HepG2-laden spherical droplet. Droplets 
are 3.0×106 HepG2 cells per mL 0.5% (w/v) sodium alginate, cross-linked in 0.5% (w/v) calcium 
chloride. Design variables for the co-culture printed droplet presented in equation 5-22. The 
printing solution are chemically inert. The reaction time is unspecified.  
ߖௌெெ஻,஽ ൌ ൤		ݐோ ൌ െ ஽ܸ ൌ 200 ݊ܮ ߛு,ா ൌ ܪ݁݌ܽݐ݋ܿݕݐ݁ܧ݊݀݋ݐ݄݈݈݁݅ܽ ൌ
7
1					൨ 5-22 
The set of process parameters to produce the set of design variables presented in equation  
5-23 and equation to relate the flow rate to the volume fraction, equation 4-6.  
ߗௌெெ஻,஽ሺݐሻ ൌ ቎
݀௫ ൌ 0
݀௬ ൌ 0
݀௭ ൌ 	1.5 ݉݉
ܳு ൌ 0.70 ݉ܮ ݏ⁄
ܳா ൌ 0.10 ݉ܮ ݏ⁄
ݒ௫ ൌ 0ݒ௬ ൌ 0
ݒ௭ ൌ 3.3 ݉݉ ݏ⁄
቏ 5-23 
No less than 600 droplets are printed. After printing, the cross-linking solution is aspirated 
from the printed droplets. Cell-laden droplets are rinsed with fresh medium, separated into two 
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equal volumes and loaded into HARVs. The HARVS are divided into two experimental groups: 
(1) model microgravity conditioning using RCCS and (2) control group under static conditions.  
Model microgravity conditioning begins when HARV is secured to RCCS and the rotation 
rate is set to maintain cell-laden droplets in circular orbits (not sinking to the bottom of the HARV 
or colliding with the sides or top of the vessel). Rotation rate is adjusted between 16-18rpm. Figure 
5-26 presents light microscope images of printed 200nL droplets embedded in 0.5% (w/v) sodium 
alginate. ImageJ analysis of fabricated droplets measured the cross-sectional area. The volume and 
diameter of the droplets are calculated to be 219 nL +/- 29 nL and ∅746 µm +/- 32 µm, respectively. 
After printing, cell-laden droplets are circular in the planar view of the light microscope. After 14 
days in RCCS culture, both 1G and µG, circular droplets are found in the culture under light 
microscope inspection. Viable cells are present in printed droplets after 14 days. Cell-laden droplets 
are incubated with Live/Dead (Invitrogen) stain to fluorescently label live cells green. Figure 5-27 
presents fluorescent image of live cells embedded in the droplet.   
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Figure 5-26: SMMB printed 200 nL cell-laden alginate droplets less than 1 day after printing 
(day 1) and day 14 after culture in a static (1G) and rotating (µG) high aspect rotary vessel 
(HARV). Calibration mark is 500µm in all images.  
 
Figure 5-27: SMMB printed Hep-G2 laden droplets after 14 days in culture stained with 
Live/Dead fluorescent probe. Viable cells observed embedded in droplet.  
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5.4.3 Effect of model microgravity on printed liver model 
5.4.3.1 Hepatocyte cell area increased after 48 hrs in model microgravity 
The model microgravity environment has a significant impact on cell volume and drug up-
take. Increase in cell volume in environments without a gravity vector have been well documented 
in literature (Kasper & Xun, 1996; Ross, 1993). It is possible the increase in cell volume causes an 
increased ability to up-take drug (as observed). However, increased volume alone would not 
increase the cell’s ability to metabolize the drug.  
After 48 hrs, HepG2-laden droplets are collected from the HARV for analysis. Cells are 
fixed and alginate is solubilized after 60 minutes 4°C incubation with 4% paraformaldehyde and 
gentle agitation. Cell are labeled with biz benzimide and wheat germ algumin to visualize 
morphological changes. The condition of the genetic material in the nucleus, chromatin, is 
determined by a fluorescent labeling of cell nucleus and plasma. The chromatin is labeled by biz 
benzimide and plasma is labeled using wheat germ algumin. The size of the cell is analyzed from 
the wheat germ algumin staining of the cell cytoplasm.  
Cell area is measured using photographs of the fluorescently labeled cells and analysis 
software ImageJ (NIH). Cell solution are suspended in low density to prevent aggregation of cells 
in images and placed on microscope slides with cover. Using the ImageJ software, each image is 
calibrated to a scale watermarked during imaging, converted to 8-bit, threshold to highlight only 
structures relevant to imaging, and analyze particle area. Figure 5-28 presents the fluorescent image 
of HepG2 recovered from printed alginate droplets after 48hrs conditioning in model microgravity 
(A) and controls (C). Fluorescent images are converted to binary (A converted to B and C converted 
to D, respectively) by ImageJ for analysis. The area of each particle is calculated from pixel count 
and a calibration bar watermarked during imaging.  
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Figure 5-28: HepG2 cell cytoplasm staining by fluorescent probe after 48hrs in RCCS model 
microgravity (A) and static controls (C). Fluorescent images are converted to gray scale for 
particle count and area quantification of each cell.  
The diameter of the cell (cytoplasm) and nucleus (chromatin) are calculated from the 
measured particles, equation  5-24 and  5-25. Size of cytoplasm and nucleus is determined for at 
least 300 cells. A histogram of cytoplasm and nucleus sizes (approximated as diameter) shows no 
significant impact on nucleus diameter, figure 5-28. Cell nucleus is not significantly affected, which 
remains consistent ~ ø4.8um. Cytoplasm histogram presents the different culture condition causes 
a shift from 7 µm for ground model to 9µm for model microgravity conditioning, figure 5-29. The 
spread of cytoplasm diameters around the model microgravity’s 9µm mean is narrower than the 
spread around the control’s 7µm mean diameter. The results of model microgravity vs ground 
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controls are summarized as follows: The mean cell cytoplasm diameter increases from ~ø7um to 
~ø9um. Change in diameters produces a 60% increase in total cell volume.  
ܦ௡௨௖௘௟௨௦ ൌ 2ටܣ௠௘௔௦௨௥௘ௗ,௖௛௥௢௠௔௧௜௡ ߨ⁄  5-24 
ܦ௖௬௧௢௣௟௔௦௠ ൌ 2ටܣ௠௘௔௦௨௥௘ௗ,௖௬௧௢௣௟௔௦௠ ߨ⁄  5-25 
 
Figure 5-29: Diameter of HepG2 nucleus cell after 48hrs in model microgravity.   
 
Figure 5-30: Diameter of HepG2 cell after 48hrs in model microgravity. 
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5.4.3.2 Urea concentration increased in co-culture and model microgravity 
Model microgravity and co-culture both increase the concentration of urea in supernatant. 
Model microgravity has a stronger effect than co-culture. Effect of 48 hours model microgravity 
conditioning in RCCS and co-culture on urea production, as presented in figure 5-31. The 
concentration of urea is greater in co-culture of hepatocytes and endothelial cells than mono-
cultures of hepatocytes alone. This observation is consistent with previous finding in HepG2-laden 
microcarriers in model microgravity presented in section 5.4.1 rationale for the study and has also 
been reported in literature (K. Kim, Ohashi, Utoh, Kano, & Okano, 2012). The concentration of 
urea is greater after 48 hours of model microgravity both mono- and co-culture cell models than 
1G controls. This observation has also been reported in literature (Baqai et al., 2009a). 
 
Figure 5-31: Effect of 48 hours model microgravity conditioning in RCCS and co-culture on urea 
production.  
5.4.3.3 Metabolic rate up-regulated in co-culture and model microgravity 
Model microgravity conditioning and co-culture with endothelial cells up-regulates 
hepatocytes’ metabolic rate in vitro.  Co-culture is a more significant factor than model 
microgravity to increase metabolic rate. Mono- and co-culture droplets are collected from HARV 
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after 14 days of either 1G (static) and model microgravity (RCCS culture) conditioning.  Fresh cell 
culture medium with 10% (v/v) Alamar blue (Serotec) is added to the recovered cell-laden droplets. 
Cells metabolize Alamar blue to excitation/emission of 535/595 nm. The rate of the reaction 
depends on cell number and the metabolic activity of the cells. Both hepatocytes and endothelial 
cells convert Alamar blue to the product detected by the excitation/emission stated. Figure 5-32 
presents the excitation/emission detected by fluorescence protocol of the Tecan GENios microplate 
reader over the reaction time. Reaction time begins when the Alamar blue is added to the cell-laden 
samples recovered from HARV after 14 days. Metabolism of Alamar blue is an indicator of viable 
cells. The rate of metabolism quantifies both (1) cell number and metabolic activity. The 
consequence of mono- vs. co-culture and 1G vs. model microgravity conditioning effects metabolic 
rate. However, this effect can be generally attributed to the experimental variable and not 
specifically to increased cell number or alteration in an individual cell’s capacity to metabolize the 
Alamar blue. The results are as follows.  
The experiment yielded a data set including time and excitation/emission RFU coordinates 
measured by the microplate reader. The measured metabolic rate (RFU/min) is determined from 
the experimental data and presented for comparison between experimental groups in table 5-3. Data 
is analyzed as a simple linear regression using least square fitting. The generalized function to 
corelate excitation/emission RFU of metabolized alamar Blue and time in minutes is presented in 
equation  5-26.  
ݕሺܴܨܷሻ ൌ ߚ଴ ൅ ߚଵݔ ሺ݉݅݊ሻ 5-26 
The detected fluorescent signal increases during the reaction time, as the cells metabolize 
the Alamar blue. The metabolism rate for mono-culture droplets in 1G and model microgravity are 
38 and 44 RFU per minute, respectively. The metabolism rate for co-culture droplets in 1G and 
model microgravity are 330 and 530 RFU per minute, respectively. Co-culture increases the 
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metabolic rate of cell-laden droplet by one order of magnitude. 1G of model microgravity 
conditioning increases metabolic rate by less than 40% for co-culture and less than 15% for mono-
culture. This effect of model microgravity and co-culture is generally attributed to increase 
metabolic rate. Increases in total cell number and alterations to the individual cell’s capacity to 
metabolize Alamar blue are considered to be the causes of the observed results. However, which 
of the causes are specifically responsible cannot be identified based on the presented results. The 
observed behavior is a consequence of co-culture and model microgravity. Therefore, the presented 
sensitivity has applications to the design of biomimetic pharmacokinetic and space life science 
models.  
 
Figure 5-32: Effect of 14 day conditioning to model microgravity using RCCS and co-culture of 
HepG2 and endothelial cells on metabolic rate of Alamar Blue. Reaction time measured from the 
time Alamar Blue is added. Em/Ex detects metabolized Alamar blue.   
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Table 5-3. Metabolic rate to convert Alamar blue to product in mono- and co- culture and 1G and 
model µG gravitational conditions.  
Culture 
Condition 
Gravitational 
Condition 
Metabolic Rate (RFU/min) 
(estimated by linear regression) 
Linearity 
Mono 1G 38 0.76 
Mono ߤܩ 44 0.81 
Co 1G 330 0.90 
Co ߤܩ 530 0.98 
 
5.4.3.4 Cell-laden droplet modulus increased after 14 days in model microgravity  
Modulus of printed mono- and co-culture nano-liter droplet measured by Nanoscope atomic 
force microscope (AFM) analysis of force volume using contact mode.  Mechanical testing for 
elastic modulus by AFM contact mode to measure deflection in sample (Lin, Shreiber, Dimitriadis, 
& Horkay, 2009). Modulus is calculated using the Hertz model of indentation and known 
mechanics of the cantilever.  Hooke’s law defines the force applied to the sample as a function of 
the cantilever spring constant and indentation, as presented in equation 5-27.   
ܨ ൌ െ݇ߜ 5-27 
The Hertz model defines the force on the sample as a function of the sample’s modulus and 
geometric parameters of the cantilever. Contact between the spherical tip cantilever and sample is 
modeled as shallow contact between two spherical bodies, as presented in equation 5-28 .   
ܨ ൌ 43
ܧ௦௨௥௙௔௖௘ ߜଷ/ଶ
൫1 െ ߥ௦௨௥௙௔௖௘ଶ ൯ඥ
ܴ௧௜௣ 5-28 
The measured indentation is the difference between the cantilever deflection and sample 
movement, as presented in equation 5-29.  
ߜ ൌ ݖ െ ݀ 5-29 
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Nanoscope analysis of the force volume from AFM contact mode generates height images 
and force plots of the spherical cantilever tip on the printed cell-laden nano-liter droplet, figure 5-
33. The spring constant and spherical tip radius of the cantilever are 2.8 N/m and 8.0 nm 
respectively. Test parameters are 1000nm z-display, retract z-direction, 34.274 nm/V deflection 
sensitivity, 0.9965 Hz scan rate, 1.816 µm ramp scale, 0.5 Poisson’s ratio and include adhesion 
forces. Software reports force plots of the cyclic extension-retraction of the cantilever on the printed 
mono- and co-culture nano-liter droplets after 14 days in model microgravity.  
 
Figure 5-33: (Left) AFM contact mode height image of spherical tip cantilever on printed cell-
laden nano-liter droplet. (Right) Force plot of cyclic extension-retraction of cantilever on printed 
mono- and co-culture nano-liter droplet using Nanoscope atomic force microscope.  
Mean modulus of co- and mono-culture printed nano-liter droplet after 14 days in model 
microgravity are 63.4 +/- 20.5 MPa and 48.8 +/- 15.2 MPa, respectively, figure 5-34. The mean 
mono-culture modulus is 77% of the co-culture modulus. Hepatocyte-endothelial co-culture 
increases micro-organ modulus compared to mono-culture. Extracellular matrix provides 
mechanical support and regulatory information (Conway & Schaffer, 2012). Matrix material and 
cell to cell contact produce biomimetic cell junctions and barrier to mass transfer, specifically 
nanoparticle diffusion (Horev-Azaria et al., 2011). 
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Figure 5-34: Probability distribution function of printed mono- and co-culture nano-liter droplet 
Young’s modulus after 14 days in model microgravity.  
5.4.4 Drug elimination rates and half life  
The objective of the drug up-take characterization on printed co- and mono-culture cell 
models is to quantify drug depletion as a function of time. The study is significant to 
pharmacokinetic rates in model microgravity for pharmaceutical dosing during long term manned 
space exploration. The drug EFC (7-ethoxy-4-trifluoromethyl courmarin) is selected because 
EFC’s fluorogenic probe properties are favorable for detection using a microplate reader. EFC is 
converted by protease activity inside the cell to drug product HFC (7-hydroxy-4-trifluoromethyl 
courmarin). EFC includes an acetone group, which allows the drug to penetrate the cell membrane 
for up-take. The acetone group is cleaved by protease inside either the cell’s mitochondria or 
endoplasmic reticulum. The protease convert the EFC to the metabolized HFC form. The 
metabolized drug HFC resides inside the cell and is not detected in the culture’s effluent without 
cell lysis.  Therefore, the presented method is effective quantify EFC depeletion but not the 
synthesis of metabolized drug.  The experimental plan included the following tasks: (1) fabricate 
200 nL droplet laden with heaptocyte and endothelial cells with volume fraction of 7:1. (2) Culture 
cells in model microgravity using rotary cell culture system for 48 hours and add EFC drug. Both 
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model microgravity and ground 1G control groups are stored with the same volume of culture 
medium in high aspect ratio vessels. (3) Collect effluent over 9 hours to quantify the concentration 
of extracellular unbound EFC remaining in culture. (4) Empirically define the first order elimnation 
rate of EFC by the printed co-culture model. Equation 5-30 mathematically defines the rate constant 
݇, as a function of the time ݐ௜, intial concentration of drug ܥ଴, and concentration of drug measured 
at time ݐ௜ to be ܥ௜. The intial concentration of drug is 120 µM EFC concentration.  The first order 
elimination rate is presented in equation 5-30 as a function of the rate, ݇, intial concentration, ܥ଴, 
a second concentration, ܥ௜, and the time lapsed between the intial and second concentration, ݐ௜. 
݇ ൌ െ 1ݐ௜ ݈݊ ൤
ܥ௜
ܥ଴൨ 5-30 
The EFC half life for comparison between the model microgravity and ground control (not cultured 
in rotary cell culture system) conditions is determined from the experimental time course data. 
Equation  5-31 defines the half life of the drug ݐଵ/ଶ as a function of the rate constant ݇.	 
ݐଵ/ଶ ൌ ݈݊ 2݇  5-31 
Figure 5-35 presents the depletion of EFC in effleunt by printed co-culture after 48 hours in 
high aspect vessels after 48 hours in rotary cell culture to mode microgravity or without to model 
ground 1G as a control. The EFC is removed from the effluent as the cells up-take drug or connvert 
the drug to metabolized form.  The half life of EFC in model microgravity is 1.0 hour and 1.9 hours 
in 1G ground control, as presented in table 5-4.  
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Figure 5-35: Deplation of EFC in effluent by printed co-culture in model microgravity and 
ground 1G conditions 
Table 5-4. EFC half life with printed co-culture of hepatocytes and endothelial cells cultured in 
high aspect ration vessels and conditioned to model microgravity using a rotary bioreactor system 
of maintained as a control of 1G without the bioreactor system.  
Culture 
Condition 
Gravitational 
Condition 
EFC Half Life 
(hours) 
Co 1G 1.9 
Co ߤܩ 1.0 
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CHAPTER 6: CONCLUSION 
6.1 Summary 
Chapter 2 develops 3D printing and replica molding processes to fabricate interconnected 
and hierarchical structural environments for cell culture. Two different 3D printing and replica 
molding processes are introduced: (1) a precision extrusion deposition and replica molding process 
to produces microfluidic networks and (2) a multi-nozzle deposition and freeze casting process to 
produce hierarchical tissue scaffolds.   Both 3D printing processes integrate a 3D motion system 
with a continuous extrusion material delivery system to print patterns of the extruded filament. 
Internal features and external surfaces are explicitly assembled due to the layer-by-layer 
construction of the printed pattern. The 3D printing process parameters control the macro-scale 
structure of the printed pattern/void space (10-3-10-1 m resolution) and extruded cross-section’s 
shape and size (10-4-10-3 m). Once fabricated, the printed pattern is embedded in a liquid-phase of 
a secondary material, which is subsequently cured. The composite printed pattern/ secondary 
material is either directly used or the printed pattern is removed, leaving a template of open 
channels or pores. Cell-material attachment is presented. The presented processes introduces the 
capability to fabricate 3D hierarchical, composite or porous/open channel architecture for scaffold 
guided tissue engineering.  
Chapter 3 integrates the advanced biomanufacturing techniques developed in chapter 2 to 
fully construct a hetero-cellular microfluidic devices for drug efficacy applications.  3-dimensional 
open channel networks fully embedded in PDMS are fabricated by precision extrusion deposition 
(PED) and replica molding. Forced convection through the channels is controlled by additional 
hardware components and a programmable syringe pump. Cell suspension is pumped into the 
device, left static for 12-24 hrs for adhesion and then perfused for nutrient supply/waste removal.  
Alternatively, multi-nozzle deposition (MND) for hetero-cellular seeding throughout the network 
and in channel cross-section defines the position of cell types, support material and matrix. 
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Applications of the system include space life science in vitro models to study radioprotective pro-
drug efficacy in co-culture. Hetero-cellular contact is controlled by forced convection through a 
multi-chamber co-culture microfluidic device. Cell-laden devices are stimulated with 
radioprotective drug and radiation exposure to study drug efficacy in co-culture compared to mono-
culture microfluidic devices.   
Chapter 4 develops the synchronized multi-material bioprinting (SMMB) system to package 
different cell types and structural matrix material in a heterogeneous array and extrude the 
heterogeneous array along a tool path to build 3D biology-laden structures. The fully integrated 
system includes a 3D motion system, multi-nozzle material delivery system with synchronized 
multi-material deposition head and temperature control system. The 3D motion system is a set of 
three linear slides, each independently controlled by automation software. The motion system is 
used in two ways (1) as a linear build cycle discretizes a design into a stack of 2D tool paths for 
layer-by-layer construction or (2) as a periodic build cycle to control the accumulation and 
dispensing of a predetermined material volume. The multi-nozzle material delivery system with a 
synchronized multi-material deposition head packages tissue matrix material-laden with cells and 
complementary support material in a heterogeneous array. The heterogeneous array is extruded 
along a tool path to produce a pattern (linear build cycle) or controlled total volume with constituent 
volume fractions of the component materials is dispensed (periodic build cycle). The resolution of 
internal features of the heterogeneous array is 10-5-10-3 m, which improves the motion system’s 
extruded filament patterning capability of 10-3-10-1 m.  Additional nozzles containing other 
heterogeneous arrangements, support material or crosslinking agents are each is independently 
controlled by automation software. A temperature control system expands the feasible set of tissue 
matrix materials to include thermally cross-linked materials such as Matrigel and collagen. The 
effect of the process on cell viability is presented.  
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Chapter 5 characterizes the synchronized multi-material bioprinting system’s controllability 
and capability to fabricate heterogeneous nano-liter droplets and   104-10-3 m diameter printed 
filaments. Applications of the system include space life science in vitro models to study metabolic 
rate and drug efficacy in co-culture. Printed hetero-cellular droplets are loaded into high aspect 
ratio vessels and conditioned to weightlessness using a rotary cell culture system to study drug 
metabolic rate in model microgravity.    
Conclusions of the conducted research and recommendations for future work are presented 
in Chapter 6.  
6.2 Research contributions 
The research contributions are summarized as follows: 
1. Development of a combined precision extrusion deposition/ replica molding process to 
fabricate a 3-dimensional open network of channels embedded in a PDMS substrate for 
use as a cell-laden microfluidic device. To define a 3D printing and replica molding 
processes to fabricate microfluidic and scaffold environments with control of the macro-
scale (10-3-10-1 m) patterning of channels/structural elements and micro-scale (10-4-10-3 m) 
channel cross-section of internal features.  
2. Development of a novel synchronized multi-material bioprinter to package multiple 
solutions as a heterogeneous combined flow prior to deposition as a printed pattern or nano-
liter droplet. To develop and characterize an integrated synchronized multi-material 
bioprinter system to produce nano-liter droplets and 10-4-10-3 m diameter filaments with a 
heterogeneous packaging resolution of 10-5-10-3 m.  To characterize the integrated 
synchronized multi-material bioprinter system to produce nano-liter droplets and 10-4-10-3 
m diameter filaments with a heterogeneous packaging resolution of 10-5-10-3 m. 
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3. For the first time, print a co-culture model of liver to study the rate of drug up-take in model 
microgravity using a rotary cell culture system. To apply the synchronized multi-material 
bioprinter system to produce hetero-cellular models to study radioprotective drug efficacy 
in co-culture and metabolism rates in simulated weightlessness environments.   
6.3 Future research recommendations 
The work presented in this thesis can be improved to include application in self-organizing 
architecture, built-biological system to capture infection agents and models of accelerated cell 
metabolism to condense the time course required to understand the effect of drug or soluble cues 
on in vitro cell models. Following research tasks have been outlined for future research and 
development. 
6.3.1 Self-organizing architecture 
Dormant inert materials such as metal, ceramic and plastic continuously weaken until failure 
during their useful life. Over time, mechanical fatigue, thermal stress and chemical erosion cause 
crystallographic defects to grow into cracks. Failure due to fracture occurs when cracks reach a 
critical length and propagate catastrophically through the structure. The cost of fracture was 
estimated to be $119 billion in 1982, despite evaluation and maintenance techniques to detect and 
repair cracks(Anderson, 1991). The estimated cost does not include injury or loss of life. In contrast 
to dormant inert materials, viable organisms adapt to maintain viability and structural integrity in 
changing physical environments. Biology has adapted to both sense and responds to the physical 
world. Further, organisms self-organize minimize energy spent while maintaining viability.  The 
objective of the proposed future work is to blend dormant inert materials with viable organisms 
using advanced manufacturing techniques to produce self-organizing adaptable architecture.  
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Living organism’s ability to sense and respond to mechanical force and structural cues has 
application to adaptable building material applications. Organisms have the potential to (1) self-
regenerate and proliferate to maintain the viability of a colony over time-scales longer than that of 
an individual constituent organism, (2) re-organize to optimize energy conservation(Nakagaki, 
Yamada, & Toth, 2000) and structural integrity of the collective colony, and (3) leverage a large 
number of individual entities over long time scales to accomplish statistically low probability 
events(Tarabichi et al., 2013) – one example being Darwinian evolution.   
Self-organization to maintain the structural integrity of the collective colony is exemplified 
by the plasticity of bone and muscle tissue. Bone and muscle atrophy or increase in strength in 
response to environmental loading to prevent damage to the tissue itself, without unnecessarily 
maintaining energy-intensive structures. Wolff’s Law states the bone in a healthy person remodels 
itself to resist applied loads. Bone is remodeled when cell secrete calcium to increase stiffness. If a 
bone is compressed or bent during walking or running, the mechanical vibrations applied to the 
bone are sensed by cells through signaling pathways connected to the nucleus. Mechanical 
perturbations effect the cell’s gene expression and cause an increase in calcium secretion, which 
produces more bone. Conversely, if the cell is not stimulated, the calcium secretion lessens and the 
bone atrophies. 
This future work has applications to NASA’s ground-based research to engineer self-
organizing adaptable architecture to ensure the health and security of humans beyond Earth’s 
surface in isolated and resource-limited environments. This work is aligned with NSBRI’s Human 
Factors and Performance science and technology team’s interest to mitigate habitability and 
environmental risks to mission success. The deliverable countermeasure to prevent the loss of 
structural stability of components during extraplanetary flight is adaptable self-regenerating 
architecture. Architecture constructed from viable organisms has the potential to regenerate, self-
organize and therefore repair after damage or fatigue. Truly adaptive self-healing built biological 
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systems diminish mission dependency on spare parts in the payload. Further, self-organizing 
architecture (such as bone or muscle tissue) is capable of automated adjustments in response to 
gradual alterations in load magnitude and direction without manual intervention by a human 
operator or crew. Automated adjustment by adaptable self-healing architecture lessen the existing 
dependence on non-invasive diagnostic measures to identify damaged and fatigued components 
prior to failure. Further, it is aligned with DOE’s 2013 Report to Congress, for which Rothschild 
represented NASA’s interests. 
The highest priority is placed on safety and mission assurance, occupational health and 
environmental protection of the public, astronauts and NASA work force. The Human Research 
Roadmap’s presents the following management architecture to prepare countermeasures against 
the effects of the space environment; evidence, risk, gap, task and deliverables. Space factors and 
habitability specifically solicits countermeasures to mitigate the risk of inadequate critical task 
design. To this end, passive adaptability and plasticity of structures and components to re-generate 
over the course of a mission bolster success in isolated resource-limited environments. The risk of 
component failing without a replacement during a mission is well recognized and increases with 
mission length. This proposed future research offers a countermeasure to increase the adaptability 
and flexibility of the built environment NASA provides astronauts during their mission. Consider 
the following risks to mission success:  
1. A component loses structural integrity during service due to cyclic stress from loading, 
temperature gradients and radiation: Conventional inert materials weaken over time as cracks 
within the part grow due to environmental forces. This requires routine 3-dimensional non-
invasive imaging to detect cracks before catastrophic failure. An adaptable built biological 
system will proliferate, migrate and secrete extracellular signals over time to maintain 
structural integrity by self-organizing to alleviate stress concentration within the architecture. 
Bone is such an example.  
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2.  A replacement component is required due to failure during an extraplanetary mission:  
NASA’s missions are engineered with interchangeable parts and operations defines which and 
how many spare components are included in the payload for such an event. However, the type 
and number of spare parts is limited by the risk of the failure and the expense of additional 
cargo. An alternative solution to redundant cargo is self-healing components. The damaged 
component does not have to be completely repaired or replaced. Imagine the damaged 
component is removed from service, a percentage of the structure is repaired and the colony of 
organisms replenished. The organisms recognize structural and mechanical cues from their 
environment and grow/align themselves to a homeostatic configuration. At which point, the 
component may be placed back in service.   
3. Additional or new components are required during the course of a long term manned space 
exploration or colonization of a non-Earth habitat: The biomanufacturing method to assemble 
structural elements and organisms in 3-dimensional space is a portable technology. A reservoir 
colony of the organism is also a portable material with the potential for expansion. Additional 
or new components can be fabricated on site by printing a porous set of structural elements and 
allowing the organisms to grow over and through the structure as a guide.  This enable modular 
design for large-scale construction of shielding or dwellings. The organisms are capable of 
integrating between fabricated components to diminish sole dependence on hardware as a 
fastener.  
6.3.2 Built biological system to diminish the spread of infection disease 
The infection disease schistosomiasis (affects 160 million people, mainly in Sub-Saharan 
Africa) is caused by unsanitary excreta disposal. One method to fight infection disease is to prevent 
the spread of the infection, or in the case of schistosomiasis, contain or dehydrate human 
waste.  Physical barriers exist to capture infectious agents. However, species of organisms also 
exist which capture infectious agents; either through detainment (the capturing organisms kills or 
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immobilizes the infectious agent) or attraction (the infection agent prefers the environment of the 
capturing organism). Advanced manufacturing and biology may have a role to fight the spread of 
infectious disease. The density of organisms can be controlled using built biological systems. If (1) 
a target infectious agent and capturing organism pair can be identified (Both must be indigenous to 
a geographic region) and (2) the capturing agent's density can be controlled using a built biological 
system to a point where it significantly contains the infectious agents then (3) engineered biological 
systems are an enabling technology to contain (and by causality, fight) infectious disease. This 
work may have NASA applications to prevent the spread of biological agents between regions of 
space craft or more broadly between Earth to space.  
6.3.3 Accelerate drug/cell interaction to condense experiment length  
Cell volume and metabolic rate are related in python (Riquelme et al., 2011). University of 
Colorado professor Leslie Leinwand of the Molecular, Cellular and Developmental Biology 
Department reported to the journal Science in October of this year cardiac cells double in size 
(hyperrophy) during digestion in burmese pythons. Snakes require this increased cardiac capacity 
because they consume very large quantities. The signal for cardiac cells to double in size is a mix 
of three fatty acids. The University of Colorado group demonstrated the relationship between the 
fatty acids and heart cell doubling in size using mice. Cardiac cells are shown to physically and 
functionally respond to the three fatty acids identified in the study.  This finding may be significant 
to pharmacokinetic work to drug metabolism in microgravity. Research already exists to 
demonstrate cell volume increases in microgravity. This recent work links cell volume increases to 
changes in metabolism, which supports microgravity environment alters drug 
metabolism.  Additionally, manipulating the concentration of the presented fatty acids could speed 
up cell’s metabolism to observe the effect of drugs or soluble cues in condensed time lines. 
Meaning, the effect of a drug on a cell model over years might be modeled over months or weeks 
using an accelerated metabolism.  
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6.4 Concluding remarks 
The novel synchronized multi-material bioprinter integrates microfluidic techniques with 
cell printing to package multiple cell-laden materials and cross-linking solutions along a 3-
dimensional tool path. Biomimetic assembly to support cell viability in vitro and solicit 
paracrine/autocrine signaling between cells presents methodological progress to guide the cell 
aggregate to perform tissue-level function; with application to tissue engineering and general built 
biological constructs.  Bioprinting is an enabling technology to engineer built biological systems.  
Interfacing biology and architecture in built biological systems with reproducibility and 
engineering process control requires advanced manufacturing(W. Sun et al., 2004). Bioprinting is 
a computer aided manufacturing method with process control over (1) macro-scale (10-3-10-1 m) 
architecture and (2) micro-scale (10-4-10-5 m) heterogeneous packaging of components and internal 
features. Macro-scale architecture is critical if the built biological system is designed to physically 
fit into a larger system.  Micro-scale heterogeneous packaging of organisms and support artifacts 
is critical to the function of the built biological system. Additional artifacts heterogeneously packed 
with the biology during printing spatial-temporally effect the built system’s mechanics, physics, 
and chemistry. Artifact candidates include - load bearing structural elements(Hamid et al., 2011; 
Shor et al., 2007), open porous network for diffusion(S. Khalil & Sun, 2009b), functionalized or 
magnetic nanoparticles (Buyukhatipoglu et al., 2010b), and piezoelectric/conductive components.  
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